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Abstracts From the 25th Annual Health Care Systems
Research Network Conference, April 8–10, 2019,
Portland, Oregon
The Health Care Systems Research Network (HCSRN) is made up of nonprofit health systems
with embedded research departments whose scientists are dedicated to public domain research.
The network’s annual conference serves as a forum for research teams to disseminate study
findings, stimulate new collaborations, and share insights about conducting research in realworld care settings. Abstracts accepted for presentation at HCSRN 2019 are published in this
supplement of Journal of Patient-Centered Research and Reviews, the official scientific journal
of the conference. (J Patient Cent Res Rev. 2019;6(1):52-126.)

IMPLEMENTATION SCIENCE
OA1.01
Sustainment of Lean Redesigns for Primary Care
Teams
Dorothy Hung,1 Caroline Gray,2 Quan Truong,1 Michael
Harrison3
Palo Alto Medical Foundation Research Institute, Palo
Alto, CA; 2VA Palo Alto Health Care System, Menlo
Park, CA; 3Agency for Healthcare Research and Quality,
Rockville, MD
1

Background: Quality improvements are notoriously
followed by “backsliding” or relapse to the status quo.
Although implementation of quality initiatives is well
studied, there is less research on sustaining changes. This
mixed-methods study examined the sustainment of Lean
workflow redesigns for primary care teams several years
after being introduced in a large, ambulatory care delivery
system.
Methods: We conducted qualitative interviews of 57
organizational leaders and primary care providers, and fielded
surveys to 1164 frontline physicians and staff in 17 primary
care clinics across the system. We analyzed interviews and
conducted independent sample t-tests to identify key factors
facilitating the sustainment of new workflows among
primary care teams. All analyses were conducted after Lean
redesigns were implemented and scaled across the system in
3 consecutive phases — first in 1 pilot site, then in 3 “beta”
sites, and finally in all remaining clinics.
Results: We found that the initial approach to implementing
Lean redesigns in each clinic was critical to later
sustainment. Adherence to Lean workflows was highest
in the pilot clinic, despite having the longest postdesign
measurement period. Pilot members reported having the
highest levels of participation in designing workflows, were
52
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most highly engaged in quality improvement efforts, and
held most favorable beliefs about Lean changes. Adherence
to redesigns was lowest among those in the second beta
phase of implementation; these members also reported
highest levels of burnout. Overall facilitators of sustainment
included active engagement of staff in designing new
workflows, favorable beliefs about Lean changes and use
of Lean management tools, and availability of time for
improvement activities.
Conclusion: This study of Lean sustainment highlights the
importance of early approaches to implementing change in
primary care clinics. Our findings reinforce the important
role of employee participation in design efforts, use of
supportive management tools, and staff identification with
organizational goals. Additional time and effort is required
to fully involve staff in design efforts, but these time
investments will likely help secure buy-in and adherence for
the long term. Transformation of these core elements will
facilitate the sustainment of Lean and similar innovations
among primary care teams.
OA1.02
Implementation of a Direct-Mail FIT Program in
Federally Qualified Health Centers: Screen to
Prevent Colon Cancer (STOP CRC)
Edward Meich,1 Beverly B. Green,2 Jennifer L.
Schneider,3 Sally Retecki,4 Tanya Kapka,4 Jennifer
Coury,4 Erin Keast,3 Gloria Coronado,3 Amanda Petrik5
Regenstrief Institute and Indiana University Center for
Health Services and Outcomes Research, Indianapolis, IN;
2
Kaiser Permanente Washington Health Research Institute,
Seattle, WA; 3Kaiser Permanente Center for Health
Research, Portland, OR; 4CareOregon, Portland, OR;
5
Kaiser Permanente Northwest, Portland, OR
1
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Background: Evidence-based interventions can only
be effective if successfully implemented; yet, little
is known about the organizational factors that drive
implementation success. Screen to Prevent Colon Cancer
(STOP CRC), a randomized, pragmatic trial of a mailed
fecal immunochemical test (FIT), is aimed at increasing
colorectal cancer screening in 8 health centers in Oregon
and California. The intervention improved rates of screening
overall, yet substantial variation was observed in the extent
that health centers implemented the intervention (ie,
percentage of eligible adults who were mailed a FIT).
Methods: We evaluated drivers of implementation success
in the inner and outer settings. We categorized the 8 health
centers as having high, medium, and low implementation
levels based on the proportion of eligible patients mailed
a FIT. We applied configurational comparative methods
(CCMs) to look across all program and clinic components
and identify the implementation conditions with the
strongest connections to implementation outcomes.
Qualitative comparative analysis and coincidence analysis
were used in R© software. Using prior theoretical knowledge
to assess this condition-level output, we identified a handful
of factors that could distinguish between high, medium, and
low implementation success.
Results: CCM analyses identified a 2-factor solution that, in
combination, perfectly distinguished high vs medium vs low
implementation with 100% consistency and 100% coverage.
The 2 factors were centralized processing level (values: high;
mixed) and separate intro letter (values: yes; no). Health
centers with high levels of implementation had centralized
staff and mailed the introductory letter separate from the FIT
kit. Health centers with medium levels of implementation
had 2 solution pathways for 1) the combination of centralized
processing level = mixed AND separate intro letter = yes; or
2) the combination of centralized processing level = advanced
AND separate intro letter = no.
Conclusion: A centralized staffing model may have provided
protected time for staff to implement the program. The mailing
of an introductory letter separately from the FIT kit may have
reflected a strong commitment to deliver all components
of the program and maximize its effectiveness. Contrary to
expectation, staffing changes, clinic growth, and training
attendance did not predict implementation success. Applied
use of CCM analyses can produce actionable findings to
guide implementation and improve health care delivery.
OA1.03
Results From a Randomized Trial Comparing
Strategies for Helping Community Health Centers
Implement Guideline-Concordant Cardioprotective
Care
Rachel Gold,1 Arwen Bunce,2 Stuart Cowburn,2 James
Davis,1 Joan Nelson,2 Deborah Cohen,3 James
Dearing,4 Michael Horberg1

Supplement

Kaiser Permanente Northwest, Portland, OR; 2OCHIN,
Portland, OR; 3Oregon Health & Science University,
Portland, OR; 4Michigan State University, East Lansing, MI
1

Background: Statins can reduce cardiovascular disease
(CVD) risk in patients with diabetes (DM), but statin
prescribing often lags behind care recommendations. We
compared how 3 increasingly intensive implementation
strategies impacted community health centers’ (CHCs)
adoption of electronic health record (EHR) clinical
decision support tools targeting guideline-concordant statin
prescribing in DM. The EHR tools (the “CVD Bundle”)
were adapted from a previously successful intervention.
Methods: In this mixed-methods, pragmatic trial, 29 CHCs
from the OCHIN network were randomized to 3 arms, each
of which received differing implementation support: 1)
implementation toolkit (CVD Bundle use instructions; QI
practice change techniques); 2) toolkit + 2-day in-person
training with follow-up webinars; or 3) toolkit, training,
webinars, plus practice facilitation. More than 300 additional
OCHIN CHCs received no implementation support and were
considered a control arm. The intervention occurred in July
2015. Using EHR data, we measured statin prescribing (per
2014 Joint National Committee and 2015 American Heart
Association/American Diabetes Association guidelines)
from 14 months preintervention through 34 months
postintervention. We gathered qualitative data from the
randomized CHCs via on-site observations and interviews,
and regular phone calls.
Results: Statin prescribing trends increased from pre- to
postintervention for all arms, but only arm 2 demonstrated
a statistically significant change in trend compared to the
control arm. Observed prescribing rates improved more
in the study CHCs (7.3%, 8.3%, and 5.0% for arms 1, 2,
and 3, respectively) compared to the control arm (3.4%).
However, these differences did not follow an additive
pattern. Qualitative data suggest these results can be
explained by variation in staff EHR skills and leadership
engagement; CHCs’ practice-change culture; and EHR tool
characteristics, which diminished their utility. In addition, the
implementation strategies were not uniformly administered:
the toolkit was infrequently used, webinar attendance was
poor, staff turnover diminished training impacts, and few
arm 3 clinics were prepared to “use” facilitation.
Conclusion: Commonly used implementation strategies
resulted in minor improvement in CHCs’ guidelineconcordant cardioprotective prescribing. Level of
implementation support appeared less impactful than
individual clinics’ readiness to make targeted changes.
Guideline dissemination efforts should start with
formative evaluation of adopters’ needs/preferences so that
subsequently deployed implementation strategies are met
with receptivity.

www.aurora.org/jpcrr
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OA1.04
Research Impact Optimization: Building on Existing
Research Impact Assessment Frameworks
Visanee Vicky Musigdilok,1 Brian Mittman,1 John
Ovretveit2
Kaiser Permanente Southern California, Pasadena, CA;
Karolinska Institutet, Stockholm, Sweden

1
2

Background: Interest in systematic assessment of research
benefits and impacts has grown in response to tightening
of national research budgets and increased calls for
accountability in government spending. Multiple research
impact frameworks have been introduced, ranging in
breadth and specificity and the types of impacts included.
We synthesized existing models to develop a comprehensive
research impact pathway to 1) help researchers identify
potential impacts in advance and guide actions to maximize
realization of potential impacts, and 2) facilitate better
understanding and achievement of research impacts for
health system-based, health system-focused research
conducted within a learning health care system.
Methods: We identified and synthesized existing research
impact frameworks, reviewing the impact domains and metrics
included and the underlying models depicting mechanisms or
pathways of impact. The synthesis includes a fully elaborated
research impact pathway relevant to health-related research
and its impacts on key stakeholders and outcomes.
Results: The synthesized framework organizes research
impact into 7 categories, incorporating the domains and
structure most current models include to depict research
output and uptake as well as a second dimension to address
research implications for health care policy and practice.
The framework covers quantifiable deliverables (eg, journal
publications and grants) and depicts how research findings
can lead to changes in multiple settings and levels to affect
patient, provider, health system, and national-level policies,
practices, and outcomes. Metrics are listed for all 7 categories,
presented as broad descriptions. This approach allows
researchers to identify and categorize expected outputs and to
understand and facilitate their likely impact pathway.
Conclusion: Improved understanding of categories,
mechanisms, and pathways of research impact will facilitate
targeted efforts to maximize impacts and benefits, guiding
researchers and other research stakeholders in knowing what
types of actions are appropriate for different types of studies
and anticipating and supporting their potential impacts.
Many studies are “early stage” and will contribute to patient
or system benefits only following significant additional
research. Others can yield benefits in the near term but only
if multiple actions are taken to ensure appropriate responses
by policy and practice stakeholders. Explicit guidance to
maximize impacts through these actions will strengthen
societal return on research investment.
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OA15.01
Novel Approaches to Measuring and Addressing
the Common Challenges of Implementation and
Long-Term Sustainability in SBIRT: Alcohol as a
Vital Sign
Stacy Sterling,1 Thekla Ross,1 Constance Weisner,1
Wendy Lu,1 Sujaya Parthasarathy,1 Felicia Chi,1 Esti
Iturralde1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background: Alcohol screening, brief intervention,
and referral to treatment (SBIRT) is increasingly being
implemented in health systems, but numerous challenges
that can impact efficacy, effectiveness, and sustainability
persist. We focus on challenges to SBIRT implementation
and long-term sustainability and illustrate novel approaches
being used to study them, in the context of a large-scale
alcohol SBIRT initiative in Kaiser Permanente Northern
California (KPNC), a large, integrated health care system.
Methods: The implementation of systematic alcohol SBIRT
in adult primary care in KPNC was informed by an National
Institute on Alcohol Abuse and Alcoholism-funded clusterrandomized implementation trial (ADVISe) of different
modalities of SBIRT delivery. It involves electronic health
record (EHR)-embedded, evidence-based alcohol screening
instruments and clinical decision support tools; medical
assistants and primary care providers (PCPs) trained in
screening, brief intervention (BI) and referral techniques;
and curricula and workflows developed for medical assistant
and PCP training, skills reinforcement, and troubleshooting.
Structures were created for measuring, communicating,
and reinforcing provider- and facility-level EHR data on
screening and BI performance.
Results: The initiative conducts an average of 145,000
alcohol screenings each month (on 86% of adult primary
care patients) and 9500 BIs. Since its adoption in July 2013,
there have been 8.7 million alcohol screenings conducted
and 536,000 BIs delivered. However, there is significant
variation in implementation outcomes (eg, BI rates varying
from 32% to 83% across medical centers and from 0% to
100% among PCPs) across medical centers and clinics and
among PCPs. Little is known about the factors causing this
variability and those contributing to long-term sustainability
of SBIRT. We describe a new approach to studying factors
associated with successful SBIRT implementation and
long-term SBIRT sustainability. Informed by the PRISM
theoretical framework, this mixed-method study uses EHR
data, PCP surveys, qualitative key informant interviews, and
patient interviews to examine intervention-, organizational-,
provider-, environmental-, and recipient-level factors,
including assessments of patient and provider experiences
of BI quality and fidelity.

Supplement

Conclusion: We discuss the challenges to successful
implementation of universal SBIRT in health system settings
and make recommendations for approaches to evaluating
factors associated with its long-term sustainability.
OA15.02
Costs of Program to Mail Fecal Immunochemical
Tests to Medicare and Medicaid Members
Richard Meenan,1 Laura-Mae Baldwin,2 Gloria
Coronado,1 Beverly B. Green,3 Malaika Schwartz,2
Jennifer Coury,4 Amanda Petrik1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Department of Family Medicine, University of
Washington, Seattle, WA; 3Kaiser Permanente Washington
Health Research Institute, Seattle, WA; 4CareOregon,
Portland, OR
1

Background: BeneFIT is a 4-year observational study
of a mailed fecal immunochemical test (FIT) program
implemented by two Medicaid/Medicare health plans in
Oregon and Washington. BeneFIT compares two approaches
to mailing FITs to enrollees: a collaborative model in which
the health plan mails FITs and enrollees return FITs to their
clinics for processing; and a centralized model of direct FIT
mailings to enrollees who return the FITs to a centralized
laboratory for processing. This paper compares Year 1 costs
of developing and implementing the BeneFIT program
across the two models and provides estimates of program
costs per screened enrollee.
Methods: Organizational staff completed activity-based
costing spreadsheets, assigning hours by intervention
activity (eg, test processing) and job-specific wage rates.
Nonlabor costs were from study data. Data matched each
plan’s development and implementation dates in 2015–2016
for Year 1; analyses were performed in 2017.
Results: Plan A (collaborative model) development
costs were $11.5K, most of which were in administrative
activities. Plan B (centralized model) development costs
were $38.7K, with 42% allocated to FIT selection and
mailing/tracking protocol design. Administrative tasks were
similar across plans, although in Plan B, comparatively
higher-paid director-level staff executed such tasks. Year 1
implementation costs were $55.2K for Plan A and $113.2K
for Plan B, reflecting Plan B’s greater enrollee outreach
(8551 enrollees vs 2812). Labor costs were 55% of Plan A
implementation costs, primarily in enrollee eligibility and
processing of returned FITs. Plan B labor costs were 22%
of implementation costs, centered in mailing/tracking and
test processing. Implementation cost per eligible enrollee
was 57% higher in Plan A ($20.81) than in Plan B ($13.25),
reflecting Plan B’s economies of scale. A similar proportion
of completed FITs among screening-eligible patients in both
plans led to a 51% lower cost per completed FIT in Plan B
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($72.75) vs Plan A ($109.73). The 1054 additional completed
FITs generated by Plan B (over Plan A) were produced at an
average additional cost of $55 ($58,073/1054).
Conclusion: Results highlight the cost implications
of adopting a collaborative vs centralized approach to
implementing a health plan-based colorectal cancer
screening intervention within two health plans serving
Medicaid/Medicare populations.
OA15.03
Practice Facilitation to Improve Quality of
Cardiovascular Disease Care in Small Independent
Practices: A Comparative Case Study
Ann Nguyen,1 Allison Cuthel,1 Nancy Van Devanter,2
Thomas Gepts,1 Erin Rogers,1 Carolyn Berry,1 Donna
Shelley1
New York University School of Medicine, New York, NY;
New York University Rory Meyers College of Nursing, New
York, NY
1
2

Background: Practice facilitation (PF) provides expertise
to help primary care practices implement innovative
care processes tailored to local context. HealthyHearts
NYC (HHNYC), funded through Agency for Healthcare
Research and Quality’s EvidenceNOW initiative, tested the
effectiveness of PF on the adoption of the Million Hearts
ABCS cardiovascular disease evidence-based guidelines:
appropriate aspirin use (A); blood pressure control (B);
cholesterol management (C); and smoking cessation (S).
Overall, the intervention implementation led to an increase in
smokers counseled, but there were no statistically significant
effects on A, B, and C. There was some variation, however,
between practices. This study aimed to identify how context
drove the PF process by exploring contextual differences
between practices.
Methods: For this mixed-methods multiple-case study,
data came from purposive sampling of 5 small independent
practices representing 2 that consistently exceeded Million
Hearts targets, 2 that improved from below to above, and 1 that
never met targets. We used quantitative data from electronic
health records, the Change Process Capability Questionnaire,
and surveys of the practice, providers, and staff. We also used
qualitative data from site observations and 15 interviews with
the PF, provider, and staff. Interview guides and coding were
informed by the Consolidated Framework for Implementation
Research. Deductive (theory-driven) and inductive (open)
approaches were used to code interviews.
Results: The practices had contextual differences that
required PFs to tailor their processes. Six themes emerged
that distinguished the practices. At the outer setting,
practices varied in: 1) their reaction to external policies for
payment reform; and 2) diverse immigrant and vulnerable
patient populations. At the inner setting, they varied in: 3)

www.aurora.org/jpcrr

55

communications and relationship between the lead provider
and staff; 4) financial status and focus on incentives; 5)
engagement of the provider with the PF; and 6) prioritization
of competing quality improvement projects.
Conclusion: Despite their size, small independent primary
care practices exhibit characteristics of a complex adaptive
system. Context drives the PF process and thus requires the
process to be substantially tailored to a practice’s context.
PFs should be prepared to align intervention implementations
with practice priorities, be willing to provide out-of-scope
information technology support, and invest time in building
relationships and practice capacity.

risk for interpersonal violence, 67% insufficient physical
activity, 67% social isolation, and 59% stress. Numerous
barriers to SDH documentation were identified, including
how to identify which patients with SDH needs want help
addressing those needs, how to connect patients with SDH
needs to local resources, and complex workflow issues.
Conclusion: To ensure widespread EHR documentation of
SDH needs in primary care CHCs, as is widely recommended,
implementation barriers to such documentation must
be identified and addressed. The results presented here
can inform future efforts to build our understanding of
implementation strategies for SDH data collection in CHCs.

OA15.04
Adoption of Social Determinants of Health EHR
Tools in Community Health Centers

P10.01
Referral to and Use of a Pharmacy-Led Opioid
Tapering Program: Interviews With Clinicians and
Pharmacists

Rachel Gold,1,3 Erika Cottrell,2,3 Stuart Cowburn,3
Miguel Marino,2 Dagan Wright,3 Arwen Bunce,3 Ned
Mossman,3 Marla Dearing,3 Mary Middendorf,3 Katie
Dambrun,3 Inga Gruß,1 Nadia Yosuf,1 Molly Krancari3
Kaiser Permanente Center for Health Research, Portland,
OR; 2Oregon Health & Science University, Portland, OR;
3
OCHIN, Portland, OR
1

Background: Social determinants of health (SDH) are
nonclinical factors, such as housing, food security, and
personal safety, that profoundly impact health risks and
outcomes. Systematically documenting/acting on patients’
SDH data in the electronic health record (EHR) could
help eliminate disparities and promote health equity
within community health centers’ (CHCs) patients, who
are especially susceptible to health impacts from SDH.
However, adoption of EHR-based SDH documentation in
CHCs has rarely been described.
Methods: We developed a suite of EHR tools for documenting
and summarizing patient-reported SDH data and implemented
these tools in OCHIN’s national network of CHCs in June
2016. Descriptive analyses of the tools’ adoption were
conducted using extracted EHR data. Qualitative data were
collected from 8 CHC organizations with high tool-adoption
rates, and content analysis was conducted.
Results: When the EHR’s SDH tools went live in June
2016, 489 CHCs were on OCHIN’s shared EHR; by
study end (December 2017), it was 681 CHCs. During
this period, 17,543 SDH screenings were conducted at
154 CHCs among 15,779 patients (≅1% of patients seen
during that period). Screenings most commonly occurred in
office visits with established patients (42% of screenings),
followed by pediatric preventive medicine visits (14%).
Respondents answered all 7 SDH domains (listed below)
in 30% of screening occurrences. Several CHCs only
collected information on a single domain. Among patients
who responded to specific questions, 52% reported financial
strain, 35% food insecurity, 19% housing insecurity, 14%
56
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Alison Firemark, Jennifer L. Schneider,1 Dea
Papajorgji-Taylor,1 Jennifer Kuntz,1 Xiuhai Yang,1 John
Dickerson,1 Lou Ann Thorsness,2 Katherine Reese,2
Mark Sullivan,3 Lynn Debar,4 Dave Smith1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Clinical Pharmacy Services, Kaiser Permanente
Northwest, Portland, OR; 3University of Washington,
Seattle, WA; 4Kaiser Permanente Washington Health
Research Institute, Seattle, WA
1

Background: Responding to growing concerns regarding
chronic high-dose opioid use, Kaiser Permanente Northwest
(KPNW) implemented a pharmacist-led program to support
patients tapering off opioid medications ─ the Support
Team Onsite Resource for Management of Pain (STORM)
program. Through interviews with the STORM team and
primary care providers (PCPs), we identified barriers and
facilitators for referring patients to this resource.
Methods: We developed interview guides and conducted
interviews by phone or in-person. Interviews were audiorecorded and transcribed. Content analysis of transcripts
resulted in identifying key themes on reasons why PCPs
refer or do not refer to the STORM program.
Results: We completed 35 qualitative interviews: 15
pharmacists and program staff, and 20 PCPs. Pharmacists
and PCPs both acknowledged that complex patients on
high doses of opioids who may require more attention than
the PCP is able to provide are likely to be referred to the
program. PCPs also identified unique reasons for referrals,
such as patient fear/reluctance to reduce opioid dosage,
violation of an opioid treatment plan, and patient request
to taper. Pharmacists observed that PCPs are likely to refer
when PCP has a large number of patients in need of taper,
has previous positive experience with the STORM program,
or is a newer provider to the health plan. Pharmacists and
PCPs both identified common barriers for referral and use of
the STORM program: PCP or patient preference for PCP to
Supplement

manage the taper; forgetfulness of the resource; and confusing
STORM with other pain management resources. Pharmacists
specifically observe that PCPs less likely to refer are
comfortable managing the taper on their own or are resistant
to being told their patients need to be tapered, while PCPs
explain that lack of direct access to a STORM pharmacist in
their clinic for consultation may reduce referral practices.
Conclusion: Interview findings elucidate under what
circumstances PCPs are likely to refer patients to the
STORM program for assistance in lowering or coming off
from opioid medications and identifies several areas that
could improve referrals to the service, including increased
program presence in clinics and reminders to PCPs about the
nature and scope of the STORM program.
P10.02
Implementing an Evidence-Based Guideline in
Dental Offices
Inga Gruß,1 Jeff Fellows,1 Charles Kaplan,2 Erick
Guerrero,2 Deborah Polk3
Kaiser Permanente Center for Health Research, Portland,
OR; 2University of Southern California, Los Angeles, CA;
3
University of Pittsburgh, Pittsburgh, PA
1

Background: Fostering the implementation of evidencebased guidelines in large, multisite dental practices
can improve oral health of patients. The pit-and-fissure
guideline, issued by the American Dental Association
(ADA), recommends the use of dental sealants to prevent
and arrest incipient caries on occlusal tooth surfaces.
Sealant placement rates, and thus guideline adherence,
remain low among dental providers. This qualitative study
assessed existing implementation strategies and barriers and
facilitators for ADA’s pit-and-fissure guideline in Kaiser
Permanente Northwest (KPNW) dental offices.
Methods: We followed a grounded-theory approach,
continuously analyzing qualitative data to inform the next
steps in the data collection process. We conducted semistructured interviews with 5 members of the leadership team,
observed clinical routines in 4 dental offices, and engaged 30
dental professionals in focus groups in 3 dental clinics. Data
collection aimed at learning about existing implementation
strategies for clinical guidelines, with a focus on the pitand-fissure guideline. We also assessed organizational and
practitioner barriers and facilitators to implementing the pitand-fissure guideline in dental offices.
Results: In KPNW, guideline selection and implementation
are managed by a clinical effectiveness committee (CEC)
consisting of one dentist from each dental office. The CEC
is tasked with screening, selecting, and recommending
guidelines for implementation into clinical care. Guidelines
might be integrated into a set of annual performance and
quality targets, with each dental office managing the
implementation of selected guidelines into clinical care
Supplement

based on local factors. Barriers to implementing the pit-andfissure guideline included limited knowledge of the guideline
content, particularly for treatment of incipient caries; lack
of ownership of the process; and limited resources to
accomplish additional care steps. Facilitators included a
recognition of the importance of following evidence-based
guidelines, well-functioning workflows within existing
subspecialties, and openness to receiving prompts and
support to accomplish the evidence-based care goals.
Conclusion: Qualitative analysis can identify important
organizational and clinical barriers and facilitators affecting
the implementation of evidence-based practice. Processes
to screen, select, and recommend guidelines are necessary
but not sufficient to successful implementation. A robust
implementation structure is necessary to facilitate the
implementation of guidelines into routine clinical practice.
P10.03
Implementation of Care Management Intervention
for Patients With Chronic Obstructive Pulmonary
Disease at Risk of Acute Exacerbation Across a
Large Integrated Health Care Organization
Richard Mularski,1,3 David Mosen,1 Sanja Uskokovic,2
Bryan Skalberg,2 Achikam Haim,2 Marianne Turley,2
Nancy Lee,2 Wui-Leong Koh3
Kaiser Permanente Center for Health Research, Portland,
OR; 2Kaiser Permanente Northwest, Portland, OR;
3
Northwest Permanente, P.C., Portland, OR
1

Background: Chronic obstructive pulmonary disease
(COPD) affects 12 million to 29 million individuals in
the United States and is responsible for 800,000 yearly
hospitalizations. Deficits in implementation of treatments
for acute exacerbations (AEs) are well documented. We
developed and tested an implementation project that used
a targeted intervention across an integrated health care
organization to identify at-high-risk individuals, provide
guideline-recommended proactive care, and evaluate process
and outcome metrics of the care delivery for this population.
Methods: We identified an at-risk COPD population in two
phases for implementation. Phases were defined as 1) age >
65 years by ICD-10 visits and 2 or more AEs in the prior year
with systemic steroid dispensing (phase I); or 2) expanding
to age > 40 years with any COPD AE hospitalizations in
the prior year (phase II). Care management teams competed
an action plan with patients (standardized symptoms
linked to actions, like start medications) and facilitated flu/
pneumococcus vaccine completion and orders for rescue
medications. Process measures assessed successful delivery of
care components; outcome metrics included AEs, utilization,
and death, comparing to historical controls and as completers
(received all planned interventions/meds) vs non-completers.
Results: We identified 149 patients in phase I and 264 in
phase II; respective historical cohorts had 118 and 149
www.aurora.org/jpcrr
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patients. Action plans were delivered in 55% of outreached
patients, vaccine rates improved from <50% to 65%
(P<0.01), and rescue medication orders improved from
<1% to 20% (P<0.0001). Nonsignificant trends were seen
in hospital admissions (26% postimplementation vs 31%
prior) and 30-day readmission (18% vs 35%). Total inpatient
hospital days were reduced in the combined analyses of
both phases of intervention in those completers (0.94 ± 2.51
days) who received all components compared to those in the
implementation group who did not receive all components
(1.90 ± 5.58 days; P<0.05). Similar trends were seen in
utilization. In the completer group, mortality trended down
from 6.0% to 1.3% (P=ns) and overall AEs from 25.0% to
20.5% (P=ns) compared to non-completers.
Conclusion: Care management intervention improved
care delivery for COPD patients. Total inpatient hospital
days were lower for intervention completers (P<0.05),
with favorable trends in utilization, AEs, and death (not
statistically significant).
P10.04
Can Guidelines Support Deimplementation of
Computed Tomography for a Common Condition?
Trends in Diagnostic Evaluation for Hematuria
Within and Across Health Care Systems
Matthew Nielsen,1,4 Michael Parchman,2 Marilyn
Kwan,3 Jenny Staab,4 Sheila Weinmann4
The University of North Carolina at Chapel Hill, Chapel
Hill, NC; 2Kaiser Permanente Washington Health Research
Institute, Seattle, WA; 3Kaiser Permanente Northern California,
Oakland, CA; 4Kaiser Permanente Northwest, Portland, OR
1

Background: Utilization of computed tomography (CT) in
the United States has soared, from 3 million scans per year
in 1985 to more than 85 million in 2010, leading to concerns
about overutilization. Hematuria is prevalent, with more
than 2 million U.S. patients referred to urologists annually
for evaluation. Historical U.S. guidelines recommend
CT for all adults with any degree of hematuria, whereas
international guidelines recommend ultrasound, explicitly
citing concerns about cost-effectiveness and radiation harms.
Against this backdrop, physicians in Kaiser Permanente (KP)
developed a new risk-stratified guideline for hematuria, with
CT restricted to patients at highest risk [gross hematuria
(GH)], renal ultrasound for patients with microhematuria and
risk factors [(MHRF) + tobacco exposure, male sex, women
over 50 years old)], and no evaluation for nonsmoking women
less than 50 years old with low-risk microhematuria (LRMH).
Methods: 156,926 patients with hematuria in 3 health care
systems from 2010 to 2016 were identified. Two systems (KP
Northern California [KPNC] and KP Northwest [KPNW])
adopted the new risk-stratified guideline in 2012–2013; the
third system, KP Washington (KPWA), did not adopt any
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specific guideline during the study period. We compared
trends in CT utilization within and between systems among
the 3 risk groups before (2010–2011) and after (2014–2015)
guideline adoption.
Results: Among patients receiving evaluation (n=81,291),
the system with highest baseline CT utilization (KPNC) had
stable utilization of CT for GH patients (74.7% to 73.8%,
P=0.2301) and substantial decreases in CT utilization for
MHRF patients (67.6% to 44.5%, P<0.0001) and LRMH
patients (52.1% to 43.8%, P<0.0001) after adoption of
the new guideline. The system with lowest baseline CT
utilization (KPNW) had guideline-concordant increase in CT
utilization for GH patients (22.0% to 68.3%, P<0.0001) but
also guideline-discordant increase in CT for MHRF patients
(21.7% to 36.7%, P<0.001) and LRMH patients (21.0% to
32.1%, P=0.0022). KPWA had more modest changes in CT
utilization (GH: 55.8% to 58.9%, P=0.0567; MHRF: 43.0%
to 48.7%, P<0.0001; LRMH: 42.5% to 42.0%, P=0.8902).
Conclusion: Adoption of a risk-stratified guideline was
associated with differential changes in utilization within and
across health systems, sensitive to baseline CT utilization
and patient risk factors. Substantial residual variation
and guideline-discordant utilization suggest additional
opportunities for improvement.
P10.05
System-Level Challenges and Successes of
a Pharmacy-Led Opioid Tapering Program:
Interviews With Clinicians and Pharmacists
Jennifer L. Schneider,1 Alison Firemark,1 Dea
Papajorgji-Taylor,1 Jennifer Kuntz,1 John Dickerson,1
Xiuhai Yang,1 Mark Sullivan,2 Lou Ann Thorsness,3
Lynn Debar,4 Katherine Reese,3 Dave Smith1
Kaiser Permanente Center for Health Research, Portland,
OR; 2University of Washington, Seattle, WA; 3Clinical
Pharmacy Services, Kaiser Permanente Northwest,
Portland, OR; 4Kaiser Permanente Washington Health
Research Institute, Seattle, WA
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Background: Responding to growing concerns regarding
chronic high-dose opioid use, Kaiser Permanente Northwest
implemented a pharmacist-led, phone-based program to
support patients tapering off opioid medications. Our study
examines the reach, adoption, and implementation of the
Support Team Onsite Resource for Management of Pain
(STORM) program. To understand implementation factors
and associated barriers of the program, we conducted indepth interviews with staff delivering the program and
referring primary care providers (PCPs).
Methods: Participants were recruited via email, and
interviews were conducted in-person or by phone using
an interview guide informed by the RE-AIM framework.
Interviews were recorded, transcribed, and content-analyzed
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by trained qualitative staff, resulting in refined themes.
Results: Thirty-five interviews were completed ─ 15
pharmacists/program staff, and 20 PCPs. Challenges to
program implementation identified by both PCPs and
pharmacy staff included occasional delays in initial outreach
due to workload or lack of staffing, and limitations in offering
nonpharmacological pain management resources to patients.
Pharmacy staff specifically described experiencing occasional
burnout and observed unclear PCP-patient communication
about the purpose of the referral. Some PCPs cited lack of
understanding regarding how the referral process works and
how STORM services differ from other pain management
resources in the system. PCPs and pharmacists identified
multiple common strengths of STORM: the training and
empathetic skill set of pharmacists; thorough documentation
of the taper process within the health record; reducing PCP
workload burden; and an individualized taper approach
allowing pharmacists to build trust and rapport with patients.
Pharmacists further identified the structure of the STORM
program as an important success factor, including referral
triage and their collaborative team-based approach. PCPs
find beneficial the ability to have on-site consultations with
pharmacists and view the program as an essential service for
managing patients with complex care needs.
Conclusion: Interviewees describe STORM as an
invaluable resource for both PCPs and patients by delivering
compassionate patient-centered care in lowering opioid doses.
More program implementation strengths than challenges
were noted by interviewees. Identifying system-level factors
important to the success and ongoing improvement of the
STORM program may be useful for other health systems
considering a similar opioid tapering program.
P10.06
Positive Deviance Approaches to Improving
Vaccination Coverage Rates Within Health Care
Systems: A Systematic Review
Sonal Singh,1 Kathleen M. Mazor,1 Kimberly A. Fisher1
University of Massachusetts Medical School / Meyers
Primary Care Institute, Worcester, MA
1

Background: Vaccination is effective in decreasing
preventable morbidity and mortality. While RCTs have
demonstrated effective interventions under controlled
conditions, vaccination rates continue to fall short of targets.
Practical strategies that can be implemented successfully
in real-world settings are needed. The positive deviance
approach is based on the principle that studying individuals
or organizations that consistently demonstrate a high level
of performance can reveal such strategies. We conducted
a systematic review to identify strategies to improve
vaccination coverage using the positive deviance approach.
Methods: In October 2017, we searched English-language
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articles in Medline, Embase, Cochrane Library, CINAHL,
and PsycINFO without any date restrictions. Two reviewers
independently and in duplicate reviewed each citation for
potential eligibility. We included positive deviance studies
of any design (qualitative, quantitative, and mixed methods).
We extracted data on the strategies and elements identified
as critical to success and conducted qualitative synthesis of
the findings. We also evaluated the quality of studies using
the 14-item QATSDD tool. Our systematic review was
registered at PROSPERO (2017 CRD42017057040).
Results: We reviewed 241 citations and included 8 studies
conducted in diverse locations, including United States,
United Kingdom, and Africa. The studies evaluated several
vaccines including H1NI, diphtheria-pertussis-tetanus,
human papillomavirus, influenza, polio, measles-mumpsrubella, Haemophilus influenzae type b, and hepatitis
B. The settings included schools, practice sites, local
health departments, and Veterans Affairs medical centers
as well as countrywide evaluations of immunization
programs in Africa. The reporting of quality elements was
variable. High-performing organizations described the
key components of the vaccination process as including a)
planning and prioritization, b) efforts to increase awareness,
c) increasing access and convenience of vaccination, and
d) program evaluation including data review. The structure
(eg, equipment) and context (eg, community engagement,
leadership involvement, team work, organizational climate)
supported the process of vaccination. Limitations include the
lack of hypothesis testing in most studies and identification
of positive deviants via peers rather than objective measures.
Conclusion: By synthesizing the findings of studies that
apply the positive deviance approach to vaccination, we
uncovered practical, real-world, efficient strategies to
improve vaccination across diverse settings. Efforts to
improve vaccination rates could consider these strategies to
reduce the burden of vaccine preventable diseases.

MENTAL HEALTH, ALCOHOL AND
SUBSTANCE ABUSE/USE
OA2.01
Depression Screening and Treatment Among Disparity
Populations in Primary Care: A Retrospective Analysis
of Electronic Health Record Data
Katherine Sanchez,1 Kiumars Zolfaghari,1 Afsaneh
Rezaeizadeh1
Baylor Scott & White Health, Dallas, TX

1

Background: Depression is the leading cause of medical
disability, health burden, and increased medical cost
in the United States and the world. Ethnic minorities
have significantly lower odds of receiving adequate
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antidepressant treatment, guideline-concordant care, and
experience a disproportionate burden of disability. Despite
recommendations from the U.S. Preventive Services Task
Force that primary care providers screen all adult patients
for depression, overall rates of depression screening remain
low, with racial minorities half as likely to be screened
compared with whites.
Methods: We conducted a retrospective observational study
of about 37,000 patient visits across 8 Baylor Scott & White
clinics in the Dallas/Fort Worth metroplex in 2017. Patient
demographics and clinical information, including PHQ-2
and PHQ-9 scores, depression diagnosis, and behavioral
health visits, were collected from the electronic health
record. Descriptive analysis included means and frequencies.
Multivariate analyses are in progress.
Results: The study cohort comprised 11,803 patients,
majority female (64.3%), with an average age of 48.0 years
(standard deviation: 12.8). Of these, 63% were Hispanic,
the majority did not speak English, and 21% were black.
The depression screening rate at the clinics was 62% of all
patients at annual visit. Of those patients, 2228 (28%) had a
score greater than 4 on the PHQ-9 (indicating the presence
of depression) and only half of those had a visit with the
licensed clinical social worker. Importantly, among patients
screened for depression (PHQ-2), 30% were diagnosed but
22% of those did not have a PHQ-9 on record. Additionally,
out of 2228 patients with full PHQ-9 greater than 4 in 2017,
only 450 (20.2%) patients had a follow-up PHQ-9 within 6
months of their first PHQ-9.
Conclusion: Since appropriate management of depression
calls for all patients diagnosed with depression, and
particularly those treated with antidepressant medications,
to have an assessment of symptoms using a validated
depression symptom measure, findings represent a deviation
from guideline-concordant care. The practice transformation
necessary for broad implementation of evidence-based
depression screening and treatment guidelines into practice
will require analysis of the contextual factors to overcome
barriers, especially those related to organizational readiness
and mechanisms to support implementation and sustain
integrated health care programs.
OA2.02
Development and Validation of Clinical Predictive
Models for the Emergence of Alcohol or Other
Drug Use Problems Between 12 and 18
Felicia Chi,1 Stacey Alexeeff,1 Joseph A. Boscarino,2
Ryan Dugan,2 Beth Waitzfelder,3 Timothy Frankland,3
Brian Ahmedani,4 Yong Hu,4 Amy Loree4
Kaiser Permanente Northern California, Oakland, CA;
Geisinger Health, Danville, PA; 3Kaiser Permanente Hawaii,
Honolulu, HI; 4Henry Ford Health System, Detroit, MI
1
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Background: Alcohol or other drug (AOD) problems and
their associated consequences have significant impacts for
many adolescents and their families. Early identification
and intervention can be beneficial, yet practical tools for
facilitating identification in clinical settings is lacking. This
study aims to develop and validate a predictive model of
adolescent AOD problem emergence, using clinical and
demographic data from a birth cohort identified across 4
health systems.
Methods: This observational, electronic health records
(EHR)-based retrospective cohort study identified a birth
cohort of 41,176 adolescents born between 1997 to 2000
in 4 health systems (Kaiser Permanente Hawaii, Kaiser
Permanente Northern California, Geisinger Health, and
Henry Ford Health System), with continuous membership
since birth, allowing for a 12-month coverage gap. For
the adolescents and their mothers, data on demographics,
socioeconomic status, diagnoses, risk behaviors,
prescriptions, and service utilization from birth through the
adolescent’s 12th birthdate were extracted from the health
plans’ EHRs. The outcome was development of an AOD
use disorder between ages 12 and18, defined as either 1) a
contact with the AOD treatment program, or 2) receiving a
nontobacco AOD diagnosis. We conducted Cox proportional
hazard models using Kaiser Permanente Northern California
data to develop a predictive model for AOD problem
development by age 18 and validated the model using
combined data from the other 3 sites.
Results: In addition to birth year, adolescents’ gender,
race/ethnicity, and ever-Medicaid-insured status as well
as diagnoses of attention-deficit/hyperactivity disorder
(ADHD), bed-wetting, bipolar disorders, conduct disorders,
depression, headache, major depression, migraine,
oppositional defiant disorder, and trauma- or stress-related
disorders by age 12 were significantly associated with AOD
problem development by age 18. The presence of maternal
alcohol or any drug use disorders, chronic pain, intimate
partner violence, major depression, minor depression,
obsessive-compulsive disorders, or tobacco use disorders
also conferred significantly higher risk for adolescents’
AOD problem development. Stratified analyses identified
gender-specific risk factors.
Conclusion: Predictive models of this kind may be useful
for targeted prevention and early intervention efforts by
clinicians and health policymakers and clinical research.
OA2.03
Antidepressant Continuation in Pregnancy in
Relation to Infant Birthweight
Paige D. Wartko,1 Noel S. Weiss,2 Daniel A.
Enquobahrie,2 K.C. Gary Chan,3 Alyssa StephensonFamy,4 Beth A. Mueller,2 Sascha Dublin1
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Kaiser Permanente Washington Health Research Institute,
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Washington, Seattle, WA; 3Department of Biostatistics,
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Background: Every year, 6%–7% of pregnant U.S. women
(~300,000 women) use antidepressants. Many studies have
assessed antidepressant use during pregnancy in relation to
risk of smaller infant birthweight; however, most did not
account for potential confounding by mental health status or
assess risk separately for male and female infants.
Methods: We addressed this question among women using
antidepressants before pregnancy in a retrospective cohort
study using electronic health data and linked Washington
State birth records of singleton, live births from 2001 to
2014 to women enrolled in Kaiser Permanente Washington.
The study included women with 1 or more antidepressant
prescription filled up to 6 months before pregnancy.
Women with 1 or more antidepressant fill during pregnancy
were considered “exposed” (n=1772); those without were
“unexposed” (n=1249). We calculated mean differences
(MD) in infant birthweight and relative risks (RR) of small
or large size for gestational age (<10th or >90th percentile,
respectively, for gestational age- and sex-specific growth
curves), low birthweight (<2500 grams), and macrosomia
(>4500 grams) using inverse probability of treatment
weighting to account for baseline characteristics, including
mental health status.
Results: Female infants of women who continued
antidepressant use in pregnancy had lower mean birthweight
compared with those who did not continue (MD: -105.4
g, 95% CI: -163.0 to -47.7 g), whereas male infants had
a smaller, nonsignificant difference (MD: -50.8 g, 95%
CI: -108.6 to 7.1 g). We observed increased risk of being
small for gestational age among female infants of women
continuing antidepressants (RR: 1.65, 95% CI: 1.09 to
2.50) but not among male infants (RR: 0.86, 95% CI: 0.58
to 1.27). After restricting continuers to women with fills in
all trimesters, among female and male infants combined, we
observed decreased risk of macrosomia (RR: 0.49, 95% CI:
0.25 to 0.99) and being large for gestational age (RR: 0.68,
95% CI: 0.52 to 0.91) among continuers compared with
discontinuers.
Conclusion: After accounting for maternal characteristics,
including mental health status, we observed greater risk
of small for gestational age specific to female infants;
however, these findings must be replicated and considered
in conjunction with other risks and benefits associated with
antidepressant use in pregnancy, including the woman’s
mental health.
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OA2.04
Trends in Marijuana Use Among Pregnant
Women With and Without Nausea and Vomiting in
Pregnancy, 2009 to 2016
Kelly C. Young-Wolff,1 Varada Sarovar,1 Lue-Yen
Tucker,1 Lyndsay A. Avalos,1 Stacey Alexeeff,1 Amy
Conway,2 Mary Anne Armstrong,1 Constance Weisner,1
Cynthia I. Campbell,1 Nancy Goler3
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2Early Start Program, Kaiser
Permanente Northern California, Oakland, CA; 3Regional
Offices, Kaiser Permanente Northern California,
Oakland, CA
1

Background: Even though previous cross-sectional studies
indicate higher marijuana use among women with nausea
and vomiting during pregnancy (NVP), it is unknown
whether the trends in marijuana use over time differ by NVP
status because prenatal use is increasing in general as the
drug becomes more socially acceptable.
Methods: Using data from Kaiser Permanente Northern
California (KPNC), we analyzed the trend in marijuana use
in pregnant women, >12 years of age, who completed a selfadministered questionnaire on marijuana use and a urine
toxicology test for cannabis during standard prenatal care,
from 2009 to 2016. Utilizing a Poisson regression with a
log link function, and adjusting for sociodemographics and
parity, we estimated the annual prevalence of marijuana use
for those with and without NVP. We tested for linear trends
and differences in trends by NVP.
Results: Of 220,510 pregnancies, 38,831 (17.6%) had an
NVP diagnosis. Prenatal marijuana use was elevated each
year among women with NVP. The adjusted prevalence of
use increased significantly from 2009 to 2016 at an annual
rate of 1.086 (95% CI: 1.069–1.104) among women with
NVP, from 6.5% (95% CI: 5.7%–7.2%) to 11.1% (95% CI:
10.2%–12.0%), and 1.069 (95% CI: 1.059–1.080) among
women without NVP, from 3.4% (95% CI: 3.2%–3.7%) to
5.8% (95% CI: 5.5%–6.1%). Trends did not vary by NVP
status.
Conclusion: From 2009 to 2016, prenatal marijuana use
among KPNC pregnant women increased irrespective of
their NVP status; however, the prevalence was consistently
higher among those with NVP. Since the effects of marijuana
on pregnancy outcomes are still uncertain, clinicians should
advice pregnant women to use alternative, evidence-based
interventions to alleviate NVP and ask them to abstain from
using prenatal marijuana.
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OA9.01
“What Will Happen If I Say Yes?” Perspectives
Among Adults With Depressive Symptoms on
Routine Questions About Firearms Access in
Primary Care
Julie Richards,1 Sarah Hohl,2 Courtney Segal,2 Casey
Luce,1 Ursula Whiteside,3 Emily Williams,4 Greg
Simon,1 Amy Lee,1 Rob Penfold,1 Evette Ludman,1
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of Washington, Seattle, WA; 3NowMattersNow.org, Seattle,
WA; 4VA Puget Sound Health Care System, Seattle, WA
1

Background: Firearms are highly lethal, the most common
method of suicide death, and receipt of health care prior to
suicide death is common. Firearm risk reduction counseling
with patients at risk of suicide is a potentially important
suicide prevention strategy. However, patient perspectives
regarding how questions about firearm access should be
asked or implemented in health care settings is unknown.
Kaiser Permanente Washington recently implemented a selfadministered monitoring tool for routine depression care
across all primary care clinics, which includes a question
about firearm access. As part of a broader qualitative
interview study focused on understanding patients’
experiences of being asked about suicidality during routine
primary care, we sought to describe patients’ perspectives of
the standard question about firearm access.
Methods: Invited patients were sampled using electronic
health record data to identify those who had a positive
2-item Patient Health Questionnaire [PHQ-2] screening
test for depression at a recent primary care visit. Enrolled
participants completed a 15–30-minute semi-structured
telephone interview focused on understanding experiences
of being asked about suicidality. Interviews (recorded
and transcribed) elicited beliefs and descriptions of the
experiences of being asked about firearm access at a
primary care visit. Thematic domain analysis was used to
comprehensively explore responses to the portion of the
interview about the firearm question.
Results: A total of 37 men and women, age 20–95 years (mean:
47.6), completed the phone interview. Three organizing
themes emerged from qualitative analysis of responses to
the part about the firearm question: 1) Respondents believed
a standard question about firearm access is appropriate in the
context of suicide risk assessment; 2) Respondents believed
the question could be improved by clarifying the rationale
for asking about firearm access (ie, suicide prevention)
and expanding to address other common lethal means; and
3) Respondents were concerned that disclosing access to
firearms may result in loss of autonomy and/or compromise
of firearm ownership rights.
Conclusion: Clarifying the rationale for asking about
firearm access and specifying what will be done with the
information may alleviate patients’ concerns and optimize
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honest disclosure. Additional patient perspectives are
needed to inform clinical guidelines for and implementation
of asking routine questions about firearm access.
OA9.02
Policy Considerations: Systematic Review of
Nonpharmacologic Treatment for Chronic Pain
Andrea Skelly,1 Roger Chou,2 Joe Dettori,3 Judith
Turner,4 Janna Friedly,4 Sean Rundell,4 Rochelle Fu,2
Erika Brodt,1 Ngoc Wasson,2 Cassandra Winter,1
Aaron Ferguson1
Aggregate Analytics, Inc., Fircrest, WA; 2Oregon Health &
Science University, Portland, OR; 3Spectrum Research, Inc.,
Tacoma, WA; 4University of Washington, Seattle, WA
1

Background: Opioids are commonly utilized for treatment
of chronic pain. In 2016, more than 2 million Americans
reported struggling with opioid use disorder and an
estimated 17,087 overdose deaths involving prescription
opioids occurred. Consideration of nonopioid management
alternatives, including nonpharmacologic options, and
assessment of the evidence for them is vital.
Methods: Randomized controlled trials of noninvasive,
nonpharmacologic treatments for 5 common chronic
pain conditions (low back pain, neck pain, fibromyalgia,
osteoarthritis, and tension headache) that reported results
for at least 1 month postintervention were included and
critically appraised. Results were summarized for function
and pain and focused on persistence of effects.
Results: A total of 202 trials were included. Exercise,
multidisciplinary rehabilitation, acupuncture, cognitive
behavioral therapy, and mind-body practices were most
consistently associated with durable slight to moderate
improvements in function and pain for specific chronic
pain conditions. Evidence was somewhat more robust for
“active” interventions that engage patients in movement
and address psychological contributors to pain versus more
“passive” treatments focused on symptom relief. Evidence
varied across pain conditions. Given variability in patient
treatment preferences and differential responses to specific
therapies in patients with various chronic pain conditions,
policies that broaden access to a broader array of effective
nonpharmacologic treatments may have greater impact
than those that focus on one or a few therapies. Although
the level of supporting evidence varied from condition to
condition, we found evidence of persistent effectiveness
across conditions for interventions such as exercise,
multidisciplinary rehabilitation, psychological interventions,
mind-body interventions, and acupuncture.
Conclusion: Our findings provided some support for
clinical strategies and policy that focus on use of “active”
nonpharmacologic therapies for specific chronic pain
conditions. Policy directions might include prioritizing
access to interventions with effectiveness across
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conditions, but policymakers need to consider the degree
to which evidence may be reasonably extrapolated across
conditions. This project was funded under Contract No.
HHSA290201500009I from the Agency for Healthcare
Research and Quality (AHRQ), U.S. Department of Health
and Human Services (HHS). The authors of this abstract
are responsible for its content. Statements in the abstract
do not necessarily represent the official views of or imply
endorsement by AHRQ or HHS.
OA9.03
Cross-Cultural Measurement Invariance of the
Patient Health Questionnaire-9 for American Indian
Adults
Melissa Harry, Stephen Waring
1

1
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1

Background: While American Indian and Alaskan Native
people have higher rates of suicide compared to other
groups, little evidence exists on the prevalence of depression
in this population. Scales developed for assessing mental
health have been predominately tested in U.S. populations
of Western European descent. However, tests of scale
reliability and validity should include assessing scale crosscultural invariance (equivalence) between diverse groups,
such as through multigroup measurement invariance
testing. Establishing cross-cultural measurement invariance,
specifically scalar invariance, is required to reliably compare
scores between groups. The Patient Health Questionnaire-9
(PHQ-9) is a widely used tool for measuring depression.
However, few studies have reported on the measurement
invariance of the PHQ-9 for American Indian people. The
goal of this study was to help fill that gap by assessing
the measurement invariance of the PHQ-9 for American
Indian adult patients at Essentia Health, an upper Midwest
integrated health care organization.
Methods: Analyses included all American Indian individuals
age 18 year and older (n=4443) and a random sample of
non-Hispanic white individuals (n=4443) with a completed
PHQ-9 in the electronic medical record at Essentia Health
from December 1, 2005, to December 31, 2017. We first
performed confirmatory factor analysis with the standard
one-factor PHQ-9 model and 5 two-factor models previously
identified in the literature separately with American Indian
and non-Hispanic white adult patients (age 18–98 years).
We then tested nested measurement invariance hypotheses
with the best fitting models.
Results: Confirmatory factor analysis showed that the onefactor PHQ-9 model and all 5 two-factor models showed
good fits for both groups separately (eg, comparative fit index
> 0.95, root mean square error of approximation < 0.05). The
one-factor model and best-fitting two-factor models (one with
9 items and another with 7 items) also displayed configural,
metric, and scalar invariance between groups.
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Conclusion: The PHQ-9 was cross-culturally equivalent
in all tested models for American Indian and non-Hispanic
white adult individuals, including the standard one-factor
model. These results indicate that the PHQ-9 is a suitable
depression screening tool for use with American Indian
adults in clinical care. However, future research could
confirm the generalizability of these findings to other
populations of American Indian people.
OA9.04
Metformin to Manage Side Effects of Psychiatric
Medications: Findings From an Integrated Health
Care Delivery System
Esti Iturralde,1 Boriska Toth,1 Lucas Van Dyke,2 Roy
Eyal,2 Jacqueline Kiang,2 Linda Kim,2 Maggie Mullen,2
J. Jewel Shim,2 Stacy Sterling1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2The Permanente Medical Group,
Oakland, CA
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Background: More than 10 million adults in the United
States have a form of severe mental illness (SMI).
Individuals with SMI face elevated risks for diabetes and
heart disease, related in part to metabolic side effects of
treatment with atypical antipsychotic medications (AAMs).
Clinical trial evidence suggests that metformin, an oral
diabetes medication, is an effective, well-tolerated treatment
for preventing and managing these side effects, but research
has not examined the translation of this evidence-based
intervention into clinical practice.
Methods: We assessed the prevalence of metabolic risk
factors, metformin prescription rates, and predictors of
metformin prescriptions among 16,282 adults (age 18–65
years) with a documented SMI diagnosis, no diagnosed
diabetes, and a filled AAM prescription during 2015
(index event), using electronic health record data from a
large integrated health care delivery system in Northern
California.
Results: Participants were of mean age 42.9 ± 13.7 years;
59% were women. The sample was racially diverse (37.0%
white, 13.6% Latino, 9.0% black, 8.6% Asian, 31.8% other
category). Primary SMI diagnoses were psychotic disorder
(29.5%), bipolar disorder (30.8), other affective disorder
(34.1%), and autism spectrum disorder (4.6%); 77% of
patients had already-established AAM treatment. Although
risk factors for adverse metabolic outcomes were common
(eg, 40.4% with obesity, 78.3% prescribed an AAM associated
with moderate or high risk of metabolic side effects), only
106 patients (0.65%) were prescribed metformin during
the post-index year. Metformin-prescribing providers often
were primary care physicians or psychiatrists, accounting
for 50.0% and 30.2% of metformin-prescribed patients,
respectively. In multilevel logistic regression models
(patients nested within AAM prescribers), independent
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predictors of metformin prescription were obesity (odds ratio
[OR]: 3.2), female sex (OR: 2.1), primary psychotic disorder
(OR: 1.9), established AAM treatment (OR: 1.9), and highmetabolic-risk AAM type (OR: 1.7); all P<0.05. Prescriberlevel effects were significant (intraclass correlation of 0.28,
P<0.05), suggesting nonsystematic implementation of
metformin treatment.
Conclusion: Many patients with SMI are at elevated risk
for adverse cardiometabolic outcomes related in part to
their psychiatric medications, but few receive metformin
medication, an evidence-based intervention to manage these
risks. Future research should focus on strategies for how to
overcome implementation barriers.

CI: 2.4–11.6, P<0.001), current depression (OR: 3.9, 95%
CI: 1.5–10.2, P=0.005), sleep problems (OR: 2.8, 95% CI:
1.3–6.0, P=0.009), and high lifetime trauma exposures (OR:
2.6, 95% CI: 1.2–5.6, P=0.019).
Conclusion: After deployments, both warzone and nonwarzone factors predicted mental health service use among
Iraq and Afghanistan veterans seen in non-VA facilities.
Further research related to non-VA mental health service use
among veterans is advised.

P12.01
Predictors of Postdeployment Mental Health
Treatment-Seeking Among Iraq and Afghanistan
Veterans Seen in Non-VA Facilities
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Background: Currently, there is interest in improving
postdeployment mental health treatments among U.S.
veterans of Iraq and Afghanistan, yet many veterans do not use
the Veterans Affairs (VA) health care system. Consequently,
learning about veterans’ treatment experiences outside of the
VA system is critical for future treatment planning.
Methods: We examined postdeployment mental health
treatment among a cross-sectional sample of 235 communitybased veterans of Iraq and Afghanistan receiving care in a
large non-VA multihospital system in Pennsylvania.
Results: The mean age of veterans was 42.1 years (standard
deviation: 9.2), 87% were male, and 52% used the VA in
the past year. Among veterans, current posttraumatic stress
disorder was 15% and current depression was 14%. A total
of 22% of participants reported using alcohol/drugs to cope
postdeployment, 33% had a history of concussion, and 16%
reported suicidal thoughts. Overall, 26% of veterans reported
receiving mental health treatment and 27% reported taking
psychotropic medicines in the past year. In multivariable
logistic regressions, significant predictors of mental health
treatment included female sex (odds ratio [OR]: 5.0, 95%
CI: 1.9–13.1, P=0.001), current concussion symptoms (OR:
3.0, 95% CI: 1.4–6.1, P=0.003), low psychological resilience
(OR: 2.7, 95% CI: 1.4–5.3, P=0.005), and using alcohol/
drugs to cope postdeployment (OR: 2.5, 95% CI: 1.1–5.4,
P=0.026). The best predictors of recent psychotropic
medicine use were VA service use (OR: 4.7, 95% CI: 2.1–
10.5, P<0.001), low psychological resilience (OR: 5.3, 95%
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P12.02
Synthesizing Sources for Calculating Morphine
Equivalents in Opioid Research

Kaiser Permanente Center for Health Research, Portland,
OR; 2Kaiser Permanente Washington Health Research
Institute, Seattle, WA
1

Background: The opioid epidemic is a top priority among
public health researchers, policymakers, and communities
across the United States. Chronic exposure to opioids
prescribed for chronic noncancer pain puts a patient at risk
for addiction, overdose, and death due to opioids. Clinicians
and researchers use morphine equivalents (MEQ) to
standardize opioid dose per day in order to assess the extent
of exposure and risk, and there are several different methods
for computing MEQ from medication-dispensing data. As
part of a multisite study evaluating the risk of overdose and
death among patients prescribed opioid medications, we
developed a strategy for calculating MEQ by synthesizing
information across methods.
Methods: We compiled literature and documentation from
the most frequently used sources for calculating MEQ. These
sources included the most recent conversion factor data file
from the Centers for Disease Control and Prevention and the
Centers for Medicare & Medicaid Services, a database from
an integrated health system, and published academic articles.
Our research team, including a pharmaco-epidemiologist
and pharmacist, synthesized information across sources by
assessing gaps in MEQ specifications, discrepancies between
sources, and overlapping information. We then developed
a lookup table for all opioid National Drug Codes (NDC)
dispensed during the study period at the 4 participating
sites, which included NDC, strength, conversion factor, and
reference source. MEQ was calculated by linking the NDC
lookup table to dispensing data from the health care systems,
which contained NDC, amount, and days’ supply.
Results: This approach allowed us to create a comprehensive
table of MEQ conversion factors for dispensed opioids
that can be applied (either centrally or locally) to opioiddispensing data from multiple health care systems.
Conclusion: By compiling information across sources and
engaging subject matter experts, we built a robust, reliable
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data source for calculating MEQ that is transportable to other
settings with dispensing data. Having high-quality MEQ data
allows researchers to more accurately characterize exposure
to opioids and assess risk for dependence, overdose, and
death.
P12.03
Piloting Specialty Addiction Medicine Consultations
in Primary Care via Live, Two-Way Video
Amy Leibowitz,1 Wendy Lu,1 Derek Satre,1,2 Constance
Weisner,1 Stacy Sterling1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2Weill Institute for Neurosciences,
University of California, San Francisco, San Francisco, CA
1

Background: Screening, brief intervention, and referral
to treatment (SBIRT) is known to help primary care
patients reduce unhealthy alcohol use, but less is known
about whether it helps patients with more severe problems
connect to appropriate treatment. SBIRT holds promise
for facilitating successful treatment initiation, but few
interventions have addressed the challenges in doing this.
We piloted an on-call service whereby specialty addiction
medicine consultants provided real-time video consultation
─ including motivational interviewing and information
about medication-assisted treatment ─ to patients presenting
in primary care with likely alcohol use disorders (AUDs).
Methods: "Alcohol as a Vital Sign 2.0: Addiction Medicine
Video Consultation" was a 1-year feasibility pilot conducted
in adult primary care in a large Kaiser Permanente Northern
California (KPNC) medical center. Researchers developed
and implemented video consult workflows, continuing
medical education (CME) trainings, an on-call staffing
protocol, and ongoing technical assistance. Observational
data included CME attendance and evaluations, consult
service utilization rates, and technological challenges
encountered. Qualitative data included interviews with key
stakeholders and results of a user survey. Preliminary data
about patient outcomes, including specialty and medicationassisted treatment initiation, were extracted from KPNC
electronic health records.
Results: A total of 91 primary care physicians (79%)
attended a CME training, and 98% rated it somewhat or very
useful; 33 physicians (26%) requested a total of 52 consults,
and specialists provided video consults for 32 primary care
patients (62% success rate). Challenges included consultant
unavailability, technology problems, and time constraints.
Physicians rated the service as valuable (average of 6.9
on a scale for which 1 = not valuable and 10 = extremely
valuable), and almost all (17 of 18 respondents) indicated
they would use the service again if technology and staffing
issues were solved. Of patients receiving a video consult, 12
(38%) initiated treatment (defined as attending 1+ addiction
medicine appointment within 14 days of the consult) and 11
Supplement

(34.4%) were prescribed an AUD medication.
Conclusion: Utilization rates and stakeholder feedback
suggest that it is feasible to implement a larger-scale, realtime addiction medicine video consult service and that such
a centralized resource holds promise for improving AUD
treatment initiation rates.
P12.04
Demographic,
Clinical,
and
Prescribing
Characteristics Associated With Future Opioid
Use in an Opioid-Naïve Population
Gabriela Rosales,1 Weiming Hu,1 Rajasekhara
Mummadi,2 Jose Benuzillo,1 David Mosen3
Kaiser Permanente Center for Health Research, Portland,
OR; 2Northwest Permanente, P.C., Portland, OR; 3Kaiser
Permanente Northwest, Portland, OR
1

Background: Opioid prescriptions in the United States
have nearly tripled since 1991. To reduce opioid utilization,
research is needed to identify risk factors associated with
future opioid use, especially among those with no prior
use (naïve users). The study objective was to examine
demographic, clinical, and prescribing characteristics
associated with future opioid use in this population.
Methods: We analyzed the electronic records of Kaiser
Permanente Northwest members with 1 or more opioid
dispenses from January 1, 2010, to September 30, 2015, who
did not have a dispense in the previous 6 months (n=23,804).
The outcome measure was receipt of a third dispense of
opioids after index dispense. Demographic, clinical, and
prescribing characteristics were age (46–65 vs >65 vs ≤45
years), race (white vs nonwhite), ethnicity (Hispanic vs nonHispanic), Charlson comorbidity index (CCI of 1+ vs 0), any
prior substance-abuse diagnosis (yes vs no), any prior mental
health diagnosis (yes vs no), prescribing location (hospital,
outpatient vs other), opioid duration (extended-release vs
short-release) and morphine milligram equivalency (MME
of ≥90 vs <90). Multivariable logistic regression was used
to the measure the associations between these variables and
receipt of a third dispense of opioids.
Results: We found a higher likelihood of a third opioid
dispense with the following: age 45–64 years (odds ratio
[OR]: 1.34, 95% CI: 1.25–1.44); age >65 years (OR: 1.23,
95% CI: 1.13–1.33), white race (OR: 1.24, 95% CI: 1.11–
1.39), CCI of ≥1 (OR: 1.14, 95% CI: 1.07–1.21), prior
substance abuse (OR: 1.19, 95% CI: 1.11–1.27), prior mental
health diagnosis (OR: 1.25, 95% CI: 1.18–1.33), extended/
long-release duration (OR: 1.53, 95% CI: 1.43–1.64), and
MME of ≥90 (OR: 3.00, 95% CI: 2.80–3.21). Two factors
were associated with a lower likelihood of having a third
opioid dispense: Hispanic ethnicity (OR: 0.60, 95% CI:
0.52–0.69) and receipt of a prescription for medication in a
hospital setting (OR: 0.20, 95% CI: 0.17–0.22).
Conclusion: Several characteristics were associated with
www.aurora.org/jpcrr
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future opioid use. Of interest, members whose prescriptions
had an MME of ≥90 at index dispense were 3 times more
likely to have a third dispense of opioids compared to MME
of <90. Future work is needed to understand how to employ
prescribing and other characteristics to develop predictive
risk tools that can be implemented to reduce opioid use.
P12.05
Navigating Practical, Legal, and IT Challenges
to Bring Assessment and Treatment of Pediatric
ADHD in Primary Care at Geisinger into the 21st
Century
Sean O'Dell,1 Alanna Rahm,1 Amanda Young,1 Paul
Kettlewell,1 Amy Kolinovsky,1 Hiyan Sun,1 Tracey
Klinger,1 Rachel Kininger,1 Christine Lee,1 Kathy
Dehart1
Geisinger Health, Danville, PA

1

Background: Although families and schools often rely on
primary care physicians (PCPs) to assess and treat attentiondeficit/hyperactivity disorder (ADHD), PCPs often go
without the necessary resources to make clinical decisions
based on validated screening tools for parents and teachers
implemented through the electronic health records (EHR).
Prior research addressing this problem is limited by lengthy
initial trainings that are infeasible in real-world settings,
proprietary fee-per-administration screening tools, and
lack of population-based clinical outcome data. The current
project developed and tested a rollout of tools to improve
PCPs adherence to American Academy of Pediatrics (AAP)
guidelines for the assessment and treatment of ADHD.
Methods: All Geisinger providers in pediatrics sites
who assess and treat pediatric ADHD were approached
for consent. All clinics with at least one consented PCP
were cluster randomized at the clinic level to intervention
or wait-list control, stratified by number of new ADHD
patients at the clinic in the last year and presence of an onsite behavioral health provider. The PRISM model (2008)
informed stakeholder interviews with site leads and medical
directors to develop intervention content. HIPAA/FERPAcompliant electronic Vanderbilt ADHD Rating Scales for
parents and teachers were developed. Survey results are
routed to the PCP for review; documentation templates and
best practice alerts facilitate follow-up assessments on the
AAP-recommended timeline. Informed by Moore’s behavior
change principles (2009), the initial 1-hour in-person
training on AAP guidelines and EHR tools are supplemented
by 1-, 3-, and 6-month performance support consultations.
Evaluation of provider satisfaction, declarative knowledge,
self-efficacy, intention to change, and perceived barriers will
be assessed pre/post training and 6-month follow-up. PCP
clinical performance will be assessed using interrupted time
series analysis on key quality indicators extracted from the
EHR or abstracted through chart review.
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Results: 21 sites (75%) had at least one PCP consent for
participation. Overall, the participation rate for PCPs was
78%. Trainings commenced in late fall 2018 and follow
newly diagnosed patients for a 1-year post-training period.
Conclusion: We were able to engage a substantial proportion
of the intended population in the intervention. Results from
the pre/post training evaluation will be discussed as well
as detailed description of implementation strategies and
analysis of key quality indicators.
P12.07
Better Outcomes, Best Care: Learning From Every
Patient to Improve Outcomes
Rachel Solomon,1 Paul Kurdyak,1 Jennifer Wilkie1
Centre for Addiction and Mental Health, Toronto, Canada

1

Background: When it comes to physical health, we would
never treat a diabetes patient without measuring their
glucose levels and knowing how they respond to treatment.
Measuring how different groups of patients respond to
different treatments is pivotal to planning and providing care
that ensures the best outcomes for patients. However, every
day in the mental health system, patients receive care that is
neither standardized nor measurement-based, often leading
to poor patient outcomes.
Methods: The Centre for Addiction and Mental Health
(CAMH) is the largest academic mental health hospital in
Canada and one of the world’s leading mental health research
centers. In 2018, CAMH launched the Better Outcomes, Best
Care initiative. The objective of the hospitalwide initiative is
to achieve: a) Gaps are systematically identified in access
and quality of care using provincial and CAMH data; b)
Research will have a patient-oriented focus by engaging
patients as partners and focusing on patient-identified
priorities; c) Solutions can be designed and implemented
using a variety of methods, including clinical trials, Lean,
implementation science, and quality improvement (QI)
methods; and d) Everything from randomized control
trials, QI implementation, and complex intervention design
can be used to evaluate interventions. The methodology
for implementation was to leverage existing and wellestablished learning health systems in acute care settings
to apply the foundational requirements of these established
models to a mental health setting.
Results: Significant capstone projects have been established
and are producing results, shifting the culture to one of
continuous measurement and improvement. Preliminary
results include an evidence-based multipronged approach
to improving discharge processes and outcomes across
the hospital, implementation of a single functional
outcome measure across the hospital using the World
Health Organization Disability Assessment Schedule, and
streamlining of clinical assessment tools and measures to
create a minimum data set for outcome measurement.
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Conclusion: Better Outcomes, Best Care is the beginning
of a transformation, not only within CAMH but across the
mental health system. Early implementation results signal the
power of the learning health system model in transforming
mental health service delivery, but also the seismic shift it
represents and the importance of a large-scale commitment
to the change.

BHC: 0.76, 95% CI: 0.64–0.91; aRR for PCP: 0.78, 95%
CI: 0.65–0.93).
Conclusion: Adolescents in both intervention arms were
less likely to use several types of health care, including
ED services. SBIRT, delivered as part of pediatric primary
care, may obviate the need for more costly specialty and
emergency care.

P12.08
Adolescent SBIRT: Health Care Utilization and
Comorbid Problems Over 3 Years

P12.09
Pharmacoeconomic Evaluation of Naloxone
Distribution for the Prevention of Opioid-Overdose
Fatalities: A Systematic Review

Stacy Sterling,1 Andrea Kline-Simon,1 Ashley Jones,1
Lauren Hartman,2 Katrina Saba,2 Sujaya Parthasarathy1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2Pediatrics, The Permanente
Medical Group, Oakland, CA
1

Background: Little is known about the effects of screening,
brief intervention, and referral to treatment (SBIRT) on
health care utilization among adolescents. We describe
health care utilization findings from a trial of SBIRT in
pediatric primary care.
Methods: We randomized clinic pediatricians (n=52) to 3
study arms: 1) pediatrician-only (PCP), in which they were
trained to deliver SBIRT; 2) embedded-BHC, in which
they could refer patients to a behavioral health clinician
(BHC); and 3) usual care (UC). We used electronic health
record data to obtain all inpatient and outpatient utilization
(emergency department [ED], primary care, psychiatry,
and chemical dependency) during the 3 years following the
index visit, across the 3 arms. We used logistic regression
to examine any ED or inpatient use and negative binomials.
The exponent of the estimated coefficient represents the
odds ratio or rate ratio, with a value less than 1 indicating
less likelihood of a visit (for logistic) or fewer visits (for
negative binomial distribution of primary care, psychiatry,
chemical dependency, and total outpatient visit counts).
Results: There were 1871 eligible patients. At 1 year
postindex, there were no differences in primary care or
inpatient utilization between the arms. Compared to UC,
adolescents in the BHC arm had less likelihood of ED use
(adjusted odds ratio [aOR]: 0.60, 95% CI: 0.34–1.05) and
were likely to have fewer psychiatry visits (adjusted rate
ratio [aRR]: 0.73, 95% CI: 0.52–1.02) or any outpatient
utilization (aRR: 0.67, 95% CI: 0.51–0.87). Adolescents
in the PCP arm also had less likelihood of ED use than
those in UC (aOR]: 0.76, 95% CI: 0.59–0.98). At 3 years
postindex, there were no differences in the likelihood of
primary care, inpatient, or ED utilization across the arms.
However, compared to those in the UC arm, adolescents in
the BHC and PCP arms had fewer psychiatry visits (aRR
for BHC: 0.56, 95% CI: 0.41–0.76; aRR for PCP: 0.73,
95% CI: 0.53–0.99) or any outpatient services (aRR for
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Toney Duong,1 Anh Thu Tran,1 Joy Alonzo,1 Lixian
Zhong1
Texas A&M University, College Station, TX

1

Background: Drug-overdose mortality has become the
number one cause of accidental deaths in the United
States. In 2017, the Department of Health and Human
Services declared the opioid epidemic a public health
emergency. Naloxone, an opioid-overdose reversal agent,
was recommended by the surgeon general to reduce opioidoverdose deaths. This study aimed to evaluate the costeffectiveness of naloxone distribution to adults at risk of
opioid overdose via a systematic literature review.
Methods: We conducted a systematic review following the
Preferred Reporting Items for Systematic Review and Metaanalysis (PRISMA) statement. MEDLINE/PubMed and
Embase were searched using key terms to identify primary
sourced articles published between January 1997 and June
2018. Two independent reviewers searched evaluated
studies based on inclusion/exclusion criteria and performed
data extraction.
Results: We identified 5 studies, including 4 costeffectiveness studies and 1 cost-benefit study. The studies
were done in different countries and different health care
settings, providing a broad assessment of different scenarios.
All cost-effectiveness studies reported low incremental costeffectiveness ratios ranging from $94 to £899 (or ~$1185) per
quality-adjusted life-year (QALY) gained, suggesting that
distributing naloxone to at-risk population costs relatively
little to gain additional QALYs. In addition, the cost-benefit
analysis suggested that such programs can be cost-saving,
as the naloxone drug acquisition cost was offset by mean
medical resource savings of about $472,000 in 2015.
Conclusion: Naloxone distribution to heroin users for lay
overdose reversal is cost-effective at standard willingnessto-pay of $50,000–$100,000 in U.S. dollars or £20,000
in U.K. pounds. Naloxone acquisition costs are offset by
medical cost reductions. Our study synthesized existing
pharmacoeconomic evidence on naloxone distribution to atrisk populations, facilitating the planning of such programs
in the future.

www.aurora.org/jpcrr
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CARE IMPROVEMENT
OA3.01
Dissemination and Sustained Use of an Outpatient
Clinical Decision System With High Use Rates,
High Clinician Satisfaction, and Positive Impact on
Quality of Care
JoAnn Sperl-Hillen,1 A. Lauren Crain,1 Jay Desai,1
Karen L. Margolis,1 Heidi L. Ekstrom,1 Deepika
Appana,1 Christina Wood,1 Rashmi Sharma,1 Patrick
J. O'Connor1
HealthPartners Institute, Bloomington, MN

1

Background: We describe the performance of an electronic
health record (EHR)-linked, web-based primary care
cardiovascular clinical decision support (CDS) system and
the facilitators and barriers to dissemination.
Methods: Algorithms identify patients at the point-of-care
and target them to receive personalized and prioritized
evidence-based treatment options. Printed versions of the
CDS for patients and providers are used to elicit treatment
preferences and facilitate shared decision-making. In
3 National Institutes of Health (NIH)-funded clusterrandomized trials, the CDS use ranged from 71%–77%
of targeted patients, and clinicians reported 85%–98%
satisfaction. Blood pressure control, glucose control, and
10-year cardiovascular risk trajectory significantly improved
in patients cared for at clinics randomized to CDS vs usual
care.
Results: This CDS system has been disseminated to 4
large care delivery systems with about 2000 primary care
clinicians in 4 states, with dissemination to an additional
60 safety-net clinics in 10 states underway. The CDS
website currently evaluates 40,000 visits a day (9 million
visits per year) with high reliability and 300 millisecond/
case processing time. Facilitators of dissemination have
included care system or payer interest in care improvement,
clinician satisfaction, high CDS use rates with minimal
impact on workflow, favorable effects on patient outcomes
and shared decision-making, positive patient perceptions,
standardization of care, and ability to rapidly translate new
evidence/guidelines into practice. Barriers to dissemination
include cost of implementation and lack of a corporate entity
to market and manage ongoing support of the CDS system
(not a strength of a research organization with limited ability
or bandwidth to devote to this). Actual implementation costs
per delivery system were about $100,000, mostly related
to effort required for data mapping and programming the
interconnectivity between EHR and the web service. Time
required for implementation was about 4–6 months after
data and service agreements were finalized and varied
depending on perceived priority of the project and skill level
of programmers at the recipient organization.
Conclusion: This CDS system had high use rates, high
primary care provider satisfaction, and significantly improved
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care in targeted adults and children. After 10 years of NIHfunded development and expansion, several potentially
remediable factors limit widespread dissemination.
OA3.02
Challenges Encountered in Linking Community
Health Centers’ Electronic Health Record Data to a
Web-Based Clinical Decision Support Tool
Mary Middendorf,1 Marla Dearing,1 Rachel Gold,1,2
JoAnn Sperl-Hillen,3 Patrick J. O’Connor,3 Erik
Geissal,1 John Heintzman,1,4 Stuart Cowburn,1 Arwen
Bunce,1 Deepika Appana,3 Christina Wood,3 Rashmi
Sharma,3 M.J. Dunne1
OCHIN, Portland, OR; 2Kaiser Permanente Center for
Health Research, Portland, OR; 3HealthPartners Institute,
Minneapolis, MN; 4Oregon Health & Science University,
Portland, OR
1

Background: Clinical decision support (CDS) tools, which
process patient data via algorithms based on up-to-date
evidence, can help disseminate care guidelines by keeping
providers abreast of current recommendations. However,
such CDS tools are often available only in the delivery
system or electronic health record (EHR) where they were
developed, necessitating reprogramming at multiple sites
when care guidelines change. This inefficiency could be
addressed if data from any EHR could be sent to a website
with regularly updated CDS algorithms. We are currently
testing the effectiveness of CV Wizard© ─ a web-based CDS
tool run by HealthPartners ─ in 68 community health centers
(CHCs) that share an EHR through OCHIN.
Methods: Between March 2017 and April 2018, OCHIN
and HealthPartners collaborated to establish a data exchange
between OCHIN’s Epic EHR and the CV Wizard CDS
website. Needed EHR data (eg, demographics, diagnoses,
labs, allergies, vitals) were sent to CV Wizard, which then
sent CDS suggestions back to the EHR.
Results: Numerous challenges in establishing this data
exchange were identified and resolved. These included
determining: who maintains records of data sent/responses
sent back; what legal agreements were required for needed
data retention; the method for sending CDS results back to the
EHR; whether to send all available medication/laboratory/
allergy/diagnosis data to the CDS or just data points currently
needed by the algorithm; how to manage security concerns
related to the transmission of real-time patient data; whether
the CDS’ cache routine could be modified to improve
performance/sustainability; how OCHIN’s unique structure
(a collaborative of many independent organizations)
necessitated rethinking managing data from more than
60 lab interfaces; how to generate data on CDS use rates;
and how to modify the CDS tool’s “feedback” function for
consistency with OCHIN’s usual support practices. Barriers
to customizing the cardiovascular disease risk cut-point that
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triggered the CDS tool also were identified.
Conclusion: Inefficiencies are inherent when new care
guidelines must be programmed in myriad CDS systems.
We demonstrated that multiple EHRs can successfully plug
into a single CDS algorithm, after resolution of multiple data
exchange challenges.
OA3.03
The Impact of a Web-Based Point-of-Care Tool on
Physician Behavior and Patient Health Outcomes
J.B. Jones,1 Xiaowei Yan,1 Hannah Husby,1 Jake
Delatorre-Reimer,1 Farah Refai,1 Shruti Vaidya,1
Ridhima Nerlekar,1 Karen MacDonald2
Sutter Health, Walnut Creek, CA; 2AstraZeneca, Wilmington,
DE
1

Background: Primary care physicians face various
challenges, including increasing numbers of patients
with cardiometabolic conditions (diabetes, hypertension,
dyslipidemia), growing patient panel sizes, more
administrative tasks, lack of user-friendly resources, and
an ever-increasing knowledge in medicine, which makes
managing patients’ cardiometabolic conditions more
challenging. In collaboration with AstraZeneca, Sutter
Health has developed CM-SHARE, a web-based point-ofcare tool for primary care physicians that aims to display
targeted information for providers to use to engage and
manage their patients while also reducing the amount of
time spent on the computer searching for information.
Methods: CM-SHARE was piloted at 2 primary sites
in Northern California with 6 primary care providers.
Application usage data were tracked, and one-on-one
interviews with users were conducted to understand user
adoption. Based on electronic health record (EHR), a pre/
post parallel, matched-control longitudinal analysis of
clinical outcomes and workflow process measures was
conducted to understand CM-SHARE’s impact on EHR
usage, clinic workflow, provider care delivery, and patient
clinical outcomes. Comparisons were made using t-tests and
Wilcoxon signed-rank test.
Results: Over 26 months since deployment, pilot providers
used CM-SHARE in 33% (N=37,131) of all patient
encounters. EHR and pilot user feedback indicate that CMSHARE was most used for complex high-morbidity patients
with cardiometabolic conditions, particularly in diabetesfocused visits (53% vs 28% usage for all encounters).
Physicians reported high value in CM-SHARE’s ability
to visualize health data and to educate high-morbidity
patients. Use of CM-SHARE was associated with a 25%–
35% reduction in EHR time and 11%–20% fewer EHR
clicks for cardiometabolic-focused encounters. Compared
with control patients, patients with diabetes who had CMSHARE launched had, on average, more hemoglobin A1c
labs ordered (P=0.0001 and P=0.0007 at 6-month and
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12-month follow-up periods, respectively) and achieved a
0.1% lower hemoglobin A1c lab value (P=0.02 at 18-month
follow-up).
Conclusion: CM-SHARE has maintained stable usage over
the course of the pilot, indicating that it fulfills a valuable
physician need. Early results indicate positive trends in
both reduction of EHR burden and improvement of disease
monitoring and patient clinical outcomes. More work is
needed to understand how CM-SHARE mediates patient
outcomes and physician behavior change.
OA3.04
Transforming Hepatitis B Care in Kaiser
Permanente Mid-Atlantic States Through a Registry
and Coordinator-Supported Pathway
Cabell Jonas,1 Michael Horberg1
Mid-Atlantic Permanente Research Institute, Rockville, MD

1

Background: Chronic hepatitis B (HBV) is a viral disease
causing significant morbidity and mortality through cirrhosis
and liver cancers such as hepatocellular carcinoma. Liver
cancer is the 5th and 8th leading cause of cancer deaths
among U.S. males and females, respectively. In developing
a hepatocellular carcinoma surveillance program, the MidAtlantic Permanente Medical Group (MAPMG) uncovered
upstream gaps in HBV diagnosis and documentation, which
were influencing hepatocellular carcinoma surveillance
eligibility. In response, MAPMG created a technologybased and coordinator-supported Hepatitis B Pathway
to update HBV diagnoses among patients new to Kaiser
Permanente Mid-Atlantic States, patients who have never
seen a MAPMG gastroenterologist for HBV, and patients
who have not seen a MAPMG gastroenterologist for HBV
in 2+ years.
Methods: The Hepatitis B Pathway uses a “back end” EMRembedded registry-based patient identification process and a
“front end” initiating order that enables providers to directly
refer patients. By using two access points, the program can
conduct proactive outreach and receive direct referrals from
physicians. Eligible patients also are identified through
gastroenterology chart reviews. Coordinators utilize an
Epic Reporting Workbench workflow tool to track patients
through each step of the Hepatitis B Pathway. The structure
of the patient registry, orders, and workflow tools are relevant
to other Health Care Systems Research Network members
planning population health management programs.
Results: Patients receive lab tests related to hepatitis B,
liver function, and co-infections as well as an abdominal
ultrasound. Patients have a gastroenterology encounter
(primarily by telephone) to review results, and hepatocellular
carcinoma surveillance eligibility is documented within the
chart. Between December 2017 and September 2018, 1329
patients participated. Preliminary data will be presented.
Conclusion: The Hepatitis B Pathway has several aspects
www.aurora.org/jpcrr
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that can inform the design of population health management
programs. These include registry construction, the Reporting
Workbench tool, lessons learned about registry-based vs
order-based access to the Pathway, performance metrics,
etc. This program serves as an example of how clinical,
operational, and research partnerships can effectively
improve clinical care.
OA11.01
Communicating Personalized Diabetes Risk With
Options for Weight Management: Recruitment,
Enrollment, and Outcomes
Craig Wood,1 Lisa Bailey-Davis,1 Jacob Mowery,1
Christopher Seiler,1 Adam Cook,1 Krystal Cunningham,1
Allison Naylor,1 Scott Jamieson,1 David Rolston,1
Christopher Still1
Geisinger Health, Danville, PA

1

Background: Primary care providers (PCPs) should offer or
refer individuals with obesity or impaired/abnormal glucose
to intensive multicomponent behavioral intervention.
However, <33% receive weight management advice, <5%
are referred for treatment, and only 15% would pursue
weight management based on a PCP recommendation alone.
Patients may be more likely to pursue weight management
if they believe weight loss will improve future health. A
personalized diabetes risk calculator was developed to
assess the impact of weight loss on future diabetes incidence.
The goal of this study was to determine if a diabetes risk
calculator (DRC) can be implemented with PCPs, result in
enrollment into effective weight management programs, and
improve diabetes health indicators.
Methods: Adult patients (N=338) with body mass index
(BMI) ≥ 27 kg/m2 and prediabetes (hemoglobin A1c:
5.7%–6.4%) received a letter describing their individual risk
of developing diabetes within 3 years and corresponding
reductions in risk with weight loss of 5%, 10%, and
15%. Interested patients were invited to select a 6-month
weight management treatment from the following options:
remote telephone counseling with a dietician, Fitbit, and
BMIQ website portal (RD); exercise class utilizing the
Diabetes Prevention Program (DPP); Weight Watchers
(WW); pharmacologic treatment plus RD (MEDS+RD);
or pharmacologic treatment plus DPP (MEDS+DPP).
Preliminary 6-month outcomes are reported.
Results: The recruitment response rate was 25% (n=84;
52% female; mean age: 57 years). The most popular
treatment selection was MEDS+RD (33%), followed by RD
(31%), DPP (15%), WW (11%), and MEDS+DPP (10%).
Of the first 67 patients who initiated the 6-month program,
79% completed treatment. Six-month data collection was
completed for 13 patients: mean weight loss was 8.4%
(standard deviation [SD]: 5.3, P<0.0001) ─ including 85%
with >5% loss of baseline weight ─ and mean hemoglobin
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A1c decrease was 0.2 (SD: 0.2, P=0.0018). When applying
these results to the DRC, the mean risk of 3-year diabetes
decreased from 24.1% to 11.6% (P=0.0017).
Conclusion: The use of a personalized DRC to motivate
weight management resulted in a high recruitment rate
and low attrition, leading to meaningful weight loss and
a reduction in hemoglobin A1c. Personalized risk letters
are a feasible means for informing patients of their risk of
developing diabetes and facilitating enrollment in available
treatment programs.
OA11.02
Predictors of Opioid Tapering Rate: FLOAT Study
David H. Smith,1 Jennifer Kuntz,1 Jennifer L. Schneider,1
Alison Firemark,1 John Dickerson,1 Xiuhai Yang,1 Dea
Papajorgji-Taylor,1 Mark Sullivan,2 Lynn DeBar,3 Lou
Ann Thorsness,4 Katherine Reese4
Kaiser Permanente Center for Health Research, Portland,
OR; 2University of Washington, Seattle, WA; 3Kaiser
Permanente Washington Health Research Institute, Seattle,
WA; 4Clinical Pharmacy Services, Kaiser Permanente
Northwest, Portland, OR
1

Background: Reducing opioid use is a high priority;
however, little is known about patient characteristics
associated with tapering. Our objective was to identify
predictors of tapering rate among patients referred to a
pharmacist-led opioid tapering program.
Methods: We assembled a retrospective cohort of adult (>20
years of age) Kaiser Permanente Northwest patients using
long-term, high-dose opioids and referred to a pharmacistled opioid tapering service between February 1, 2010, and
December 31, 2016. Time zero was the first contact with
the program; patients were required to have continuous
membership and drug coverage during the baseline year.
The outcome was the rate of change in milligram morphine
equivalents per day (MMED) each month over the year
following index. Candidate predictors were identified a priori
based on published literature and clinician input and were
measured during the baseline year using Kaiser Permanente
Northwest’s electronic health record. Predictors included
age, sex, socioeconomic status (SES), smoking, body
mass index (BMI), MMED, comorbid conditions (mental
health, type of pain diagnosis), health care utilization, and
baseline opioid trajectory. Generalized estimating equations
estimated the monthly change in MMED for each predictor,
controlling for concomitant medications; significance was
defined as alpha < 0.05.
Results: We included 1424 patients who were referred for
tapering. Patient’s average age was 57 years; 62% were
female. Patient’s MMED were high (>200) and stable at
baseline. Controlling for baseline medication use, faster
tapering (negative coefficient) was associated with nonwhite
patients (monthly MMED change: -1.07, 95% CI: -1.97 to
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-0.16), lower SES (-0.77, 95% CI: -1.48 to -0.06), lower
BMI (-1.50, 95% CI: -2.25 to -0.74), more emergency
department (-0.16, 95% CI: -0.31 to -0.02) and urgent care
visits (-0.02, 95% CI: -0.04 to -0.01), higher comorbidity
(-0.30, 95% CI: -0.45 to -0.16), and highest baseline opioid
trajectory (-1.25, 95% CI: -2.14 to -0.35). Slower tapering
(positive coefficient) was associated with smoking (monthly
MMED change: +0.82, 95% CI: 0.16 to 1.47), pain group
visits (+0.47, 95% CI: 0.30 to 0.64), more hospital stays
(+0.87, 95% CI: 0.46 to 1.27), diagnoses of depression
(+1.14, 95% CI: 0.58 to 1.71), fibromyalgia (+0.68, 95% CI:
0.11 to 1.25), more unique pain diagnoses (+0.37, 95% CI:
0.19 to 0.55), and lowest baseline opioid trajectory (+0.63,
95% CI: 0.01 to 1.25).
Conclusion: These data may help in designing tapering
interventions, including setting expectations for patients and
clinicians and identifying patients needing greater resource
intensity (eg, mental health consult) to successfully taper.

disease were associated with longer duration of treatment,
as measured by proportion of patients covered in the 5 years
after starting PPI treatment (18–29 years of age: 5% vs ≥60
years of age: 27%–41%; reflux disease: 20%; and H. Pylori
infection: 10%). Interestingly, approximately 15% of those
who had no record of any gastrointestinal-related diagnosis
maintained PPI therapy in the 5 years of follow-up.
Conclusion: Despite potential risks and current
recommendations to minimize long-term use, there is
evidence for PPI overuse. The prevalence rate of PPI use
increased steadily, often with no apparent clinical indication.
Further examination of indications for continued PPI
treatment is advised, especially among those ≥60 years old
who are more likely to be treated for longer periods.

OA11.03
Proton-Pump Inhibitor Treatment Patterns Among
Israeli Adults, 2000–2015

Michael Parchman,1 Lorella Palazzo,1 Gabrielle
Gundersen,1 Paula Blasi,1 Nora Henrikson,1 Brian
Austin1

Vered Rosenberg,1 Gabriel Chodick,1 Clara Weil,1
Varda Shalev,1 Kariv Revital1

1

Maccabi Healthcare Services, Tel-Aviv, Israel
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Background: Proton-pump inhibitors (PPIs) are a leading
effective therapy for acid-related disorders. Several studies
have found that PPIs are overused in ambulatory care
settings. The current study aims to describe patterns and
duration of PPI treatment in a real-world setting.
Methods: We conducted an observational study using the
computerized database of Maccabi Healthcare Services.
Study population included adult members who first purchased
PPIs between January 1, 2000, and December 31, 2015.
Annual incidence and prevalence rates were calculated. The
total annual PPI consumption was measured using defined
daily dose (DDD). Indications for initiating PPI treatment
were defined according to gastrointestinal-related diagnoses
and dispensed medications. Duration of PPI treatment, up
to 5 years after the first purchase, was assessed using the
proportion of patients covered (PPC) method.
Results: Study population included 528,420 patients. The
mean annual incidence rate was 2780.4 (standard deviation:
202.9) per 100,000. The annual prevalence rate increased
steadily, from 2360.9 per 100,000 in 2000 to 12,683 in
2015. The total annual consumption increased from 1.3
million DDDs in 2000 to 34.7 million in 2015. At least
one gastrointestinal-related diagnosis was available at
treatment initiation for 325,786 patients (62%). The most
common diagnoses were signs, symptoms, and functional
disorders (116,421 [22%]). Approximately 15% of all
patients maintained PPI therapy in the 5 years of follow-up.
In the subgroup analyses, older age and diagnosis of reflux
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OA11.04
Reducing Medical Overuse Across Three Diverse
Health Care Settings: Lessons Learned

Kaiser Permanente Washington Health Research Institute,
Seattle, WA
Background: Health care organizations frequently struggle
to reduce the use of services for which the risk of harm
exceeds the possible benefit. Herein, we describe findings
from 3 diverse health care organizations that applied the
Taking Action on Overuse Framework to address overuse.
Over 15 months, study team members and external facilitators
supported each organization’s efforts to engage providers,
patients, and care teams in an overuse-reduction quality
improvement initiative. A large hospital system addressed
overuse of the emergency department, an academic specialty
department addressed overuse of endoscopy, and a statewide
primary care association addressed opioid overprescribing
in community health clinics.
Methods: Stakeholders from each organization described
experiences with their overuse-reduction initiative during
midpoint phone interviews and during a 2-day capstone
meeting at the end of the project. The team reviewed
interview transcripts and capstone meeting notes, identified
common themes and lessons learned, and triangulated
findings with observations from external facilitators and
study team members. We were particularly interested in
understanding how their work and experience with reducing
overuse compared to traditional quality improvement.
Results: Sites chose their overuse-reduction topic based
on both fit with organizational strategic priorities and the
prevalence of overuse; 15 months into the initiatives, all
sites had engaged with leadership and gathered data to
frame their overuse problem. None had fully engaged frontline providers and staff or gathered data about the impact
of their initiative. Common challenges included a lack of
www.aurora.org/jpcrr
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leadership support, difficulty securing data, and competing
organizational priorities. Framing the work around physical,
emotional, or financial harm to patients was important in
efforts to engage providers and staff. Those leading the
projects emphasized that changing complex, entrenched
practices required significantly more time and effort than
anticipated.
Conclusion: Although overuse reduction shares similarities
with the areas of traditional quality improvement and patient
safety, this work requires unique approaches and more time
and effort than often anticipated. Key elements of successful
overuse-reduction efforts include engaged leadership and a
focus on reducing patient harm. Future work is needed to
explore which combinations of strategies are most effective
in supporting overuse reduction.
P3.01
Patient Perspectives and Patient-Reported Barriers
to Kidney Care From Southeastern Chronic Kidney
Disease Patients
Jennifer Gander,1 Musu Sesay,1 Doraina Walker
Williams,1 Lee Cromwell,1 Teaniese Davis,1 J. Patrick
Austin,1 Adam Wilk,2 Rachel Patzer,2 Nirvan Mukerji1
Kaiser Permanente Georgia, Atlanta, GA;
University, Atlanta, GA
1

Emory
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Background: Treatment education significantly improves
patient outcomes and access to care for the growing
number of patients with advanced chronic kidney disease
(CKD). Few studies have examined CKD patient-reported
experiences regarding accessing kidney care, including key
barriers and facilitators, and how their experiences may
be augmented through patient education. We conducted
a qualitative study to capture the experiences of advanced
CKD patients accessing kidney failure treatment, including
any modifying effects of CKD treatment education, within a
southeastern integrated health care system.
Methods: We completed 3 focus groups with 2 types of
patients with advanced CKD: a) 2 focus groups among
patients referred and attended the kidney treatment education
class (attendees); and b) 1 focus group of patients who
were referred and did not attend the education class (nonattendees). Each participant gave written consent and was
asked about 1) patient-health care provider relationships, 2)
kidney care education, and 3) social support.
Results: Preliminary results from the 3 completed focus
groups involved 17 CKD patients (76.7% black, 47.1%
female) with average age of 59 years. The “attendees” (n=11)
reported being satisfied with their health care team and were
encouraged by the formal kidney treatment education class;
reported barriers included needing more information on
CKD treatment options and uncertainty about treatment cost.
“Non-attendees” (n=6) primarily reported only interacting
with their nephrologist, reported transportation and
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scheduling conflicts as barriers to attending the education
class, and were interested in other modes of education.
Both attendees and non-attendees reported having a strong
social support system. Attendees and non-attendees reported
feeling overwhelmed with their advanced CKD diagnosis
and feeling that they had insufficient time between being
referred for the class and when they would start dialysis.
Conclusion: Kidney treatment education was informative
but could be improved by occurring more frequently and
offering information on treatment cost. We plan to complete
1 additional focus group among non-attendees and 2 focus
groups among patients that achieved a non-catheter-based
dialysis start (optimal starters). In our efforts to close the
information gap for patients with advanced CKD, we will
continue to enhance our patient engagement processes
utilizing the results from our focus groups.
P3.02
MedTrue™: Triangulating Patient-Reported Data
With Electronic Health Record and Claims Data
to Create Accurate Medication Lists and Facilitate
Conversations
Michael Gionfriddo,1 William R. Kaledas, Jr.,1 Katie
Frusciante,1 Melissa S. Kern,1 Nevan Elder,1 Stephen
Castor,1 Eric Wright1
Geisinger Health, Danville, PA

1

Background: Medication lists are often incomplete, which
can lead to serious adverse consequences. To help patients
and their clinicians have better conversations around
medication use and to create a more accurate medication list
for care management, we developed MedTrue™. MedTrue
is a web-based, electronic health record (EHR)-agnostic,
workflow application that integrates medication data sources
related to reconciliation and adherence from the patient,
provider, and external pharmacy claims systems, such as
Surescripts®. Herein, we describe MedTrue and discuss the
development process.
Methods: MedTrue was developed using an iterative design
process that included clinical observations and feedback
from end users. Project team members were embedded in
the clinic test sites to identify and troubleshoot technical
issues, gather observations on usability and utility, and
collect enhancements for the application.
Results: MedTrue has both a patient-facing and a health
care professional-facing interface. Initial prototypes of
MedTrue covered a comprehensive review of medication
use and contained several different screens addressing not
only medication reconciliation but medication adherence
and medication scheduling. Based on stakeholder feedback,
adherence and reconciliation screens were combined and
the scheduler screen was removed due to minimal utility
with the current use case. MedTrue can be accessed by
patients ahead of a scheduled office visit via our patient
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portal and immediately in the clinic prior to the office visit
through an iPad. Once accessed, patients can confirm their
medication list, add any additional medications, and report
their adherence to their medications over the last month.
Health care professionals can access MedTrue through
the patient’s EHR from within an embedded iFrame or a
web link opening the application in a browser. Health care
professionals can then review a patient’s medication changes
as well as existing medications, which are also listed with
patient-reported and pharmacy claims adherence data. To
date, MedTrue has been accessed by more than 7000 patient/
clinician dyads with over 35,000 unique uses.
Conclusion: MedTrue™ is a novel technology solution
that aims to create better conversations around medication
use and produce more accurate medication lists, ultimately
improving patient safety and outcomes. We are currently
evaluating MedTrue in a cluster-randomized trial.
P3.03
Developing a Center for Evaluation in a Learning
Health System
Meghan JaKa, Jeanette Y. Ziegenfuss,
Renner,1 Casey Easterday,1 Nico Pronk1
1

1

Jennifer

HealthPartners Institute, Minneapolis, MN

and developing a core set of plans focused on strategic
direction, operations, collaboration, and center performance.
Important performance goals such as number of repeat
customers and right-sized budgets will be assessed over the
coming year. An advisory board and peer-review process for
evaluation products also were developed to ensure rigorous
methodology and promote growth of the newly formed
center. As evidence of early success, the center has secured
operational funds to implement a number of programs in its
first year and is regularly receiving new project requests.
Conclusion: Continued success of the quickly growing
center depends on fostering strong relationships, prioritizing
and operationalizing projects, leveraging scientific rigor, and
receiving ongoing input from key stakeholders. Conceptual,
operational, and fiscal lessons learned during the first year of
implementation will be discussed.
P3.04
Screening and Referral of Orthopedic Patients Into
Care Coordination to Decrease Readmissions
Danielle Miller,1 Theodore Manson,2 Nathan O’Hara,2
Joan Davenport1
University of Maryland School of Nursing, Baltimore, MD;
University of Maryland Medical Center, Baltimore, MD

1

1

2

Background: Measuring program effectiveness is necessary
in a learning health system. A suite of services typically
exists to assess various aspects of program success (eg,
quality improvement, health informatics). However, these
specialized services are not intended to be cross-functional,
nor do they have methodologic expertise needed for
systematic program assessment. Research can address this
gap, but reliance on external funding results in misaligned
timelines and competing priorities. Evaluation services have
the potential to complement research efforts by leading crossfunctional collaboration of existing services to rigorously
assess programs on tighter timelines and potentially lower
costs. The development of an evaluation center within a
research setting is presented here. Specific challenges,
including demonstrating value, establishing stakeholder
buy-in, and developing operations, will be addressed.
Methods: To meet growing demand, a pilot evaluation
service line was established within a learning health
system’s research institute. Through several test projects,
the service line expanded its existing skillset and cultivated
client “champions.” In parallel, a development team with
expertise in research, evaluation, business intelligence, and
project management was established to formally develop the
service line into a center. Informed by feedback from center
members, leaders, and stakeholders, the team held a series of
meetings to develop a strategic direction and establish goals
for creating a solvent center.
Results: This process resulted in securing stakeholder
buy-in through client champions, hiring new expertise,

Background: Unplanned hospital readmissions negatively
impact patient outcomes and continue to place a financial
strain on the health care system. It is estimated that Medicare
spends $17.4 billion on unplanned readmissions in a year,
and 30-day readmission rates are a hospital quality indicator
reported by the Centers for Medicare & Medicaid Services
(CMS). Hospitals face monetary penalties for readmission
rates that exceed national benchmark under the Affordable
Care Act. In 2014, hip and knee replacements were added
to the Hospital Readmission Reduction Program, thus
authorizing CMS to financially penalize hospitals for
readmissions within 30 days of discharge.
Methods: This is a quality improvement project aimed at
reducing readmission in orthopedic patients undergoing a
revision of a total hip replacement or total knee replacement.
The LACE risk-screening tool identifies patients at high,
intermediate, and low risk for readmission to refer those
patients into care coordination. LACE index screening
chronicled in multiple studies has proven to be a superior
tool in determining readmission risks. The low-risk patients
receive a telephone phone call prior to the first appointment
postdischarge. The intermediate-risk and high-risk patients
receive phone calls for 30 days postdischarge.
Results: Planned data analysis will examine the readmission
rates in quarter one of 2018 (July–September) and compare
those readmission rates in quarter two of 2018 (October–
December) when the LACE screening tool was implemented.
In addition, the number of no-show appointment rates will
be compared from quarter one to quarter two of 2018 as
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well. Emergency department visits will be tracked in quarter
two for patients screened by the LACE tool.
Conclusion: The LACE index is a screening tool to help
health care systems make decisions on management of
care based off likelihood of survival and readmission into
the hospital. In 2010, Walraven et al endorsed this tool
due to extensive testing in more than 1 million randomly
selected medical and surgical patients after their discharge.
Introducing care coordination can assist with adequate
postdischarge support ─ increasing the likelihood of proper
follow-up with the health care team ─ and improve hand-off
between the inpatient and outpatient setting of health care.
P3.05
Direct-to-Patient Outreach to Improve Laboratory
Monitoring of High-Risk Medications in Ambulatory
Care
Lisa Pieper,1 Susan Shetterly,1 Marsha Raebel1
Kaiser Permanente Colorado, Denver, CO

1

Background: Many high-risk medications require
laboratory monitoring for safe use. At Kaiser Permanente
Colorado (KPCO), we identified a quality gap in completing
laboratory monitoring for high-risk medications, specifically
disease-modifying antirheumatic drugs (DMARDs).
Although most patients eventually completed monitoring,
there was a gap in timeliness to monitoring. Herein, we
describe the steps we took to develop and implement an
intervention that successfully reduced the gap, present best
practices for transitioning the work into routine operations,
and discuss expansion to other departments and medications.
Methods: KPCO is an integrated health care delivery system
with about 600,000 members in the Denver/Boulder area.
When organizational leaders were interviewed about quality
improvement priorities, monitoring of high-risk medications
was identified as of high importance. A multidisciplinary
team comprised of laboratory leaders, content experts
with knowledge of quality issues, clinical medicine
and pharmacy experts, health information technology
professionals, medical education specialists, evaluators,
researchers, virtual data warehouse (VDW) experts, and
project managers collaborated to develop/implement directto-patient interactive voice response (IVR) reminders.
Reminders were sent by text or phone call to patients taking
DMARDs who were due/overdue for monitoring. Data
resources to ensure appropriate patients received correct
reminders included the VDW, the electronic health record,
and the IVR system. System outcomes were measured.
Results: Employing a multidisciplinary team to develop/
implement an intervention for a quality gap identified
through an organizational leadership interview process
enabled strong operational support for the project. IVR
reminders to rheumatology patients were implemented
by researchers in 2017 and transitioned into usual care in
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2018. The reminders were supported by a patient helpline.
Outcomes demonstrated 1) the proportion of patients
chronically taking DMARDs, with guideline-concordant
monitoring increased from 52.8% (baseline) to 65.4%
(outreach) (P<0.001); and 2) the 95th percentile for time
to monitoring declined from 149 days (baseline) to 117
days (outreach). Patient and clinician feedback has been
positive. The project was expanded in December 2018 to
additional high-risk medications prescribed by dermatology,
gastroenterology, and neurology.
Conclusion: Automated communication outreach to remind
patients to obtain ordered laboratory monitoring improves
timeliness of testing for high-risk medications, is liked by
patients, and has been incorporated into usual operations.
P3.06
Examining Workflow Issues When Designing a
Clinical Decision Support Intervention to Reduce
Opioid Prescribing for Dental Extractions
D. Brad Rindal,1 Robert P. Schwartz,2 Jan Gryczynski,2
Stephen Asche,1 Jeanette Y. Ziegenfuss,1 Don Worley,1
Anjali R. Truitt,1 Tracy Shea,1 Sheryl Kane,1 Shannon
G. Mitchell2
HealthPartners Institute, Minneapolis, MN;
Research Institute, Inc., Baltimore, MD
1

2
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Background: The implementation of clinical decision
support (CDS) within an electronic health record (EHR)
to reduce opioid prescribing following dental extractions
poses significant challenges related to workflow and timely
activation. Failure to consider these issues could reduce the
effectiveness of the CDS intervention. We describe how
these issues were addressed prior to developing a CDS for
a trial focused on deimplementing opioid prescribing in
dentistry.
Methods: Three study team members conducted observations
of 15 dental extractions, with a focus on provider-patient
interactions as well as provider use of the EHR as it relates
to analgesic prescribing for extractions. A structured
checklist was developed by the team and completed for
each extraction observation, with follow-up clarifying
questions asked of the clinical staff when necessary to better
understand content accessed and sequencing of EHR-related
activities. Activities were specified as occurring before or
after the extraction.
Results: The observations provided valuable information
about when provider-patient discussions of analgesic
medications occurred and how the EHR was utilized during
these interactions. The observations illuminated variation
in processes and challenges of ensuring appropriate CDS
activation in circumstances when a dental extraction is
added into the treatment plan for a visit. Observations
revealed that general dentists and oral surgeons have
different workflow processes. These differences include
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when provider-patient discussion of analgesics occurs, the
level of involvement of other clinic staff, EHR use, and
visit types where dental extractions could occur. Findings
have implications for informing CDS content as well as the
content of implementation trainings.
Conclusion: CDS is a potential tool within an EHR that
can be utilized to implement evidence-based practices
or to deimplement ineffective and/or potentially harmful
practices. These results foster our understanding of the
issues and challenges of using CDS in dentistry.
P3.07
System and Patient-Level Barriers to Timely
Follow-Up Colonoscopy Completion: Qualitative
Exploration Within Safety-Net Clinics
Jennifer L. Schneider,1 Jennifer Rivelli,1 Inga Gruß,1
Amanda Petrik,1 Beverly B. Green,2 Gloria Coronado1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Kaiser Permanente Washington Health Research
Institute, Seattle, WA
1

Background: Fecal immunochemical testing (FIT) is an
effective colorectal cancer (CRC) screening method. Its
effectiveness, however, relies on follow-up diagnostic
colonoscopy when the FIT result is abnormal. Many patients
with an abnormal FIT result, particularly those within safetynet clinics, do not complete a timely follow-up colonoscopy.
Methods: As part of the Strategies and Opportunities to
STOP Colon Cancer in Priority Populations (STOP CRC)
study, which tested the effectiveness of mailed FIT outreach
to increase CRC screening rates in safety-net clinics,
we conducted interviews with participating patients. We
sought to understand facilitators and barriers to the timely
completion of a follow-up colonoscopy after an abnormal
FIT result. We interviewed both Spanish-language (SL)
and English-language (EL) patients who completed their
colonoscopy “early” (≤2 months of FIT result), “later”
(>2 months of FIT result), or not at all. Interviews were
completed by telephone, lasted approximately 45 minutes,
and were transcribed for content analysis.
Results: We completed 32 patient interviews (16 SL, 16
EL), mostly with females (66%), and representing 13 early
completers, 14 later completers, and 5 noncompleters
of follow-up colonoscopy. The most commonly stated
challenge to timely colonoscopy completion was fear
about the procedure, and this was endorsed more often
by SL participants and those who completed later. SL
participants cited as additional challenges cost and lack of
clear information about the procedure, while EL participants
described lack of reliable transportation. Being able to
discuss concerns about the colonoscopy process with a
provider prior to the procedure was the greatest facilitator
to colonoscopy completion, endorsed strongly by both SL
and EL early completers. Noncompleters of the colonoscopy
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(both SL and EL participants) described simultaneous
barriers including not understanding their abnormal FIT
result, having other health concerns, and cost.
Conclusion: Our interviews provide insight into challenges
patients experience that can delay or prevent completion of
a follow-up colonoscopy and add to our previous interview
findings with gastroenterologists that showed lack of
understanding, logistical issues, cost/insurance challenges,
and poor referral documentation/communication created
barriers to follow-up colonoscopy completion. Overall,
these findings can inform the design of programs to improve
rates of colonoscopy completion in safety-net clinics.
P3.08
Peer Support Needs of Young Adult Patients
With Self-Identified Complex Medical Conditions:
Opportunities for Improved Connection With
Clinical Care
Karen Wernli,1 Sarah Evers,1 Heidi
Consuelo Norris,1 Dori Rosenberg1

Berthoud,1

Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Younger adults with chronic or complicated
medical conditions often experience different care needs.
Peer support is a valuable tool to improve patient selfefficacy, knowledge, motivation, and patient empowerment.
However, little is known about who is using peer support
and why. We evaluated peer support needs among young
adult members with chronic or complex medical conditions
within Kaiser Permanente Washington (KPWA).
Methods: In the summer of 2018, we conducted via email
a cross-sectional survey of KPWA members 25–45 years
of age. Participants (N=322; 3.8% of those contacted, 74%
female, mean age: 37) self-identified as having a complex
medical condition (receiving care for a condition that is not
resolved by a single medical treatment, including surgeries).
Statistical analysis was conducted in SPSS to evaluate
descriptive statistics.
Results: Majority of respondents were currently receiving
care for a chronic or complex condition (78%) or had
received care within the past 2 years (22%). Most commonly
reported conditions included mental health/depression/
addiction, inflammatory/autoimmune, women’s health,
musculoskeletal/bone disease, cardiac/vascular disease,
and cancer; 25% of respondents used peer support for their
condition. Among those who did use peer support, most
common reasons for support were ongoing support for quality
of life (n=60, 75%), and coping and to better understand or
learn about their condition (n=61, 76%). Among users of
peer support, 25% were referred from their medical team.
Most reported their medical care team was not aware of their
peer support (n=49, 61%). Of all survey respondents, almost
40% wanted their main health care provider, in particular
www.aurora.org/jpcrr
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their physician, to talk with them about getting peer support
(n=123). Further, respondents wanted to use online support
groups (51%), social media-based support group for people
with the same conditions as them (36%), in-person support
group (35%), or mentoring-based one-on-one peer support
(34%).
Conclusion: Patients with chronic and complex medical
conditions reported self-needs for peer support across a
variety of medical conditions. Young adult patients would
like improved integration of their peer support needs with
their medical team. Further research will be to develop
interventions to support young adult patients through peer
and online support tools.

PATIENT, CLINICIAN, AND HEALTH
SYSTEM ENGAGEMENT
OA4.01
Characteristics of Learning Health System-Based
Research Programs
Brian Mittman,1 Bhanuja Dub,1 Chunyi Hsu,1 Visanee
Musigdilok,1 John Ovretveit,2 Michael K. Gould1
Kaiser Permanente Southern California, Pasadena, CA;
Karolinska Institutet, Stockholm, Sweden
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Background: Embedded or partnership research involving
close collaboration between researchers and health system
leaders is a promising strategy for enhancing the relevance,
timeliness, value, and beneficial use of research in health
system decision-making. Embedding researchers into health
care systems and facilitating active, sustained collaboration
and partnership between researchers and decision-makers
can facilitate the identification of important research
questions, improved study design and conduct, and more
valid interpretation and application of findings. We sought
to characterize existing embedded research programs in
private and public academic and nonacademic U.S. health
systems to identify features of successful programs.
Methods: Reviews of published descriptions of health
system-based research programs, community-based
participatory research, and stakeholder-engaged and
partnership research, supplemented by discussions with key
experts, guided development of a framework listing key
features of such research and a new online survey collecting
detailed descriptions of these features. Key domains in the
framework and survey include organizational placement
and governance arrangements (including details of policy/
practice and research leader collaboration in governance
decisions), funding sources, staffing and inventory of skills
and expertise, types of projects conducted, dissemination and
implementation practices, etc. Respondents were identified
through membership lists of relevant associations (eg, Health
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Care Systems Research Network [HCSRN], Association of
American Medical Colleges Research on Care Community,
Veterans Affairs’ Quality Enhancement Research Initiative
[QUERI]), through a prior survey of health system-focused
research conducted by AcademyHealth (Washington, DC),
and through snowball sampling.
Results: Health system-based research programs are
prevalent among academic health systems, large and mediumsized private health care systems, and private and public
safety-net systems, in addition to well-established programs
based at HCSRN member institutions and VA’s QUERI.
Programs vary widely in their organizational placement (eg,
within an academic health system or associated medical
school), funding (eg, support internal health system funding
vs primarily on extramural research funding), staffing (fulltime, dedicated vs “virtual” staffing arrangements drawing
from academic departments), and strength of connection to
health system priorities and oversight.
Conclusion: Characterizing existing health system-based
embedded research programs is a key step toward developing
explicit guidance and recommendations for program features
and toward growth in health system-focused research and
learning health care systems.
OA4.02
OpenNotes in Chronic Obstructive Pulmonary
Disease: Patient Perceptions of Their COPDSpecific Clinic Notes
Kimberly A. Fisher,1 Kara Kennedy,2 Sigall Bell,3
Mayuko Ito Fukunaga,2 Kathleen M. Mazor1
Meyers Primary Care Institute, Worcester, MA; 2University
of Massachusetts Medical School, Worcester, MA; 3Beth
Israel Deaconess Medical Center, Boston, MA
1

Background: Patients report many benefits of access to
their clinic notes (OpenNotes), including increased patient
activation and self-management, which are particularly
important in chronic illnesses such as chronic obstructive
pulmonary disease (COPD). Despite this promise and
increasing numbers of patients being provided access to their
clinic notes, little is known about how patients understand
and react to the information in clinic notes.
Methods: In-depth “think-aloud” interviews were
conducted with patients with COPD who had been provided
a written copy of their most recent COPD-specific clinic
note. Interviews were audio-recorded, transcribed verbatim,
and analyzed using thematic analysis. Emergent themes
were organized according to communication function.
Results: Interviews were conducted with 31 participants
who were predominantly (93.5%) white, 48.3% female, and
older (mean age: 65.9 years). Patients reacted positively to
statements in the notes suggesting the provider listened to
them (“He’s got my thoughts in here, which … makes me
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feel good about the fact that he listened to me.”), saw them
as a person, and was attentive to details (“I don’t even realize
that he does that.”); all of which fostered the relationship.
Reading notes enabled patient self-management through
motivation (“seeing it [smoking history] in black and white
makes you think”), prompted patients to seek more healthrelated information, and reminded them of action steps.
Patients indicated notes facilitated information sharing with
other providers and family members, served as a longitudinal
record of care, and provided an opportunity for patients to
learn details of their condition they had not gleaned from the
visit (“I didn’t get all this from the doctor. I got this from
reading.”) ─ each strengthening information exchange.
Most patients reacted negatively to medical terminology,
abbreviations, incorrect information, and wording that was
perceived as disparaging (“He is an active smoker would’ve
been fine, instead of putting abuse down there.”).
Conclusion: Sharing clinic notes with patients is a promising
communication tool that can strengthen the patient-provider
relationship and enable self-management and information
exchange. As patients increasingly access their clinic notes,
more research is needed to ensure notes are written in a way
that optimizes communication with patients while fulfilling
other functions of clinical documentation.
OA4.03
Live Phone Calls More Effective Than Automated
Reminders for a Direct-Mail Fecal Testing Program
in Community Health Centers
Jamie Thompson,1 Amanda Petrik,1 Michael Leo,1
Denis Nyongesa,1 Melinda Davis,2 Brittany Younger,3
Melissa Castillo,3 Anne Escaron,3 Gloria Coronado1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Oregon Health & Science University, Portland, OR;
3
AltaMed Health Services Corporation, Los Angeles, CA
1

Background: Colon cancer is a leading cause of cancer
death in the United States, and screening rates are
disproportionately low among Latinos. Our study seeks to
raise rates of colon cancer screening in a Latino-serving
community health center. Using patient-refined materials,
we examined fecal immunochemical test (FIT) completion
rates following automated and live approaches in a 3-arm
pilot pragmatic trial.
Methods: Eligible participants were 50–75 years of age,
not up-to-date with colon cancer screening, and had a clinic
visit in each of the previous 2 years at either of 2 health
center clinics. A total of 1767 participants were randomized
(1:1:1) to receive a text alert, mailed FIT, and 2 automated
phone call reminders (automated); a mailed FIT and up to 3
live call reminders (live); or the combination of text alert,
mailed FIT, 2 automated call reminders, and up to 3 live
call reminders (automated plus live). The format and content
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of the messages were selected using a patient-engagement
approach, boot camp translation. We assessed FIT return
rates in the 3 arms.
Results: Among randomized participants (N=1767), 553
(31.3%) completed a FIT within 6 months. Participants
had a mean age of 59 years and 57% were female. FIT
completion rates were 26.0% (automated), 32.3% (live), and
35.7% (automated plus live). Controlling for clinic, adults
allocated to the live condition had a significantly higher
FIT completion rate than those in the automated condition
(adjusted difference: 6.3 percentage points; 95% CI: 1.1–
11.4), as did adults allocated to the automated plus live
condition (adjusted difference: 9.7 percentage points; 95%
CI: 4.4–14.9). FIT completion rates differed significantly by
preferred language (English: 25.5%; Spanish: 35.1%; Other:
39.7%; P<0.01); number of clinic visits in the past year (Yes:
33.9% vs No: 21.2%; P<0.01); and prior FIT testing (Yes:
45.1% vs No: 17.1%; P<0.01). No significant interactions
were observed between treatment conditions and language,
number of clinic visits, or prior FIT testing.
Conclusion: Live call reminders, either alone or with
automated alerts and reminders, outperformed automated
approaches alone. Using multiple touchpoints and
communication modes might have the greatest impact on
FIT completion rates.
OA4.04
Use of Novel Patient-Facing, Self-Directed Health
Information Technology to Improve Patient
Engagement in Preventive Care: Focus on
Colorectal Cancer Screening
Erin Hahn,1 Aileen Baecker,1 Eric Haupt,1 Andre Ajura,1
Wahid Wakach,1 Tracy Imley,1 Brian Mittman,1 Ernest
Shen,1 Michael K. Gould,1 Michael Kanter1
Kaiser Permanente Southern California, Pasadena, CA

1

Background: Engagement in health care via patient-facing
online tools may be an effective method to increase use of
preventive care services, including colorectal cancer (CRC)
screening. Within Kaiser Permanente Southern California,
the online patient portal includes an Online Personal Action
Plan (oPAP), a tailored messaging tool intended to enhance
patient engagement. We evaluated an oPAP CRC screening
outreach strategy that allowed patients to directly request a
CRC cancer screening kit (FIT Kit) to be delivered to their
home using a self-directed “Order Kit” button.
Methods: Kaiser Permanente Southern California
members, age 50–74 years, who were eligible for annual
CRC screening and who had a portal account received the
CRC oPAP “button” message from December 14, 2016, to
October 2, 2017. Those who did not use the button were
mailed a kit as a passive outreach strategy. We compared
demographics, comorbidity, proxy measures of engagement
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(eg, missed appointments, portal use), and completion and
timeliness of the FIT Kit for button-users vs non-users. We
compared the number of button-users who completed a FIT
Kit within the prior year to determine if the availability of
the button engaged additional patients.
Results: We identified 177,209 eligible members; 9%
(n=16,941) used the order button. Among button-users,
83% completed the FIT Kit vs 37% of non-button users
(P<0.0001). Mean number of days to completion was 56 days
in the button-users vs 90 days (P<0.0001). In multivariate
regression, button-users were more likely to be white (odds
ratio [OR]: 1.23, P<0.001), less likely to have 4 or more
comorbidities (OR: 0.74, P<0.001), more likely to have 10
or more patient-portal logins in the past year (OR: 3.21,
P<0.001), and less likely to have no-show appointments
(OR: 0.72, P<0.0001). Of button-users, 12,076 were eligible
for a FIT Kit in the prior year. Of those, 63% (n=7592)
completed a kit, compared to 87% (n=10,448) post-button
(P<0.0001).
Conclusion: A higher proportion of button-users completed
FIT Kits than those who received the kit via the passive mail
strategy; button-users completed the kits in a significantly
shorter number of days. Of button-users, a significantly
greater number completed FIT Kits after the button was
introduced. Button use appears to reflect patient engagement,
with greater number of health care contacts and fewer missed
appointments for button-users.

2018. The study population included members, age 18 years
or older, diagnosed with persistent asthma without chronic
obstructive pulmonary disease. Members overfilling a BA
received an automated (phone, text, or email) 1-question
survey asking whether they experienced asthma symptoms
in the last month. Asthma exacerbation data were collected
from the EHR of patients responding to the survey for 1
month before and 1 month after the BA overfill. Asthma
exacerbations were defined as prednisone bursts or emergent
visits (emergency room, urgent care, or hospitalizations) with
a primary diagnosis of asthma. Agreement was evaluated
between survey responses and exacerbations using Cohen’s
kappa coefficient (κ).
Results: Of the 1278 patients contacted by the automated
system, 508 (39.7%) responded to the survey. In the month
prior to the BA overfill, of 11 patients with an exacerbation,
10 (90.9%) reported symptoms; of 497 without an
exacerbation, 293 (59.0%) reported symptoms. Agreement
between self-report of symptoms and past exacerbations
was poor (κ=0.023). In the month following the BA overfill,
of 20 patients with an exacerbation, 16 (80.0%) reported
symptoms; of 488 without an exacerbation, 287 (58.8%)
reported symptoms. Agreement between symptoms and
future exacerbations also was poor (κ=0.027).
Conclusion: Poor agreement between symptoms and either
past or future exacerbations indicates self-report of asthma
symptoms does not correspond with asthma exacerbations.

P14.01
Patient Self-Reported Symptoms Do Not
Correspond With Asthma Exacerbations Identified
in the Electronic Health Record

P14.02
Improving Clinical Research Through Citizen
Scientist Engagement

Courtney Anderson,
Glenn Goodrich,
Susan
Shetterly,1 Jo Ann Shoup,1 Nicole Wagner,1 Bruce
Bender,2 Marsha Raebel1
1

1

Kaiser Permanente Colorado, Aurora, CO; 2National
Jewish Health, Denver, CO
1

Background: Filling a short-acting inhaled beta-agonist
(BA) more frequently than recommended (overfill) is a
predictor of asthma exacerbations. Asthma care nurses
at Kaiser Permanente Colorado outreach to patients with
BA overfills, a resource-intensive activity. To reduce
this demand, the Breathewell project was implemented.
Breathewell uses an automated system to contact patients
overfilling a BA to identify patients currently experiencing
asthma symptoms and those with recent exacerbations.
However, whether patients’ self-report of asthma symptoms
is linked with asthma exacerbations is unknown. We therefore
analyzed whether patients’ self-reported symptoms agreed
with asthma exacerbations identified within their electronic
health record (EHR).
Methods: The intervention was conducted within Kaiser
Permanente Colorado between February 2017 and February
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Janet Brishke,1 Christy Evans,1 Elizabeth Shenkman1
University of Florida, Gainesville, FL
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Background: Stakeholder engagement is an important part of
the research process, yet many community stakeholders lack
knowledge about clinical research. The OneFlorida Clinical
Research Consortium utilizes community stakeholders
(citizen scientists) to bridge the gap between researchers and
community members by offering lay perspective on research
studies. As not all citizen scientists are familiar with research
logistics, this may sometimes foster miscommunication
or unrealistic expectations between citizen scientists and
researchers.
Methods: Using instructional design principles such as a
formative evaluation, a multimedia approach, and learning
assessments with color-coded feedback, an online, selfpaced curriculum was created to operationalize training
of new citizen scientists. The curriculum was pilot tested
with institutional review board approval from July 2017 to
January 2018, and data was collected from initial scores on
assessments completed at the end of each module as well as
a postcurriculum evaluation.
Results: The overall score across all modules was 81%, with
Supplement

scores ranging from 76% for the clinical and translational
science module to 98% for the stakeholder engagement
module. Notable differences were observed in the cultural
competency module, in which younger participants scored
higher than older participants (90% vs 77%), and in the
orientation to citizen science module, in which established
citizen scientists scored higher than new members (93%
vs 81%). Citizen scientists completed an evaluation that
asked questions about comprehension, video quality, and
assessment items. Most citizen scientists felt it was easy
to understand the information in the video tutorials, while
75% of citizen scientists felt that the assessment items were
comprehensive and 62.50% felt that the assessment items
matched the learning objectives.
Conclusion: The citizen scientists felt this curriculum was
an effective approach to providing background on topics
relevant to their work. The instructional design principles
utilized were rated favorably, with minor suggestions
to strengthen the program for future implementation.
Participants gained a deeper understanding of the processes
involved in conducting clinical research and have been able
to give more focused, actionable feedback. Understanding
how research works can help community stakeholders
better understand their contribution to research, offer
critical feedback to help advance health care, and inform
other community members of the value in participating in
research studies.
P14.03
Clinician Engagement in Health Systems Research:
A Survey of Clinicians Affiliated With a Clinical
Data Research Network
Irina V. Haller,1 Pat Conway,1 Joseph A. Bianco,2
James Conniff,3 Steven Eyer,2 Rozalina McCoy,4
Sarah Olimb,1 Allise Taran,1 Tameka Sama,5 Catherine
A. McCarty6
Essentia Institute of Rural Health, Duluth, MN; 2Essentia
Health, Ely, MN; 3Duluth Family Medicine, Duluth, MN;
4
Mayo Clinic, Rochester, MN; 5Arizona State University,
Phoenix, AZ; 6University of Minnesota, Duluth, MN
1

Background: Clinicians are critical stakeholders in patientcentered research, as they can make research relevant to
real-world settings. However, engagement of clinicians
in research can be challenging. Clinicians from two sites
of the Patient-Centered Network of Learning Health
Systems (LHSNet) were invited to participate in a survey
regarding supports and barriers to engaging in research to
better understand their experiences and inform strategies to
increase engagement.
Methods: An anonymous electronic survey included
multiple-choice and open-ended questions focusing on
clinician experience and interest in research, barriers, and
resources needed for engagement in research. Barriers and
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resources were analyzed using descriptive methods and their
variation by clinician demographic characteristics, clinical
role, and level of rurality of health care setting calculated.
Scales regarding level of interest in conducting research,
barriers, and resources needed for clinician engagement
were created using factor analysis. Open-ended data were
analyzed using NVivo and modified grounded-theory
approach.
Results: Survey responses were received from 719
clinicians from community-based, academic, and integrated
health systems (35% response rate). Among respondents,
46.6% were physicians, 17.5% nurse practitioners, and
6.1% physician assistants. Most clinicians (75%) reported
no current engagement in research. The 13 items regarding
research roles formed a reliable scale (Cronbach’s
alpha=0.933). Participant’s score on the interest in research
scale did not vary by gender, age, years in practice, or
clinical role but did vary by level of rurality of health care
setting (P<0.001). Lack of protected time for research
and competing clinical responsibilities were the highestrated barriers, followed by access to other research team
members, research time reimbursement at salary level,
and organizational culture that values research activities.
Ratings of barriers did not vary by age, level of rurality,
or clinical role. Female respondents rated organizational
barriers and lack of resources higher than males (P<0.05).
When asked about the type of research they wish to
engage in, participants identified a wide range of topics,
including research methods, education, medical conditions,
populations, organizational development, and care delivery
models. Some reiterated their concern about participating in
research because of the time involved.
Conclusion: Survey results provided a foundation for
developing strategies for clinician engagement in health
systems-based research.
P14.04
Creating Sustainable Infrastructure for Ongoing
Patient Engagement: Qualitative Findings From
the PORTAL Patient Engagement Council
Chalinya Ingphakorn,1 Carmit McMullen,1 Carolyn
Taylor,1 Suzanne Gillespie,1 Charles Anderson,1 Mickie
Bowe,1 Florence Kurttila,1 Loretta Nierat,1 Nicole
Sanchez,1 Leslie Taylor,1 Janice Tufte,1 Henry Werch1
Kaiser Permanente Center for Health Research, Portland,
OR
1

Background: Nearly a decade ago, the Patient-Centered
Outcomes Research Institute (PCORI) recognized that
creating a sustainable infrastructure for meaningful and
reciprocal patient engagement is essential to advancing
medical care. PCORI established a network of clinical
data research networks (CDRNs). One CDRN, PORTAL,
represents Kaiser Permanente, HealthPartners, and Denver
www.aurora.org/jpcrr
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Health systems. PORTAL established a patient engagement
council (PEC) to provide patient engagement resources
aligned with PCORI’s mission.
Methods: In 2014, PORTAL staff identified and recruited
patient stakeholders to join the PEC. PEC members
participated in training sessions on topics such as “Reading,
Reviewing, and Critiquing Research Articles;” “Reviewing
Grant Proposals;” “Using Twitter to Enhance Your Advocacy
Voice;” and “Understanding Conference Posters.” Each
PEC member has completed a self-assessment of their
advocacy skills and learning goals. They have attended
national conferences to meet with researchers, learn about
and comment on research findings, and further develop their
expertise. PORTAL staff helped to create personal profiles
and biosketches for PEC members that have been included in
grant applications. There have been on average 10 members
on the council, with some turnover.
Results: PEC members have responded to more than
50 requests from researchers. PEC members have made
research more patient-centered by offering their input
(mostly via webinar or email) about study conceptualization
and design, proposal ideas, study implementation and data
collection plans, manuscripts, and dissemination. Five of our
PEC members are formal patient partners on grant-funded
studies, and all PEC members now have enhanced their
skills and confidence to make their advocacy voice heard
across a broad range of research topics. With the conclusion
of PORTAL funding, we offer a patient engagement toolkit
as a freely available resource for researchers hoping to
increase patient engagement.
Conclusion: The real-world experience and perspective
that the PEC brings to research is needed and invaluable.
We found that patients are eager to partner with researchers,
to have their voices heard, and to develop the expertise to
make meaningful contributions to research. They also have
a message to researchers: “Seek us out!”
P14.05
Graphic Medicine as Physician Tool to Understand
Their Patient’s Experience of a Medical Condition
Tom Janisse1
The Permanente Federation, Portland, OR

1

Background: Engaging patients in their health care,
listening to their stories, and improving the quality of their
experience also depend on physicians understanding their
patient’s experiences of a medical condition. Physicians
have little time to converse with patients about this in the
visit. Graphic medicine ─ the use of comics (pictures and
words together in sequence to tell a story) ─ is a way to gain
insight into a patient’s experience of what it’s like.
Methods: This is a small, mixed-methods study to test
the effect on physicians of reading a comic book, “My
Degeneration: Parkinson’s Disease.” The 13 participants,
80
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including 11 physician-editors (representing 10 disciplines),
answered a 7-question presurvey before receiving and
reading the book and a 10-question postsurvey. Also, the
12 participants present at the recent Permanente Journal
editorial team meeting, held 3 days after the postsurvey,
offered comments (60 minutes) on the survey results, then
related their experience of reading the book, its attributes,
and their recommendations for the comic book as an
educational tool for residents and patients.
Results: Greatest improvements were “know patients’
wants” (54%), “know treatments” (37%), “know patients’
needs” (34%), and “know patients’ experience” (30%); 82%
recommended the comic book for resident education and
73% for patients. Notable physician comments included:
“My patients say: ‘Doc, you guys really need to understand
what’s going on for me. It’s really hard for me.’” Another
senior editor who just disclosed he’s been living with
Parkinson’s disease for 10 years exclaimed, “Excellent
book! And I’m well into my 80s.” Other comments were:
“For a patient to have a conversation with his disease, as in
the book, is a wonderful idea.” “The things that people do
to deal with their condition are remarkable!” “Combining
pictures with words has triple the educational value for
millennial residents who demand high yield.” “Recommend
for all who may be interested, including family members.”
Conclusion: A graphic comic format improves the level of
knowledge and treatment of a chronic medical condition, the
understanding of a patient’s needs and wants from a physician,
and the patient experience, among a multidisciplinary group
of physician-editors.
P14.06
Geisinger Provider
Authorization

Experience

With

Prior

Ilene Ladd,1 Christina Gregor,1 Jove Graham,1 Michael
Evans,1 Michael Gionfriddo,1 Laney Jones1
Geisinger Health, Danville, PA

1

Background: The prior authorization (PA) process
was created to improve appropriate use of prescription
medications and to manage health care costs. However, the
process as currently practiced has engendered high levels
of dissatisfaction among medical staff. The American
Medical Association (AMA) issued a survey in 2017 to
assess physicians’ views on the impact of PA on patients and
providers. We adapted the AMA 2017 survey to establish
a baseline snapshot of providers’ views of PA prior to the
implementation of an intervention to improve PA in our
health system.
Methods: The 14-question survey was emailed to 2307
providers at Geisinger who had written any prescription
since July 2018. A reminder email with a link to the survey
was sent 1 week and 2 weeks after the initial survey. The
first question of the survey screened out providers who had
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not written a prescription that required PA in the past year.
Results: Overall, 509 providers responded to the survey
for a response rate of 22%. Of those who responded, 401
(79%) reported they had prescribed a medication requiring
PA. The majority of providers (62%) reported waiting at
least 1 day to receive PA approval; 88% of the respondents
believe that the PA process delayed access to necessary care,
and 89% said the PA process led to negative impact on their
patients’ clinical outcomes. The burden of the PA process on
providers and staff was described as high or extremely high
by 80% of the providers, and 73% believed the burden of the
PA process has increased over the last 5 years.
Conclusion: Overall, the perceived burden of the PA
process to providers and patients was mostly similar with
the AMA’s study, but fewer local providers reported that
the burden of PA had changed in the past 5 years (73% vs
86%, respectively.) After additional responses have been
collected, this survey will serve as a baseline for provider
views of the process prior to implementing a PA intervention
at our system.
P14.07
Developing a Research Strategy in a Network of
Outpatient Behavioral Health Clinics for Veterans
and Their Families
Rajeev Ramchand,1 Anthony Hassan,1 Alice Kim,1
Crystal Shelton,1 Heather Chiarello1
Cohen Veterans Network, Silver Spring, MD

1

Background: The Cohen Veterans Network (CVN) was
established in 2016 to provide low- or no-cost mental health
care to veterans and their families. With 10 clinics open
and 15 more scheduled to launch across the United States
by 2020, CVN is currently establishing a research strategy
to learn from its experiences and use this information to
improve future performance.
Methods: Through consultation with the CVN scientific
advisory board as well as a review of key research findings
from existing learning health systems (ie, the Mental Health
Research Network), a research strategy was developed
specific to CVN’s practices and operations.
Results: There are two elements to the CVN research strategy
─ the research foundation which establishes the processes
that will guide CVN’s research activities (eg, human
subjects protection, quality assurance, and dissemination),
and the research strategy itself. The strategy is composed
of 5 interrelated areas of focus: the use of existing data; the
collection of new data; informing and improving clinical
practices; enhancing business efficiencies; and contributing
to the scientific collective.
Conclusion: A formal approach to conducting research will
help ensure that CVN clients continue to benefit from highquality outpatient behavioral health care. The goal is for the
strategy to be dynamic, with continuous adaptations as CVN
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continues to learn how to incorporate research learnings
into program improvement and contributes to the emerging
science of health systems and mental health research.

DATA SCIENCE, INFORMATICS AND
DATA MODELS
OA5.01
Variation in Care Improvement Opportunities
Suggests Need for Tailored Clinician-Specific
Improvement Interventions
Patrick J. O'Connor,1 Jeffrey Anderson,1 JoAnn SperlHillen,1 A. Lauren Crain,1 Jay Desai,1 Pritika Kumar,1
Rebecca Rossom1
HealthPartners Institute, Bloomington, MN

1

Background: Various organizations, including Centers for
Medicare & Medicaid Services, have defined accountability
measures that are publicly reported and used to adjust
payment for clinical services. We posit that if primary care
clinician (PCC) performance on accountability measures
(such as diabetes or cardiovascular care) is suboptimal,
then PCC-specific care improvement opportunities can be
identified through automated monitoring of a broad set of
specific underlying process-of-care measures pertaining to
clinical actions.
Methods: As part of a clinical decision support (CDS)
system implemented within a large health care delivery
system, we provided individualized patient treatment
recommendations related to optimal management of
6 cardiovascular risk factors at adult encounters. We
developed process-of-care measures related to recognition
of conditions, timely monitoring of disease states, time to
medication intensification for patients in suboptimal control,
medication choices, frequency of drug/condition and drug
interaction safety concerns, and appropriate referrals by
calculating the provider’s proportion of patients that each
of 60 clinical recommendations were generated by the CDS
system (10 blood pressure, 15 glucose, 29 lipid, 4 aspirin,
and 2 smoking). We then quantified variation across 597
PCCs (minimum 20 patients) on these process-of-care
measures by analyzing the data from 128,679 clinic visits
made by 75,855 adults with diabetes or cardiovascular
risk factors from January 1, 2017, through December 31,
2017. Providers were classified as high-performing (10th
percentile) and low-performing (90th percentile) for each
recommendation based on the proportion of patients for
whom the recommendation was generated.
Results: We observed substantial variation when comparing
low- vs high-performing providers, with as much as a 29%
difference in the proportions of patients for whom CDS
recommendations were generated. Across measures, low-
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performing providers had a proportion of patients for a
CDS recommendation at least 1.9 times greater than highperforming providers.
Conclusion: In a care delivery system frequently recognized
for high-quality care, we observed many clinician-level
opportunities to improve underlying processes of care that
are linked to optimal diabetes and cardiovascular risk factor
management. Wide variations observed in performance on
process of care presents actionable opportunity to design and
deliver PCC-specific quality improvement interventions.
The dissemination potential for this automated surveillance
technology is high.
OA5.02
Using Seasonal-Hybrid Extreme Studentized
Deviate Method to Detect Anomalies in Virtual Data
Warehouse Quality Assessment
Qing Zhou,1 Matthew Slaughter,1 Ning Smith,1 Alan
Bauck1
Kaiser Permanente Northwest, Portland, OR

1

Background: Kaiser Permanente’s Center for Effectiveness
& Safety Research (CESR) conducts data quality
assessments of virtual data warehouse (VDW) data regularly
to ensure that the data collected through the VDW meet the
specification defined by the data dictionary. The goal of this
quality check is to reveal any potential issues in the data
and the extract, transform, load (ETL) process by detecting
anomalies in the counts of the raw records at different time
intervals.
Methods: In the past, the moving average (MA) method
has been used successfully to detect regular outliers without
seasonality trend but failed to differentiate the recurrent
seasonal jumps/drops from the real outliers when seasonality
exists (for example, number of flu vaccination encounters).
To solve this problem, we used the seasonal-hybrid extreme
studentized deviate (S-H-ESD) method, which builds upon
the generalized extreme studentized deviate test, to detect the
anomalies. In this project, we applied the method to monthly
encounter counts of 5 encounter types within the VDW
where known anomalies exist at different time points. An
open-source R software package named AnomalyDetection
was used to perform the analysis. We also conducted MA
analysis for comparison purpose.
Results: The results showed that, using AnomalyDetection,
the S-H-ESD method correctly identified all anomalies
while avoiding the seasonalities. In contrast, MA incorrectly
labeled seasonal jumps as outliers. We also implemented
the R code block in the SAS/Interactive Matrix Language
procedure, which will allow us to deploy the R package
directly from SAS and automate the AnomalyDetection
process in the future.
Conclusion: Applying the seasonal-hybrid extreme
studentized deviate method to data quality assessments
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complements and enhances the ability to correctly identify
potential problems within the data.
OA5.03
Patient Navigation Following an Abnormal FIT: Use
of a Predictive Model for Precision Delivery
Eric Johnson,1 Matthew Slaughter,1 Sacha Reich,1
Gloria Coronado,1 Amanda Petrik1
Kaiser Permanente Northwest, Portland, OR

1

Background: Colon cancer is a leading cause of cancer
death in the United States. Only ~70% of Kaiser Permanente
Northwest patients who are due for a follow-up colonoscopy
obtain one within 6 months of their positive fecal
immunochemical test (FIT) result. Patient navigation can
increase follow-up colonoscopy rates but is “high-touch,”
and not all patients need it. This study, Colorectal Cancer
Screening Follow-up Risk at Kaiser Permanente Northwest
(KPNW CRC Risk), is a pilot for testing patient navigation
among patients determined to be unlikely to complete a
follow-up colonoscopy.
Methods: Patients were 50–75 years of age, had an abnormal
FIT test, and were due for a colonoscopy. The risk prediction
model included data from the electronic health record.
Patients are assigned a risk prediction model-generated
“colonoscopy adherence score” based on their probability
of completing colonoscopy. Patients are randomized,
within probability strata, to a phone-based program of
patient navigation or to usual care. Patient navigation was
conducted through the delivery system and within the
KPNW gastroenterology teams. Primary effectiveness
outcomes are colonoscopy completion within 60 days and
time to colonoscopy receipt.
Results: To date, 320 patients have been randomized (160
assigned to patient navigation, 160 to usual care). All patients
have a predicted probability of less than 0.70 of obtaining
a colonoscopy within 6 months. With 60 days of followup, across all probability groups, more patients receiving
navigation support are completing their colonoscopies than
usual care patients (50.0% [95% CI: 36.9–63.1] vs 40.8%
[95% CI: 28.2–54.8]). The number of days from abnormal
FIT result to colonoscopy completion is less in the patient
navigation group than in the usual care group. On average
across all probabilities at 60 days, the colonoscopies are
completed about a week earlier (6.8 days). In the 50%–60%
probability range, colonoscopies are completed about 3
weeks earlier with patient navigation than in the usual care
group.
Conclusion: Knowing which patients could benefit from
patient navigation could optimize the delivery of these
services, address health disparities, reduce associated costs,
and support broad adoption of patient navigation programs.
Further application of risk prediction modeling for health
services delivery should be explored.
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OA5.04
DIY Analytics for HMOs: How You Can and Why
You Should

P6.01
An Integrated Analytic Database to Support
Genomic Research

Roy Pardee,1 David Cronkite1

Alan Bauck,1 Gwyn Saylor,1 Anand Sethuraman2

1
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1

Background: There is a robust market for predictive
analytic products in both health care and health insurance.
Some provide locally installed software (eg, ACG® System
at Johns Hopkins University [Baltimore, MD]), while
others offer services that give predictions for uploaded
data (eg, Jvion [Johns Creek, GA]). Both are expensive but
provide significant value. The increased availability and
quality of open-source software for data science re-opens
the “build or buy” question. Many of our organizations
straddle both market segments (providers and insurers),
affording more data than is used by most vended software.
We hypothesize that this combination of data may yield
greater insights than either would alone. We will tell the
story of an effort at “building” a local model — similar to
the risk of hospitalization component in ACG — to predict
who is likely headed into the hospital for prioritizing case
management efforts.
Methods: We pulled diagnoses, procedures, pharmacy
fills, body mass index measures, blood pressures, and
lab results for a cohort of 70,000 chronically ill patients
observed during a 3-month period in 2016. We then
identified inpatient admissions among those patients in
the subsequent 12 months. Using a data science approach,
we trained several classifiers from Python’s scikit-learn
package to discriminate between patients who were and
were not hospitalized on the basis of their claims and
clinical data together. We used the remainder of the data to
evaluate those trained classifiers.
Results: The support vector (SVC) and random forest (RF)
classifiers performed best, producing samples of more than
50% hospitalized people among their top 100 most-likely
patients, comparable to the predictor of inpatient risk that
ACG produces (SVC: 63%; RF:55%; ACG:46%), though
ACG relies on 12 months of data prior to the observation
period rather than our use of only 3 months.
Conclusion: With modest efforts, virtual data warehouse
data, free software, commodity hardware, and almost no
clinical expertise, we constructed a predictor of inpatient
risk that worked as well for our purposes as ACG, despite
using fewer months of input data. Our results demonstrate
that “building” analytics tools is a viable choice for
organizations desiring to explore analytics, especially if
they have access to more data sources than is expected by
vended solutions.

Background: The Kaiser Permanente Research Bank
(KPRB) is one of the most population-diverse biobanks in
the United States and contains collections of blood, saliva,
and diverse patient data for more than 330,000 individuals.
Eight geographically separate KP regions participate
in the KPRB. Participants consent to broad use of their
biospecimens, electronic health record data, survey data,
and genomic data for health research. To make its data
available for precision medicine and genomic research,
the KPRB developed a single integrated analytic database.
Nine research investigators with knowledge of a broad
range of research domains developed a comprehensive list
of electronic health record (EHR) data to include in the
database. The Center for Effectiveness and Safety Research
(CESR) virtual data warehouse (VDW) was identified as
the primary source for EHR data.
Methods: Data extraction programs were developed to pull
data from the 8 participating regions’ CESR VDW for the
KPRB-consented participants, perform quality checks, and
load the data into the KPRB analytic database. In addition
to incorporating a large portion of the CESR VDW, the
KPRB analytic database also includes a thousand-item
survey, demographic information, and lab specimen data
on KPRB-consented participants. To facilitate researchers’
understanding of the KPRB analytic data, a population
summary report was developed that can be regenerated
using an existing data characterization program. The report
provides more than 70 pages of summary statistics about
the KPRB population and can be readily enhanced.
Results: The KPRB analytic database resides in a
Microsoft SQL Server database with schemas for EHR,
survey, and subjects and includes a total of 58 tables. All
the data are linked through 1 of 3 key linking identifiers
or child linking identifiers. The linking identifiers are
accessible only within the database and not shared. When
data are provisioned for researchers, a project-specific
linking identifier will be generated, enabling access for that
project. A comprehensive data dictionary of the database is
built and maintained.
Conclusion: The integrated KPRB analytic database
incorporates and links EHR, survey, demographic, and
specimen information. It provides a rich and curated set of
data from which KPRB analysts can efficiently provision
data needed for health research.
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P6.02
The Center for Effectiveness and Safety Research
Virtual Data Warehouse (VDW) Model, an
Extension of the Health Care Systems Research
Network VDW
Alan Bauck,1 Don Bachman,1 Phillip Crawford,1 Reesa
Laws,1 Tamara Lischka,1 Gwyn Saylor,1 Sanchita
Sengupta,1 Jenny Staab1
Kaiser Permanente Northwest, Portland, OR
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Background: The virtual data warehouse (VDW) for Kaiser
Permanente’s Center for Effectiveness and Safety Research
(CESR) is a distributed set of standardized research data
tables. In addition, it is a set of common data warehouses
that are maintained by each site. The CESR VDW extends
and complements the core patient/health care data in the
Health Care Systems Research Network (HCSRN) VDW to
include new data domains, such as patient-reported outcomes,
radiation therapy, personal health records, pregnancy, benefits,
bone mineral density, infusion, and additional medication data.
Methods: CESR collects input on potential data domains
to standardize for multisite research through surveys,
meetings, and informal feedback. That information is
collated to identify areas of high interest, and those
with the highest interest are then explored through data
feasibility assessments. The data feasibility assessments
look at data availability, likelihood of use, and effort to
develop and maintain. Data domains that pass the feasibility
assessment are developed through multisite workgroups of
researchers and programmers. The final deliverables are 1) a
standardized and well-specified data dictionary; 2) common
ETL (extract, transform, load) code, where applicable, or
agreed-on business rules to transform the data to the new
standard; 3) data that meet the common data specification
and are refreshed and available for use by all researchers at
all sites; and 4) a data characterization report summarizing
the new data across the sites.
Results: The CESR VDW expands on the HCSRN VDW and
more than doubles the number of tables available for multisite
research from 19 to 52 tables and growing. The data definitions
and specifications are readily shared with organizations
seeking to build all or parts of the data for collaboration.
Conclusion: The CESR VDW complements and enhances
the HCSRN VDW. It provides researchers the ability to
efficiently conduct health research across organizations with
an expanded set of research domains.
P6.03
An Algorithm to Identify Ongoing Pregnancies in
the Vaccine Safety Datalink
Brad Crane,1 Don Bachman,1 Stephanie Irving,1
Kimberly Vesco,1 Eric Weintraub,2 Natalie McCarthy,2
Allison Naleway1
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Background: Using data from 7 integrated health care
systems (sites), the Vaccine Safety Datalink (VSD) monitors
vaccine safety. Evaluating vaccine safety during pregnancy
is a priority for the VSD. The existing VSD Pregnancy
Episode Algorithm (PEA) is effective at identifying
pregnancy episodes after a pregnancy outcome but is unable
to identify ongoing pregnancies. To address this limitation,
we developed the Dynamic Pregnancy Algorithm (DPA) to
identify pregnancies with or without pregnancy outcomes in
the electronic medical record or claims data.
Methods: The DPA identifies medical encounters associated
with pregnancies (pregnancy indicators) and incorporates coded
diagnostic, procedural, and gestational age data to estimate
several pregnancy-related variables. To test functionality, we
implemented the DPA at all VSD sites to identify pregnancies
occurring during 2016. Using the VSD PEA as a gold standard,
we retrospectively compared DPA results with the PEA to 1)
assess how quickly the DPA was able to identify pregnancy
episodes, and 2) assess data quality of pregnancy episodes
identified exclusively by the DPA. Results were stratified by
live birth and non-live birth outcomes.
Results: The DPA identified 243,409 pregnancy episodes
in 2016. Of those, 152,779 (63%) had outcomes in 2016
identified by the PEA. Across sites, 99% of PEA episodes
with outcomes in 2016 were found by the DPA (range:
98.4%–99.8%). The PEA identified 8971 live birth and
4,194 non-live birth outcomes that occurred in December
2016. Of these, the DPA found at least 1 pregnancy indicator
6 or more months prior to outcome for 89% of live births
(range: 85%–92%) and found at least 1 pregnancy indicator
1 or more months prior to outcome for 47% of non-live
births (range: 45%–60%). Of pregnancies identified by
the DPA during February 2016 (n=86,147), 92% had
subsequent outcomes identified by the PEA in 2016 (range:
86%–92%). Among those DPA-identified pregnancies with
no subsequent PEA outcome, 70% did not have continuous
health plan enrollment for all of 2016.
Conclusion: The VSD DPA reliably captures pregnancy
episodes relative to the VSD PEA. By not requiring
outcomes to identify pregnancies, the DPA can identify, in
real time, ongoing pregnancies previously not available for
study in the VSD.
P6.04
Using
Predictive
Analytics
Appointment No-Shows

to

Decrease

Sharon Fuller,1 Owen Kanaga,1 Sarah Wray,1 Yates
Coley,1 Adam Elder,1 Emily Westbrook1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1
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Background: Patients do not show up for 6% of their
appointments at Kaiser Permanente Washington clinics, and
another 5% of appointments are same-day cancellations.
This costs millions of dollars each year in unused provider
and resource capacity and makes it harder to achieve patient
access goals. Patients’ health is also at risk when they do
not follow through on their care. In 2018, we implemented
a predictive model from Epic, our electronic health record,
to identify appointments with a high risk the patient will noshow. As part of Kaiser Permanente Washington’s Learning
Health System (LHS) Program, researchers are collaborating
with the delivery system to evaluate the model’s accuracy
and implement improvements.
Methods: The Epic model estimates the likelihood a
patient will no-show for a given appointment. The first
prediction occurs when the appointment is made, followed
by 1 prediction a day for the 7 days before the appointment.
We examined the area under the curve (AUC) to assess
the model’s accuracy. The AUC for the current model
is approximately 0.70, which is respectable, but leaves
room for improvement. We have developed an external
dataset including the 22 stock Epic data elements, along
with additional Epic variables of potential interest. To test
improvements, we will first create our own prediction model
using these variables and compare it with Epic’s model. We
will add or remove variables to attempt to increase the AUC.
Our revised model can be built back into our Epic instance.
Results: We will present AUC results for our custom model,
discuss relevant variables, and preview new interventions to
decrease the no-show rate.
Conclusion: We plan to use our increased predictive
capabilities to focus interventions where they will be most
effective. Reducing no-shows will increase efficiency and
improve patient access and care. The advanced data and
biostatistical and analytic capabilities of the LHS Program
have helped the enterprise to move quickly toward an
important strategic and operational goal. This collaborative
effort also provides the opportunity to begin developing a
framework for harnessing the power of predictive analytics
for future projects.
P6.05
Development and Validation of an Algorithm to
Identify Chronic Obstructive Pulmonary Disease in
Individuals Eligible for Lung Cancer Screening
Duc Ha,1 Chan Zeng,1 Andrea Burnett-Hartman,1 Brian
Hixon,1 Caroline Joyce,1 Debra Ritzwoller1
Institute for Health Research, Kaiser Permanente Colorado,
Aurora, CO
1

Background: The balance of benefits and harms of lung
cancer screening (LCS) can be optimized through better
characterization of underlying comorbidities. Chronic
obstructive pulmonary disease (COPD) is a major
Supplement

comorbidity that can modify outcomes in individuals
eligible for LCS. This study’s objective is to exploit uniquely
available clinical and administrative data to develop and
validate an algorithm to more accurately identify COPD in
individuals eligible for LCS.
Methods: In a retrospective cohort study we identified
individuals 55–80 years of age who are eligible for
or have received LCS at a large integrated health care
system from 2014 to 2017. In addition to descriptive
statistics, we develop multivariable logistic regression
models to predict COPD using input associated variables:
demographics (eg, age, sex, race, body mass index,
tobacco exposure); diagnoses of COPD, asthma, and
other comorbidities captured within 2 years of the date of
LCS eligibility or initial low-dose computed tomography
by the respective providers (primary/pulmonology) and
clinical context (outpatient/inpatient); pharmacy dispenses
related to COPD and smoking cessation; durable medical
equipment claims (eg, supplemental oxygen, nebulizers)
and spirometry data (eg, peak expiratory flow rate, FEV1,
forced vital capacity); health care utilization related to
COPD exacerbations (eg, emergency department visit,
hospitalization); and referrals to smoking cessation and
pulmonary rehabilitation programs. We will use the Global
Initiative for COPD definition as the reference standard
and consider alternative diagnoses of obstructive airway
diseases (eg, chronic obstructive asthma, bronchiectasis).
The model performance will be evaluated by discrimination,
calibration, sensitivity, and specificity.
Results: We identified more than 16,000 individuals who
were eligible for LCS, of whom 3375 received baseline lowdose computed tomography. The median age was 64 years;
most (56%) were male, current smokers (>55%), and had
≥30 pack-years of tobacco exposure (95%). The majority
(>50%) of eligible or screen patients had a diagnosis of
asthma, COPD, or both, and received 1 or more COPDrelated pharmacy dispenses. Efforts are underway to capture
spirometry values and develop multivariable logistic
regression models.
Conclusion: Using a unique set of clinically derived input
variables from a cohort of patients potentially exposed to both
the benefits and harms of LCS, our algorithm may enhance
the effectiveness, precision, and delivery of populationbased LCS by more accurately identifying eligible patients
with COPD.
P6.06
Validating the Use of Order Instructions to Predict
Days Supply
Luesa Jordan,1 Dustin Key,1 Lawrence Madziwa,1
Matthew Nguyen1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1
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Background: Pharmacy (Rx) dispensing data is a gold
standard in measuring medication use in observational
studies. Research studies using pharmacy data often require
days supply. Days supply can be an important element in
a study. For example, it may be required to determine the
eligibility of a participant or exposure status at a given point.
When days supply is not available, the pharmacy instruction
can be used to impute it.
Methods: Days supply is equivalent to the ratio of drug
quantity to pills-per-day (PPD) and can be estimated by
the instruction field also known as SIG. The SIG variable
provides directions for medication use (eg, “TAKE 1
TABLET BEFORE BED”). Most SIG values can be
translated to PPD. To automate this process, the authors
have built a macro that takes SIG values and pharmacy
amounts to derive a PPD value. This macro, which uses
regular expression analysis, looks for common patterns
of interest within each SIG value (“X TIMES A DAY,”
“EVERY X HOURS,” etc). We compared the algorithmderived days supply to that of a pharmacy fills dataset for
which the quantity was readily available. The mean absolute
percentage error (MAPE) statistic and agreement accuracy
were used for validation. Further stratification was done by
drug form and SIG translation difficulty.
Results: After correcting for outliers, the PPD macro
performs well against the validation data (MAPE mean:
17.1; overall accuracy: 76.2%). For certain types of
pharmacy dosage forms ─ tablets, capsules, and pills (TCP)
─ the macro performs even better (8.1; 85.3%). For all other
dosage forms, the macro performs poorly (81.4; 11.9%).
Within TCP, performance on SIGs that were classified as
difficult is moderately poor (64.2%; 19.0%).
Conclusion: The PPD program can be a valuable tool for
studies needing to analyze a prescription’s days supply.
Careful application of the program is necessary, however,
due to known limitations/potential pitfalls (eg, weaknesses in
handling certain dosage forms, inability to consider tapering,
receiving SIG values with protected health information from
outside sites).
P6.07
Visualizing the Benefits Characteristics of a Large
Health Care Provider’s Membership
Don McCarthy,1 Mike Santema1
Kaiser Permanente Southern California, Pasadena, CA

1

Background: Visualization can be a valuable tool when
dealing with complex data such as the benefits information
associated with the membership of a large health care
provider. We present several geographic visualizations of
Kaiser Permanente Southern California (KPSC) membership
insurance and benefits information.
Methods: We use the newly implemented at KPSC Center
for Effectiveness and Safety Research benefits and the Health
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Care Systems Research Network virtual data warehouse
enrollment and census files (based on membership and
benefit data extracted from KPSC membership data
warehouse) as well as Base SAS software to create
geographic visualizations of selected data elements (eg,
copay, Medicare, Medicaid, Affordable Care Act status).
Results: We generate geographic visualizations of, for
example, utilization and drug copay (in-network/out-ofnetwork), plan type, Medicaid status, Medicare status, and
ACA status.
Conclusion: Mapping insurance data displays interesting
and sometimes surprising patterns about the geographic
location of different types of KPSC members and provides an
excellent example of the power of geographic visualization.
P6.08
The Validation of a Predicted-Risk Model to Improve
Completion of Colorectal Cancer Screening in
Community Health Centers
Amanda Petrik,1 Eric Johnson,1 Matthew Slaughter,1
Carrie Nielson,1 Jamie Thompson,1 Ricardo Jimenez,1
Gloria Coronado1
Kaiser Permanente Center for Health Research, Portland,
OR
1

Background: Colorectal cancer (CRC) screening by annual
fecal immunochemical test (FIT) depends on follow-up
colonoscopy after an abnormal FIT to remove precancerous
lesions or expedite CRC diagnosis and treatment. Up to 50%
of FIT-positive patients fail to complete this essential followup component. Predicting and Addressing Colonoscopy in
Safety Net Settings (PRECISE) aims to validate and apply
a risk-prediction model to identify patients who are likely to
forgo follow-up colonoscopy.
Methods: The original risk-prediction model from a prior
study identified patients, 50–75 years of age, with an abnormal
FIT result. Electronic health record data were used in a Cox
regression model to predict colonoscopy completion within
6 months of an abnormal FIT. In the PRECISE project, we
assembled a similar cohort and validated the original riskprediction model.
Results: The original model included 5-year age group,
nonwhite race, insurance type, quintiles of income inequality
(by Gini index), long-term anticoagulant use, receipt of a
flu vaccine in the past year, frequency of missed clinic
appointments, and clinic site. The PRECISE validation
model produced a naïve c-statistic, and because of the high
slope shrinkage and inapplicability to the clinic setting, the
model was redeveloped. The use of “health system” as a
predictor was not applicable to this single health system,
therefore we used county as a determinant of geographical
differences, which remained a strong predictor. This, as
well as a higher probability of colonoscopy, warranted
redevelopment. We are refining the model by updating the
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predictions using the baseline rate of colonoscopy at Sea Mar
Community Health Centers to improve agreement between
observed and predicted probabilities of colonoscopy and
recalibrating the model’s predictor coefficients by fitting a
new Cox regression within the Sea Mar cohort.
Conclusion: The redeveloped model leverages readily
available data in the electronic health record and tailors the
model to the Sea Mar population. The model helps remove
patients who would be unlikely to need patient navigation
because of their high probability of follow-up. Predicting
follow-up colonoscopy after an abnormal FIT allows clinics
to target patient-navigation resources to patients who need it
the most. The approach may represent a sustainable way to
improve follow-up colonoscopy completion in community
health center patients.
P6.09
Tracking eConsult Note Views
Arvind Ramaprasan,1 James Ralston1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Electronic consultations or eConsults are
asynchronous, non-face-to-face consultations between the
primary care provider (PCP) and the specialist via a secure
web-based platform. In August 2017, Kaiser Permanente
Washington providers were the first in the United States
to invite patients to read the eConsult notes, which use
the electronic health record (EHR) to connect a primary
care provider (PCP) to a specialty provider for advice on
a patient. As with all current clinic notes, eConsult notes
are shared with the patients. The objective of this poster is
to provide insight on patient viewership of eConsults and
compare it with progress note views from face-to-face visits.
Methods: We extracted face-to-face visits and eConsults
from EHR and tracked the corresponding note views from
January 1, 2017 to August 31, 2018. We used Tableau for
visualization of results.
Results: During the study period there were 2,826,420
encounters, including 2,805,798 (97.5%) face-to-face
visits and 20,622 (0.7%) eConsult referrals with associated
progress notes accessible to 477,186 patients, and 70,507
(2.5%) encounters either with progress notes hidden
from patient view or without any notes attached. Of those
accessible, progress notes from 187,499 (6.8%) face-to-face
visits and 1193 (6.4%) eConsults were viewed at least once
during the study period.
Conclusion: eConsults aim to simplify the process of
seeking input from specialists, thereby reducing the need
for specialty referrals that directly result in time and cost
efficiencies. However, relatively few patients are viewing
eConsult notes. We hypothesize that many patients are not
aware that the eConsult notes are being shared and that those
looking for notes may be experiencing difficulties finding
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them on the web portal. More research is needed to ascertain
the reasons for low patient viewership of eConsults.
P6.10
Converting Opioids to Morphine Milligram
Equivalents for Research Purposes: Comparing
an In-House Macro to Centers of Disease Control
and Prevention’s SAS Program
Arvind Ramaprasan,1 Ladia Albertson-Junkans1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA

1

Background: Over the years, health care organizations have
independently developed algorithms to compute morphine
milligram equivalent (MME) for standardizing opioid
exposure for research and clinical purposes; however,
inconsistencies in strength and conversion factors coupled
with a lack of standardized programming approaches
leaves room for error and compromises replicability and
comparability across studies and data sources. The Centers
for Disease Control and Prevention (CDC) developed and
published a SAS program that calculates average daily
dose (in MME) at the dispensing level. The SAS program
is parsimonious and thus amenable to a variety of data
models. It does not, however, include National Drug
Codes (NDCs) for medications that are not typically used
in outpatient settings, such as powders and solutions. To
support current studies related to opioids, programmers
at Kaiser Permanente Washington Health Research
Institute (KPWHRI) recently developed a SAS macro for
calculating average daily dose (in MME) at the dispensing
level, using a comprehensive list of extended-release/longacting (ERLA) and immediate-release/short-acting (IRSA)
opioids compiled and vetted by pharmacy experts across
several health care sites. This poster examines two existing
tools for calculating MME that researchers could use to
ensure greater consistency, reliability, and programming
efficiency in opioid-related studies.
Methods: We extracted 1,168,130 ERLA and IRSA opioid
dispenses for 36,746 individuals from January 1, 2006, to
September 30, 2015. We independently computed the daily
MME per dispensing using the CDC and KPWHRI SAS
tools. We used Tableau to visualize results.
Results: Comparing results from KPWHRI and CDC tools
show 99.967% (n=1,167,740) concordance in daily MME.
There were 342 (0.03%) dispensing records with discordant
daily MME, of which 53 (13.6%) dispenses, corresponding
to 9 NDCs, had varying strengths and 289 (84.5%) dispenses,
corresponding to 3 NDCs, had different conversion factors
in the two macros. Overall, neither of the two programs
computed daily MME for 48 (0.004%) dispensing records.
Conclusion: KPWHRI has developed an algorithm
within its virtual data warehouse common data model
for accurate computation of average daily dose in opioid
www.aurora.org/jpcrr
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MME. Preliminary results have shown a very high level
of concordance between the KPWHRI macro and CDC
program. Further validation on a larger sample and broader
time frame could enhance robustness of the KPWHRI
macro, potentially benefitting other opioid-related multisite
studies.
P6.11
Making the Kaiser Permanente Northwest Virtual
Data Warehouse Compatible With SAS’s FedSQL
and DS2

P6.12
Transition From Claims to Electronic Health Record
Data in National Health Care Research Within the
Hospital Setting
Sonja Williams1
National Center for Health Statistics, Hyattsville, MD

Matthew Slaughter,1 Catherine Cleveland1

1

Kaiser Permanente Center for Health Research, Portland,
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Background: The National Hospital Care Survey (NHCS)
is a survey of hospital care in the United States designed
to provide reliable health care utilization data for hospital
inpatient and ambulatory settings. National estimates
are not yet possible because of low hospital response
rates. NHCS collects a year’s worth of hospital visits
from a sample of hospitals. Since 2011, NHCS collected
Uniformed Bill (UB)-04 claims data. Claims data collect up
to 25 ICD diagnosis and procedures codes. The diagnosis
codes are optimized for billing purposes and are not
always reflective of the entirety of the hospital visit. In an
effort to address the known limitations of claims data, the
NHCS began collecting electronic health records (EHR) in
addition to claims, with the ultimate goal of all data being
collected from EHR systems. The NHCS’s transition from
UB-04 claims data to EHR data can provide insight on the
successes and challenges of using hospital data in health
care research.
Methods: In 2016, most participating hospitals provided
either UB-04 data (n=89) or EHR data (n=31). Data were
extracted and integrated into a final dataset.
Results: Available data elements varied widely between
UB-04 claims hospitals and EHR hospitals. UB-04 claims
data provided most information needed to create estimates
of care in the hospital but lacked clinical note information.
Claims data have no information on medications and labs
conducted. Most claims visits (~87%) are missing race
or ethnicity data. Some EHR hospitals do not have an
identifiable hospital setting. In addition, some EHR records
do not include diagnoses information and most are missing
procedures.
Conclusion: Although claims data are standardized, there
are known limitations, namely unreliable race and ethnicity
data and no clinical note information that can give more
knowledge about the hospital stay. EHR are rich with
contextual information such as clinical notes but are based on
open standards that vary by EHR source, EHR vendors, and
hospital preferences and needs. The results from this study
will inform future data collection and integration efforts of
EHR and claims data in support of health care research.

1

Background: The Health Care Systems Research Network
(HCSRN) virtual data warehouse (VDW) facilitates research
data collection and analysis across sites by providing a
common set of tables according to standard definitions and
formats. The distribution of SAS code across sites depends
on the use of standardized table names provided as SAS
macro variables and site-specific SAS data connections.
New SAS features, such as the FedSQL and DS2 procedures,
can improve VDW multisite programs by taking advantage
of the SQL:1999 American National Standards Institute
standard and allowing multithreaded data processing.
However, changes to the Kaiser Permanente Northwest
(KPNW) StdVars program were necessary for compatibility
with these procedures.
Methods: The KPNW StdVars program must allow access
to VDW data tables through a single set of data connections
and macro variables, regardless of programming context.
The FedSQL and DS2 procedures do not allow duplicate
library connections to the same data source. Therefore,
duplicate legacy library connections were eliminated
from the program. In addition, current SAS releases do
not support database management system schemas in
FedSQL and DS2 data connections for some data sources.
Consequently, standard 2-level SAS data references were
replaced with 3-level table references, including the schema
name when those tables were referenced in FedSQL or
DS2. Initially, a separate StdVars program was created
for these procedures, but this solution was insufficient, as
3-level names are not allowed in other contexts. To create
a single StdVars program for use with all SAS procedures,
the &SYSPROCNAME automatic macro variable was used
to make variables referencing VDW tables resolve to a 2- or
3-level name dynamically.
Results: Changes to the KPNW StdVars program allowed
new SAS procedures to access KPNW VDW data using
single set of data library connections and macro variables.
Conclusion: Issues with FedSQL and DS2 implementation
will vary across HCSRN sites, but the KPNW experience
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may be a useful model. Full VDW compatibility with
new SAS procedures will allow the use of potentially
more efficient and powerful programming techniques in
distributed SAS code.
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P6.13
Exploration of Differences Between Medication
Dispense Data and Pharmacy Claim Data in
Estimating Proportion of Days Covered for Statins
Satish Mudiganti,1 Xiaowei Yan,1 J.B. Jones,1 Hannah
Husby,1 Jake Delatorre-Reimer,1 Farah Refai,1 Karen
MacDonald2
Sutter Health, Walnut Creek, CA; 2AstraZeneca, Wilmington,
DE
1

Background: Pharmacy claims data are the gold standard
for assessing adherence, but most health care systems do not
have access to these data in a way that supports point-of-care
management. Medication dispense data (MDD) identify
medications filled at pharmacies, regardless of claims status.
As MDD become increasingly available in electronic health
records, it is important to understand how they compare to
claims data for assessing adherence, which we explore in
this study.
Methods: We completed a retrospective analysis from
January 1, 2017, to December 31, 2017, on claims and MDD
for primary care patients with dyslipidemia who were ≥35
years old, enrolled in a managed care program in an open
health care system, and had evidence of statin medication
dispenses in the electronic health records. The proportion
of days covered (PDC) was calculated for each patient
using each data source. Patients were divided into 3 groups:
equal (claims PDC = MDD PDC); higher-MDD PDC; and
higher-claims PDC. A logistic regression model was applied
to estimate how demographics and the number of statins
dispensed from claims were associated with each group.
Results: Among 1035 patients (average age: 58 years),
64%, 56%, and 79% were white, male, and non-Hispanic,
respectively. The equal group (mean PDC: 0.8 [standard
deviation (SD): 0.3]) comprised 566 (55%) patients, with
9505 and 8833 dispenses recorded in MDD and claims data,
respectively. Patients with more dispenses (31–40) were
more likely to have the same PDC from both claims and
MDD (odds ratio [OR]: 1.7, 95% CI: 1.1–2.4) compared
with reference level (1–10 dispenses). There were 279 (27%)
patients in the higher-MDD PDC group, with significantly
fewer dispenses compared with the equal group (5562 MDD
and 4078 claims dispenses). PDC mean value was 0.8 (SD:
0.2) for MDD and 0.6 (SD: 0.2) for claims. Patients with low
dispenses (1–10) were more likely to have higher PDC from
MDD compared with higher number of dispenses (31–40)
(OR: 2.4, 95% CI: 1.4–4.0).
Conclusion: A surprising 27% of patients had higher
PDC derived from MDD than claims data. This difference
could not be explained by demographic factors but was
significantly associated with a lower number of dispenses.
Additional studies are needed to understand the differences
and quality of MDD PDC measure.
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P6.14
Choosing
the
Bestwithdrawn
Database by
Tool
for Your
Study
Abstract
P6.14
authors
after
initial publication
Rebecca Ziebell,1 Julia Anderson,1 Garth Arnold,1
Robin Lee,1 Matthew Nguyen,1 Tyler Ross1
Kaiser Permanente Washington Health Research Institute,
Seattle, WA
1

Background: Kaiser Permanente Washington Health
Research Institute (KPWHRI) recently implemented an
internal instance of REDCap, a web-based tool for building
and managing online surveys and databases that is popular
in the health research world. A small task force of KPWHRI
staff have been charged with assessing the benefits of
developing REDCap expertise to supplement the Microsoft
Access and/or DatStat tools we typically use for participant
tracking, chart abstraction, and web surveys. Herein, we
summarize our assessment of REDCap’s pros and cons
compared to those of the more familiar tools.
Methods: We queried both developers and end users of
REDCap, DatStat Illume, and Microsoft Access to gather
input on the benefits and challenges associated with using
these three tools for participant tracking, chart abstraction,
and/or web survey data collection in the KPWHRI research
study environment.
Results: We are preparing decision matrix for researchers,
project managers, investigators, and other staff who need to
decide which database tool or tools will best serve their study.
The matrix summarizes the key features of REDCap, DatStat
Illume, and Microsoft Access along the dimensions of cost,
security, chart abstraction development and functionality,
web survey development and functionality, and required
developer skills. The results are not easily summarized in
abstract format but are suited to poster or oral presentation.
Conclusion: As relative newcomers to the world of REDCap,
our KPWHRI task force seeks to share our discoveries about
the benefits and trade-offs of using this popular tool for both
single- and multisite research studies.

HEALTH SERVICES DELIVERY,
UTILIZATION, AND COVERAGE
OA6.01
Implementation and Effectiveness of Two Models
of Direct-to-Member-Mailed Colorectal Cancer
Screening Outreach for Medicaid and Medicare
Enrollees
Beverly B. Green,1 Imara West,2 Malaika Schwartz,2
Jennifer Coury,3 William Vollmer,4 Jean Shapiro,5
Amanda Petrik,4 Laura-Mae Baldwin,2 Gloria Coronado4
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Background: Colorectal cancer screening rates are low and
particularly low among individuals enrolled in Medicaid. Little
is known about the success of Medicaid health plans’ direct-tomember outreach to raise rates of colorectal cancer screening.
Methods: We conducted a hybrid implementationeffectiveness study that compares the implementation and
effectiveness of two program models that health plans
developed for a mailed fecal immunochemical test (FIT)
intervention. The health plans mailed FITs to the homes of ageeligible Medicaid and Medicare health plan members overdue
for colorectal cancer screening. One health plan (Health Plan
A) used a collaborative approach of mailing co-branded
introductory letters, FIT kits, and reminder postcards along
with relying on clinics’ standard procedures for ordering and
processing completed FIT kits; the other health plan (Health
Plan B) used a centralized approach of mailing FITs directly
to patients, processing them at a centralized laboratory, and
delivering live reminder phone calls to patients who had
not completed their FITs. We report the implementation and
effectiveness of these two models using activities delivered
and FIT return rates overall and for member subgroups.
Results: A total of 2812 enrollees in Health Plan A and 8551
enrollees in Health Plan B were mailed an introductory
letter in the first year of the program; 2650 (94%) and 8551
(100%), respectively, were mailed a FIT kit. Overall, FIT
return rates were 17.4% in Health Plan A and 18.2% in
Health Plan B. Partnering clinics in Health Plan A carried
out a variety of activities to support the program, including
reviewing lists of patients prior to the mailing, delivering
live phone call reminders, and offering patient incentives for
FIT completion; screening rates appeared highest in clinics
that reviewed the lists prior to the mailing. Among enrollees
in Health Plan B, 9.8% (839 of 8551) of those eligible
received a reminder phone call; return rates were higher for
those who received the reminder phone call compared to
those who did not (76.2% vs 11.9%).
Conclusion: Our findings may help health plan decision-makers
choose between models of delivering mailed FIT outreach that
work best for their unique populations and organizations.

Background: The objective of this study was to examine
utilization of inpatient rehabilitation facility (IRF), skilled
nursing facility (SNF), and home health care (HHA) in
posthospital 90-day time period for Medicare beneficiaries.
Methods: The study was a secondary analysis of 100%
Medicare claims data (2012–2014). We used data files
that linked hospitals and post-acute hospitalization claims,
patient-level assessment associated with post-acute
hospitalization, provider-level information, and market-level
variables. Our study cohort was comprised of cases with
index acute hospitalization for 3 conditions: stroke (ischemic
and hemorrhagic), lower extremity fractures (hip fractures
and other fractures), and lower extremity joint replacements
(hip and total knee replacements) (N=887,754).
Results: For stroke, approximately 31% of patients did
not receive any post-acute hospitalization care, followed
by IRF (27.4%) and SNF (26.2%). For lower extremity
fractures, more than 70% of the patients went to SNF after
acute hospitalization, followed by approximately 21% going
to IRF. For lower extremity joint replacements, 40% were
discharged to SNF, followed by 35% to HHA. For all the
conditions, HHA was utilized both as an index post-acute care
setting (after acute hospitalization) and as a subsequent postacute care setting (after SNF or IRF stay). We computed and
plotted “dominant patterns” for post-acute care utilization,
by conditions and by hospital referral regions, to examine
regional variation in utilization of post-acute care. For lower
extremity fractures and lower extremity joint replacements,
we found significant variation in utilization of post-acute
care by hospital referral regions, which is indicative of
nonclinical factors influencing discharge planning and
delivery of post-acute care.
Conclusion: With so much attention given to episode-based
payment models (bundled payment models), it is important
to take into account the transition of patients between
the post-acute care settings to ensure such transition in a
continuum are done to actually improve health outcomes for
patients rather than to avoid the unintended consequences
(hospital readmission) in a given time period, which can
result in a financial penalty to providers. Future work
needs to risk adjust for case severity, provider networks
(relationship of acute and post-acute care settings), and
regional level factors to control for underlying differences
to make unbiased comparison of outcomes across different
patterns of post-acute care utilization.

OA6.02
Utilization of Post-Acute Hospitalization Settings
in a Sequence of Care in Medicare Beneficiaries

OA6.03
Lean Redesigns and Time Working Among Primary
Care Physicians

Amol Karmarkar,1 Yong-Fang Kuo,1 Chih-Ying Li,1 Amit
Kumar,2 Kenneth Ottenbacher1

Dorothy Hung,1 Su-Ying Liang,1 Quan Truong,1 Harold
S. Luft1

Kaiser Permanente Washington, Seattle, WA; 2University
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Background: As primary care continues to face high
patient demand and provider burnout, health systems are
increasingly turning to interventions that improve work
efficiency. While research points to the effectiveness of Lean
methodology, few studies examine its impact on the amount
of time physicians spend engaged in either direct or indirect
patient care activities. We used time-stamped electronic
health record (EHR) data to reconstruct daily physician time
working over the course of 6 years. With these longitudinal
data, we assessed impacts of Lean on physician work
patterns in a large ambulatory care delivery system.
Methods: This study was based on EHR capture of 15
million daily transactions among 316 primary care physicians
over 6 years. We used a stepped-wedge study design and
interrupted time series analysis to examine effects of Lean
redesigns on daily physician work time. Redesigns included
standardizing equipment and patient education materials in
all examination rooms, co-locating physician and medical
assistant (MA) dyads in a shared workspace, and creating
new workflows for care teams. These workflows included
care team huddles, agenda setting by MAs at the start of
patient visits, and joint management of the electronic inbox.
Results: We found a 6.6% reduction in the amount of time
that physicians spent in the EHR each day after the last
patient visit (P<0.001). Additionally, there was a small
but statistically significant 1.1% decrease in hours that
physicians continued to work in the clinic or remotely
each day, beyond the time spent caring for patients during
office visits (P<0.001). These decreases were observed
immediately following the introduction of Lean redesigns
and were sustained over a continuous 3–4-year period
following Lean intervention. We found no change in number
of hours that physicians spent caring for patients during
scheduled office visits.
Conclusion: Findings align with previous research on Lean
efficiencies in primary and specialty care. Specifically, we
found the most benefit in the alleviation of physician time
spent on indirect patient care and administrative duties. A
lack of observed impact on daily hours spent in office visits
suggests that Lean did not adversely impact time allocations
for providing direct patient care.
OA6.04
Leveraging the Electronic Medical Record for ValueBased Improvement and Physician Engagement
Vivian Wu,1 Steven Chang1
Henry Ford Health System, Detroit, MI

1

Background: Electronic health records have significantly
changed health care delivery for both physicians and patients.
However, the full potential of the data has not been utilized
by the health care system. The barriers to using the available
data resources to their full extent are complex. Henry Ford
Cancer Institute (Detroit, MI) has developed a methodology
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to leverage the current available data resources to engage
physicians in increasing the value (ie, cost/outcomes) of health
care provided. The objective of this study was the development
of a comprehensive real-time data reporting mechanism for
physicians to understand their clinical practices.
Methods: A multidisciplinary team of hospital
administrators,
analysts,
statisticians,
performance
improvement staff, and clinicians were brought together to
develop a comprehensive real-time data reporting structure.
Specific data elements included were volumetric data
based on cancer stage, outcomes (both patient-reported and
survival relative to national benchmarks), process metrics,
financial data, and patient safety data.
Results: The development of the dashboards resulted in
significant improvement in many key quality indicators for
the health system, including readmission, hospital-acquired
infections, and length of stay. Key findings included that
data transparency drove clinician engagement into the
performance and quality improvement efforts. Engagement
has driven constant quality improvement cycles and
continued improvement in patient care.
Conclusion: The electronic medical record can be mined
to identify key performance indicators that can inform on
processes that may require operational changes. Real-time
reporting and transparency can provide the fuel for valuebased improvement as our health care systems move away
from fee-for-service to fee-for-value.
OA10.01
Building Multisector Relationships for Health
Care Innovation: Network Analyses of Regional
Collaborations
Tessa Heeren1
Public Policy Center, University of Iowa, Iowa City, IA
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Background: The purpose of the State Innovation Model
(SIM) grant in Iowa is to support the development and
execution of innovative plans to achieve better quality of care,
lower costs, and improve health for a state’s population. One
component of the Iowa SIM is the Community and Clinical
Care (C3) Initiative, which awarded 7 regions funding to
develop community-based coalitions across medical, public
health, and social service delivery systems to provide
enhanced care coordination for patients. Network analyses
were conducted to evaluate how collaborative relationships
developed within each of the 7 regions of the C3 initiative.
Methods: An online survey was administered to
organizations involved in the C3 to gather perspectives
about relationship development and collaborative endeavors.
Respondents were asked to report about involvement in 3
types of collaborative activities: 1) care coordination; 2) data
sharing; and 3) resource sharing. To learn more about the C3
role in stimulating and maintaining collaboration, respondents
were asked about the strength and perceived sustainability of
www.aurora.org/jpcrr
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relationships. UCINet software was used to analyze networks
and identify key organizations within networks.
Results: The networks captured were diverse and engaged
stakeholders in clinical health care settings, public health,
social services, community programs, insurers, and
government entities. The C3 grant had varying degrees of
impact across sites. Sites that reported robust collaborative
networks before the grant had lower rates of attributing
collaborative relationships to the C3. Perceptions of
sustainability were promising; across sites, respondents
expected around 39% of the current relationships to continue
beyond the funded period. Overall, relationships across
sites were rated highly, with nearly half of all reported
relationships across C3 sites receiving the strongest possible
rating. Network development varied by activity type, as
indicated by the average densities of networks. Across all
C3 sites, the most developed networks were those involved
in resource sharing, followed by care coordination, and data
sharing networks were substantially less developed.
Conclusion: The C3 initiative was integral to the
development of local networks and fortified relationships that
are collaborative, multifaceted, cross-sector, and sustainable.
Organizations took advantage of the opportunity to share
resources with collaborative partners, while establishing
data sharing networks has been challenging.
OA10.02
Facility-Specific Barrier Assessment to Guide
Local Adaptation of Intervention Strategies to
Increase Human Papillomavirus Vaccination
Chunyi Hsu, Chun Chao, Nancy Cannizzaro,
Bhanuja Dub,1 Visanee Musigdilok,1 Brian Mittman1
1
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and 9 items, respectively) sent to 125 providers (physicians,
nurses, and administrative leads). Respondents were asked to
rate barriers as either very important, moderately important,
or not important.
Results: Completed surveys were received from 5 physicians
and 2 nurses in one clinic (58% response rate) and 21
physicians, 16 nurses, and 8 online leads in the other (43%
response rate), for a total of 52 surveys returned. Four of the
top five barriers were consistent between the two clinics and
were each related to parent knowledge and attitude (vaccine
not required by school, not understanding the benefit of the
vaccine, wanting it deferred to a later time, and believing the
child not at risk). One of the clinics also identified a systemlevel barrier (competing priorities for physicians and nurses)
as a top barrier. In one clinic the physicians identified parentlevel barriers as top five, whereas the nurses identified one
provider-level barrier (physician’s perception of parental
concerns) and four parent barriers.
Conclusion: Provider-identified barriers to HPV vaccination
differed modestly across two clinics and, within one,
between physicians and nurses. Tailoring interventions to
address identified local barriers may enhance success in
improving vaccination rates.
OA10.03
Using the Electronic Health Record to Identify
Patient-Level
Factors
Related
to
Missed
Opportunities for Human Papillomavirus Vaccine
Among Youth 11–13 Years of Age
Christine Joseph,1 Lois Lamerato,1 Amy Tang,1 Vivian
Wu,1 Charles Barone,1 Gwen L. Alexander,1 Linda
Kaljee,1 Paul Kilgore2
Henry Ford Health System, Detroit, MI; 2Wayne State
University, Detroit, MI
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Background: Human papillomavirus (HPV) is the causative
agent for cervical, penile, and anal cancers, among others.
HPV vaccines are effective in preventing incident infection
and precancerous lesions in HPV-naïve individuals. Centers
for Disease Control and Prevention recommends routine
HPV vaccination for boys and girls 11–12 years of age.
However, despite significant vaccination benefits and
evidence-based recommendations, HPV vaccination rates
remain suboptimal. Studies show that barriers for HPV
vaccination are multifactorial and multilevel and may be
heterogeneous across clinics. We conducted a systematic
barrier assessment in two Kaiser Permanente Southern
California (KPSC) pediatric clinics as part of a pilot study to
evaluate tailored interventions to improve vaccination rates.
Methods: Two KPSC clinics with significant vaccination
gaps were selected. A focus group of providers in one clinic
generated an initial list of barriers, augmenting barriers
identified through a comprehensive literature review.
Barriers were grouped as system-, parent- and providerlevel barriers and incorporated in an online survey (4, 16,

Background: The 2006 introduction of a vaccine to
prevent infection with the sexually transmitted human
papillomavirus (HPV) has engendered much controversy.
HPV vaccine coverage in the United States is 53.5% for
age-eligible youth. This is well below the Healthy People
2020 target of 80% coverage. “Missed opportunities”
(patient was eligible and due to receive the vaccine and a
dose was not administered) is a major contributor to low
rates for Gardasil® 9, a 9-valent HPV vaccine (9vHPV).
We used our electronic health record, which is linked to the
statewide immunization registry, to describe patient-level
factors associated with missed opportunities and for series
completion of 9vHPV.
Methods: We retrieved all clinical encounters for youth
11–13 years of age presenting to Henry Ford Health System
pediatric or family medicine clinics in 2016. Analyses
were restricted to clinics seeing more than 100 age-eligible
patients/year and to age-eligible patients for whom there
was no evidence of diphtheria, tetanus, pertussis (Tdap),
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meningococcal vaccine (MenACWY), or 9vHPV in the
previous 12 months.
Results: A total of 7724 youth 11–13 years of age made
visits during the period under study and had no evidence
of previous Tdap, MenACWY, or 9vHPV (49.5% female;
mean age: 11.7 [standard deviation: 0.8]; 60.1% white,
23.4% African American). Of the 2187 (28.3%) receiving
Tdap and/or MenACWY during the observation year, 52%
did not receive 9vHPV. Factors associated with missed
opportunities for initiation of 9vHPV included older age
(odds ratio: 1.2 [95% CI: 1.0–1.5] for every year increase),
white race (1.5 [1.2–1.8]), commercial insurance (1.7 [1.4–
2.0]), and suburban residence (1.8 [1.4–2.3]; all P<0.05.
Factors associated with missing the second dose, however,
were older age (1.5 [1.1-2.0]), nonwhite race (1.4 [1.0–1.9]),
and noncommercial insurance (1.3 [1.0–1.7]).
Conclusion: In this sample, overall adolescent vaccine
coverage was low and uptake of 9vHPV was considerably
less than the targeted 80%. Our examination of patient-level
factors revealed a patient profile for missed opportunities
that is somewhat different from that of missing the second
dose. Targeted strategies might account for this difference.
Electronic health records linked to statewide immunization
registries can help health care systems identify subgroups
for whom missed opportunities for administering the 9vHPV
are more prevalent.
OA10.04
Budgeting to Breathe: Strategies Families Use to
Manage Asthma Care Costs
Lauren A. Cripps,1 Melissa B. Gilkey,2 Deidre V.
Washington,3 Kathryn M. Przywara,3 Alison A.
Galbraith1
Center for Healthcare Research in Pediatrics, Harvard
Pilgrim Health Care Institute and Harvard Medical School,
Boston, MA; 2Gillings School of Global Public Health,
University of North Carolina, Chapel Hill, NC; 3Asthma and
Allergy Foundation of America, Landover, MD
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Background: In the United States, the annual cost of
managing asthma has risen dramatically in recent years to
over $3000 per person on average. Families affected by
asthma report difficulty adhering to care regimens because
of the high cost of preventive medications and other care
coupled with increased cost sharing required by some
insurance plans. To inform efforts to reduce asthma cost
burden and improve medication adherence, we conducted
a qualitative study to explore how commercially insured
families affected by asthma manage the cost of care.
Methods: In 2018, we conducted semi-structured telephone
interviews with a national sample of 61 commercially insured
adults who had asthma and/or were the parent of a child
with asthma. Our purposive sample included participants
with high-deductible health plans and traditional plans with
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low or no deductibles. Using a standardized codebook, we
analyzed data qualitatively via content analysis.
Results: Across health plan types, participants reported
three primary types of consumer behavior for managing
asthma care costs. First, participants budgeted for asthma
care. Strategies included planning for asthma care in the
household budget, putting aside funds in a health-related
savings account, or “stockpiling” medications received at
no or low cost upon meeting an annual deductible. Second,
participants shopped for care to reduce costs. Strategies
included comparing medication prices across pharmacies,
searching for medication coupons, asking health care
providers for samples, and working with providers to
identify lower-cost medications. Finally, participants sought
to minimize the amount of care they used. For some, this
meant avoiding asthma triggers and adhering strictly to
preventive medication regimens to avoid costly acute care
visits. For others, it meant forgoing preventive medications,
sharing them with others, or replacing them with essential
oils or other unproven alternative therapies.
Conclusion: Findings of this national study suggest that
families affected by asthma are highly engaged as consumers
of health care in ways that have both positive and negative
implications for medication adherence. Our typology of
consumer behaviors can inform efforts to support families
in selecting and adhering to high-value care plans while
seeking to protect them from the cost burdens that can lead
to forgone care.
P9.02
Defining
and
Characterizing
Frequent
Attenders: A Systematic Literature Review and
Recommendations
Erik Faber,1 Dip Shukla,1 Brian Sick1
University of Minnesota Medical School, Minneapolis, MN
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Background: To decrease cost and improve efficiency,
health care organizations have focused on frequent attenders
(patients with inappropriately increased health care
utilization). Prior studies of this population have investigated
singular health care settings, rather than whole health care
systems, and they use inconsistent definitions of frequent
attendance. Furthermore, there is variation across studies in
the factors correlated with frequent attendance. The purpose
of this article is to suggest a uniform definition of frequent
attendance, including whether it should vary across different
health care settings, and to determine the factors correlated
with frequent attendance.
Methods: This systematic review of 3 databases found
1835 unique articles, of which 140 met inclusion criteria.
These studies were analyzed for their definition of frequent
attendance and the factors they found associated with
frequent attendance.
Results: Most studies (n=108) defined frequent attendance
www.aurora.org/jpcrr
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by number of health care visits within a set time period,
whereas 34 used a top percentile cut-off. This definition
varied across primary care, emergency room, and inpatient
settings. Based on averages across studies, we propose the
following definitions for frequent attenders: for primary care
setting, either the top 10th percentile or at least 11 visits in
12 months; for emergency room setting, at least 5 visits in
12 months; and for inpatient setting, at least 4 admissions
in 12 months. Common factors correlated with frequent
attendance were mental health, drug/substance abuse, and
chronic disease.
Conclusion: We propose a definition of frequent attendance
for three common health care settings: primary care,
emergency room, and inpatient. Furthermore, future studies
should include mental health, drug/substance abuse, and
chronic disease as factors when studying this population.
Adoption of these recommendations will allow comparisons
across studies such that meta-analyses could better determine
the best interventions for more appropriate utilization of
health care resources.
P9.03
Trends in Medical Imaging From 1996 to 2016 in
Pregnant Women in North America: The RadiationInduced Cancers Study
Marilyn Kwan,1 Diana Miglioretti,2 Emily Marlow,2 Erin
Bowles,3 Sheila Weinmann,4 Kamala Deosaransingh,1
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Francisco,4 Matthew Lakoma,7 Joanne Mohr,8 M. Kay
Theis,3 Julie Munneke,4 Charisma Jenkins,4 Casey
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Background: Over the last 20 years, the use of advanced
medical imaging has increased dramatically. Medical imaging
improves diagnosis of disease and injury, yet many modalities
expose patients to carcinogenic ionizing radiation. Rates of
imaging in pregnant women, where the risks to the fetus are
particularly detrimental, are unknown.
Methods: We evaluated patterns of medical imaging
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(computed tomography [CT], magnetic resonance imaging
[MRI], angiography and fluoroscopy [fluoroscopy],
conventional radiography [x-rays], and nuclear medicine
[NUCS]) during pregnancy from 1996 to 2016 in 6 U.S.
integrated health care systems and Ontario, Canada. Imaging
utilization was ascertained using standardized diagnosis,
procedure, and billing codes mapped to each imaging
modality. We calculated per pregnancy imaging rates stratified
by country and birth year using marginal standardization.
Results: In the United States, CT rates increased from 2.0
to 11.4 exams/1000 pregnancies from 1996 to 2007 and
declined to 9.3/1000 in 2016. In Ontario, growth in CT rates
was less than in the United States, increasing from 2.0/1000
in 1996 to 4.5/1000 in 2007 to 6.2/1000 in 2016. Magnetic
resonance imaging (MRI) rates increased steadily and
surpassed CT rates in 2013 in the United States (9.9/1000
vs 9.5/1000, respectively) and in 2007 in Ontario (5.4/1000
vs 4.7/1000, respectively). NUCS rates decreased in the
United States from 2004 forward but increased in Ontario
to 2.5-fold higher than the United States by 2016 (3.3/1000
vs 1.3/1000). X-ray rates decreased in the United States
from 72.6/1000 in 1999 to 47.6/1000 in 2016 but increased
in Ontario from 36.2/1000 in 1996 to 44.8/1000 in 2016.
Similarly, fluoroscopy rates decreased in the United States
from 4.1/1000 in 2001 to 2.4/1000 in 2016 and increased in
Ontario from 2.6/1000 in 2005 to 5.2/1000 in 2016.
Conclusion: Overall rates of CT and MRI are higher in the
United States than in Ontario. However, the United States
had more recent decreases in CT use and increases in MRI
use in the last 5 years, while Ontario had gradual increases in
both CT and MRI use within the last 10 years. It is important
to continue monitoring imaging rates in pregnant women to
avoid unnecessary testing and radiation exposure.
P9.04
A Predictive Model for Chaplain Taxonomy Patterns
Identified Through Latent Class Analysis Among
Newborns in Health Care Delivery
Xiaobo Zhong,1 Madhu Mazumdar,1 Vansh Sharma,2
Lina Jandorf,3 Denise Welsh,4 Deborah B. Marin2
Institute for Healthcare Delivery Science, Department
of Population Health Science and Policy, Icahn School
of Medicine at Mount Sinai, New York, NY; 2Center for
Spirituality and Health, Department of Psychiatry, Icahn
School of Medicine at Mount Sinai, New York, NY; 3Center
for Behavioral Oncology, Department of Population Health
Science and Policy, Icahn School of Medicine at Mount
Sinai, New York, NY; 4Center for Spirituality and Health,
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Background: Several studies describe the nature of
chaplains’ care, but a major limitation is the lack of a
standardized terminology to describe chaplains’ activities
across different clinical settings. A standard inventory,
Supplement

called the Advocate chaplaincy taxonomy, was developed
to describe chaplains’ activities in 2015 at a tertiary-care
teaching facility. The taxonomy includes 100 items divided
into 3 categories: intended effects (n=15), methods (n=26),
and interventions (n=59). The intended effects category refers
to the outcome that a chaplain hopes to accomplish during
a visit. Methods describe the manner by which the intended
effect is achieved. Interventions refer to what a chaplain does
to achieve the desired outcome. The taxonomy was originally
suggested to be implemented in an order of intended effect →
method → intervention. Consequently, 23,010 (15 × 26 × 59)
pathways may result from this order of progression.
Methods: We performed latent class analysis (LCA) to
identify underlying taxonomy patterns with newborns in an
inpatient setting and built a predictive model.
Results: A 3-class LCA model was selected with pattern
1 showing high probabilities of a collection of 3 intended
effects (“Helping someone feel comforted,” “Build
relationship of care and support,” and “Faith affirmation”),
with 1 method (“Offer spiritual/religious supports”), and
1 intervention (“Active listening”). Pattern 2 exhibited
high probabilities of delivering “Demonstrate caring and
concern,” “Offer spiritual/religious support,” and “Pray,” but
lower for the other items. The remaining visits were grouped
together as a reference pattern. By assigning each newborn
to 1 of the 3 identified patterns based on the highest posterior
probabilities, we created a categorical latent variable with
133 cases in the reference pattern, 129 in pattern 1, and 559
in pattern 2. Multivariate analysis showed that, compared to
newborns in the reference pattern, being a female (odds ratio
[OR]: 1.86), a follow-up visit (OR: 3.01), a long-stay visit
(OR: 2.67), and department type (NICU/PICU/ED/labor
and delivery) were significantly associated with pattern 2.
Meanwhile, a follow-up visit (OR: 4.12) and a long-stay
visit (OR: 3.11) were significantly associated with pattern 1.
Conclusion: This is the first study with large sample size
(821 visits from 433 patients) and is easily scalable due to its
data collection module in Epic electronic medical records.
P9.05
Effect of Clinical Decision Support on
Appropriateness of Advanced Imaging Use Among
Physicians-in-Training
Jashvant Poeran, Lisa J. Mao,1 Nicole Zubizarreta,1
Madhu Mazumdar,1 Bruce Darrow,1 Nicholas Genes,1
Joseph Kannry,1 Paul Francaviglia,1 Parley D.
Kennelly,1 Jayson Whitehorn,1 Galen Kilroy,1 Darion
Garcia,1 David S. Mendelson1
Icahn School of Medicine at Mount Sinai, New York, NY
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Background: Clinical decision support (CDS) tools have
been shown to reduce inappropriate imaging orders. We
hypothesized that CDS may be especially effective for
house-staff physicians who are prone to overuse of resources.
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Methods: Our hospital implemented CDS for computed
tomography/magnetic resonance imaging (CT/MRI) orders
in the emergency department, with scores based on the
American College of Radiology’s appropriateness criteria
(range of 1–9; higher scores represent more appropriate
orders). Data on CT/MRI orders from April 2013 to June
2016 were categorized into pre-CDS (baseline), post-CDS
1 (intervention) with active feedback for scores of ≤4, and
post-CDS 2 (intervention) with active feedback for scores
of ≤6. Segmented regression analysis with interrupted time
series data estimated changes in scores stratified by house
staff and non-house staff. Generalized linear models further
estimated the modifying effect of the “house staff” variable.
Results: Mean scores were 6.2, 6.2, and 6.7 in the preCDS, post-CDS 1, and post-CDS 2 periods, respectively
(P<0.05). In the segmented regression analysis, mean
scores significantly (P<0.05) increased when comparing
particularly pre-CDS vs post-CDS 2 for both house staff
(+0.41 from baseline, 95% CI: 0.17–0.64) and nonhouse staff (+0.58 from baseline, 95% CI: 0.34–0.81),
demonstrating no differences in effect between the cohorts.
The generalized linear model demonstrated significantly
higher scores compared to pre-CDS, particularly in postCDS 2 (0.44 increase in scores; P<0.05). The “house staff”
variable did not significantly change estimates in the postCDS 2 period.
Conclusion: Implementation of active decision support
increased overall scores of CT/MRI orders. However, there
was no significant difference in effect on scores between
house staff and non-house staff.
P9.06
Segmentation Based on Disease Burden for
Primary Care Populations With Cardiometabolic
Conditions
Xiaowei Yan,1 J.B. Jones,1 Hannah Husby,1 Jake
Delatorre-Reimer,1 Farah Refai,1 Frangiscos Sifakis,2
Karen MacDonald2
Sutter Health, Walnut Creek, CA; 2AstraZeneca, Wilmington,
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Background: Population health management depends
on segmenting patients with common clinical needs into
distinct groups to facilitate targeted services. Historically,
segmentation has relied on ad-hoc methods. Longitudinal
electronic health records (EHRs) enable data-driven methods
to create clinically meaningful segmentation recommendations
that explicitly recognize disease burden and severity.
Methods: We completed a retrospective EHR analysis on
adult primary care patients, ≥35 years old, with more than
1 cardiometabolic disease (ie, hypertension, hyperlipidemia,
diabetes) and 1 related clinical measure (blood pressure,
hemoglobin A1c, or low-density lipoprotein cholesterol)
during the study period (October 1, 2015–September 30,
www.aurora.org/jpcrr
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2017) in a large health care system in Northern California.
For each patient, we generated a feature vector that included
demographic, disease burden, disease complexity, and
biometric measures and imputed missing data values using a
discriminant function method. To generate reliable clusters, we
applied a consensus latent class analysis method and repeated
the process for 3-cluster, 4-cluster, and 5-cluster models.
Results: A 5-cluster model was selected based on Akaike
information criterion and Bayesian information criterion.
Among the 182,884 patients identified, 10.6%, 13.6%,
25.4%, 22.3%, and 28.2% were assigned to clusters 1
through 5, respectively. Prevalence of cardiometabolic
conditions varied significantly, and 3 clusters had distinct
cardiovascular disease (CVD) risk ranges. In cluster 1, the
patient mean age was 67 years, average body mass index
was 32, 70% had all 3 cardiometabolic conditions, and
88% had high CVD risk. Mean age for cluster 2 (66 years)
was similar to that of cluster 1, with most patients having
hyperlipidemia (95%) and 38% having all 3 cardiometabolic
conditions. Cluster 3 was the oldest group (mean age: 69
years), and had a female majority (68%), a high prevalence
of psychiatric conditions (32% anxiety, 28% depression),
and the highest care utilization (mean primary care visits in
2 years: 8; mean specialist visits: 13). Clusters 4 and 5 were
similar in terms of age (59 and 60 years, respectively) and
prevalence of diabetes (12% vs 13%) and CVD (2%–3%).
Conclusion: We used data-driven methods to cluster
cardiometabolic patients into more homogeneous subgroups
to facilitate individualization of care. We will conduct
clinical validation with clinicians to test distinction of
clusters, clinical usefulness of segments, and care protocols
that meet needs for each cluster.

measures of disease burden, complexity, and clinical need.
Methods: Akaike and Bayesian information criteria
were used to segment 182,884 primary care patients with
cardiometabolic conditions into 5 segments. Segmentspecific profiles were created to describe each segment
on the basis of decreasing cardiovascular risk (segment 1
to segment 5), demographics, and/or morbidity. Profiles
were shared with 3 primary care physicians, and separate
semi-structured interviews were conducted focusing on
3 questions: 1) From a patient management perspective,
were 5 segments too many or too few to manage? 2) Are
the segments clinically distinct? 3) Can a physician correctly
assign patients from their panel to the correct segment?
Results: Physicians understood the value of segmentation
and believed it will improve patient care, quality, and
efficiency if used in a team model. All 3 physicians
suggested combining segments 4 and 5 into one segment due
to similarities in cardiovascular disease risk and health gaps
and believed the other 3 segments have distinct features that
distinguish them from each other. All physicians were able to
correctly assign patients selected from the highest-risk and
the lowest-risk segments, but 2 had difficulty differentiating
patients in segment 4 from those in segment 5. Clinicians
recommended including clinically relevant and actionable
factors for each segment to improve point-of-care utility.
Conclusion: We completed the initial step of establishing
the clinical validity of a data-driven segmentation approach
derived using measures of disease burden; however, largescale clinical validation with more clinicians is needed to
determine the final segments. Future work will focus on
refining the description and interpretation of segments and
developing segment-specific care models.

P9.07
Clinical Face Validation of a Segmentation Model
for Classifying Patients With Cardiometabolic
Conditions

P9.09
Five-Year Assessment of Health Care Utilization
for Patients With and Without Migraine in a Large
Health Care System

Xiaowei Yan,1 J.B. Jones,1 Hannah Husby,1 Jake
Delatorre-Reimer,1 Farah Refai,1 Frangiscos Sifakis,2
Karen MacDonald2

Reeti Sharma,1 Alice Jacobson,1 Shruti Vaidya,1
Victoria Chia,2 Dawn Buse,3 Richard Lipton,3,4 Walter
Stewart,5 Alice Pressman1
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Sutter Health, Walnut Creek, CA; 2AstraZeneca, Wilmington,
DE
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Background: Population health management strategies are
important for effective and efficient management of chronic
conditions. Many population health management approaches
group patients based on measures such as cost; however,
data-driven methods based on measures of clinical risk
and/or clinical needs have not been extensively evaluated.
Such methods can serve as the basis for developing distinct
care models for different subgroups of patients, optimizing
the way care is personalized to match clinical needs. We
conducted a face validation exercise to evaluate the clinical
validity of a 5-cluster segmentation model developed using

Background: Most evidence on health care utilization of
those with migraine is based on self-report and has not been
validated by documented use of health care. We describe
health care utilization among primary care patients with and
without migraine in a large health care system and examine
factors that account for variation in use of care.
Methods: Longitudinal electronic health record (EHR) data
from Sutter Health in Northern California were obtained on
1.5 million primary care patients between January 1, 2013,
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Sutter Health, Walnut Creek, CA; 2Amgen Inc, Thousand
Oaks, CA; 3Albert Einstein College of Medicine, New York,
NY; 4Montefiore Medical Center, New York, NY; 5HINT
Consulting, Orinda, CA
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and December 31, 2017. A previously developed and validated
diagnostic algorithm was used to identify 94,149 patients who
sought care for migraine and 1.4 million who did not. We
stratified migraine patients by those who sought care exclusively
from primary care (PC-M) and those who saw a neurologist
(N-M). We extracted counts of encounters for any reason for
primary care, neurology, emergency department (ED), and
inpatient visits for all patients during the 5-year period.
Results: Compared to primary care patients without migraine,
patients with migraine experienced statistically significantly
more encounters per patient (EPP) over 5 years for primary
care (10.8 migraine vs 6.4 no migraine), neurology (1.2 vs
0.2), inpatient (0.17 vs 0.11), and ED (0.67 vs 0.26) visits
(P<0.05 for all). Among migraine patients, N-M had more ED
EPP than PC-M (0.86 vs 0.62, P<0.001). For ED encounters,
N-M were more likely to have a discharge diagnosis of
migraine than PC-M (14% vs 9%, P<0.001).
Conclusion: During the 5-year period, migraine patients
averaged higher any-reason EPP compared to those without
migraine for all types of encounters assessed, with the
majority of visits occurring in the primary care setting.
N-M were more likely to have ED encounters, and those
encounters were more likely to be for migraine. A limitation
to this analysis is that we are unable to distinguish between
episodic and chronic migraine patients. It is likely that
neurologists see a higher percentage of chronic migraine
patients than primary care physicians, and these patients
may utilize health care resources more. Further studies are
planned to understand factors that contribute to higher health
care utilization rates for N-M patients.
P9.10
A Web-Based Clinical Decision Support System
(Wizard©) Increases Appropriate Cardiometabolic
Diagnostic Coding at Primary Care Visits
JoAnn Sperl-Hillen,1 Jeffrey Anderson,1 Rebecca
Rossom,1 Kris Ohnsorg,1 Jay Desai,1 Heidi L. Ekstrom,1
A. Lauren Crain,1 Patrick J. O'Connor1
HealthPartners Institute, Bloomington, MN

1

Background: Accurate coding of complex patients is
essential for care systems to remain viable in a value-based
payment world that includes risk-adjustment. The objective
of this study was to determine if use of the Wizard© clinical
decision support (CDS) system that improves quality of care
for patients with uncontrolled cardiovascular risk increases
appropriate diagnostic coding of cardiometabolic conditions
at primary care visits.
Methods: We conducted a clinic randomized trial of a webbased CDS system at 17 primary care clinics in Minnesota
from March 15, 2017, to December 31, 2017. The CDS
system a) identified adults at primary care encounters with
high reversible cardiovascular risk, and prompted nurses
to print Wizard handouts and give them to patients and
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providers immediately antecedent to the visit; b) provided
prioritized evidence-based clinical care recommendations
for any uncontrolled major cardiovascular risk factors to
promote shared decision-making; and c) retained data from
eligible encounters at intervention and control clinics in a
data repository that was later mapped to electronic health
record Clarity data to identify encounter-level ICD-10
diagnostic codes for diabetes, hypertension, hyperlipidemia,
smoking, and obesity.
Results: At 34,281 targeted encounters with 18,782 patients
with reversible cardiovascular risk, mean age was 57.7, 50%
were female, 13% were black, 6% Asian, 3% Hispanic, and
75% white, mean 10-year atherosclerotic cardiovascular
disease (ASCVD) risk was 15.7%, and mean body mass
index (BMI) was 33.0. Wizard handouts were printed for
75% of targeted encounters in intervention clinics. The
percentage of encounters with ICD-10 codes identified were
(control vs intervention, P-value): diabetes coded if diabetes
identified (70.8% vs 74.5%, P<0.0001); hypertension coded
if hypertension identified (57.9% vs 60.9%, P<0.0001);
hyperlipidemia coded if statin intensification was indicated
(29.9% vs 31.9%, P=0.005); ASCVD coded if ASCVD
identified (24.7% vs 26.8%, P=0.051); obesity coded if BMI
was ≥30 (14.8% vs 17.3%, P<0.0001); and smoking coded
if current smoking identified (25.8% vs 32.4%, P<0.0001.
Conclusion: This CDS system significantly increased the
likelihood that known cardiovascular risk factors were
assigned clinically appropriate ICD-10 diagnostic visit
codes at primary care encounters.
P9.11
Prescription Drug Price Variation
Community Pharmacies in Texas

Among

Lixian Zhong,1 Ashley Parambil,1 Niraj Patel,1 Toney
Duong1
Texas A&M University, College Station, TX

1

Background: Prescription drug prices pose a significant
boundary to medication access in uninsured patients in
the United States. In Texas, data on retail and independent
pharmacies’ prescription drug prices impact in communities
were limited. This study seeks to evaluate the variation in
out-of-pocket prices for different prescription drugs sold
in community pharmacies across the state of Texas and
to assess demographic, socioeconomic, and disease-state
factors that may influence prescription drug prices.
Methods: Telephone interviews were conducted to
each pharmacy to collect listed cash prices for 5 common
prescription drugs (levothyroxine 25 mcg, lisinopril 10 mg,
simvastatin 20 mg, metformin 500 mg, and azithromycin 250
mg). Furthermore, county-specific information on population
median age, median household income, education level,
marital status, the rate of uninsured individuals, obesity rate, the
density of pharmacies, and the population density of 254 Texas
www.aurora.org/jpcrr
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counties were collected to assess factors that may influence
prescription drug prices. Descriptive statistics and multivariate
regression analysis were performed to describe the price pattern
and identify factors associated with price variations.
Results: A random sample of 203 community-independent
pharmacies was generated from a list provided by the
Texas State Board of Pharmacy. Telephone interviews were
administered to the pharmacies listed in the random sample.
Of the 203 pharmacies, 144 participated in the interview,
with 57% in metro areas and 43% in nonmetro areas. The
mean price for levothyroxine 25 mcg was $18.85 (standard
deviation [SD]: $7.83), for lisinopril 10 mg was $12.10 (SD:
$7.85), for simvastatin was 18.71 (SD: $29.33), for metformin
was 14.63 (SD: $11.43), and for azithromycin was $20.01
(SD: $14.69). We found that drug prices varied significantly
across different pharmacies. Multivariate regression model
suggested that pharmacy density and population density had
statistically significant impact on the drug prices.
Conclusion: We found that drug prices varied significantly
across different pharmacies. Our study identified key factors
that impact drug prices. Overall, they were positively
associated with population density and negatively associated
with pharmacy density (P<0.05).

HEALTH EQUITY AND SOCIAL NEEDS
OA7.01
Social Needs Programs Across Kaiser Permanente:
Findings and Recommendations From an Inventory
and Scoping Review
Andrea Paolino,1 Caroline Joyce,1 Tina Kimpo,1 John
Steiner1
Institute for Health Research, Kaiser Permanente Colorado,
Denver, CO
1

Background: Social, economic and behavioral needs
(SEBN) are critical determinants of health. Kaiser
Permanente (KP) has developed programs to identify
and mitigate those needs across its 8 geographic regions,
actively collaborating with community organizations that
provide basic resources. The KP Social Needs Network
for Evaluation and Translation (SONNET) identified these
social needs programs and conducted a scoping review that
assembles evidence from them.
Methods: In 2017–2018, SONNET identified 33 programs
that address basic resource needs. Information about the
design, conduct, and impact of these programs was collected
through discussions with program leaders and community
organizations, qualitative interviews and focus groups with
members and front-line staff, member and staff surveys,
analyses of data from the electronic health record and other
information systems, program evaluations, and published
research. Information from these programs was synthesized
98
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using a 5-step care continuum framework: 1) plan the
assessment and intervention; 2) assess for basic resource needs;
3) connect members to community organizations; 4) improve
health outcomes; and 5) spread effective interventions.
Results: SONNET made program information available to KP
staff in a searchable database. Evidence from these programs
was synthesized into a scoping review that uses a populationbased, community-engaged care continuum model to discuss
program findings and make recommendations. Of the 33
programs studied, most target high-risk members (complex
care, Medicaid, high-cost members) and assess food, housing,
transportation, and medical costs. Moreover, most programs
rely on community health workers or patient navigators to
connect members to community resources. Only 5 programs
had been rigorously evaluated, while 15 had collected some
data. Three were conducted in multiple regions, and 30 took
place in a single region.
Conclusion: In addition to detailed recommendations at each
step of the care continuum, general recommendations for
KP that arise from this scoping review are: set priorities and
expectations for needs to assess; prospectively define outcomes
to judge the success of interventions; plan systematically
to address all steps of the care continuum; include multiple
perspectives (members/patients, staff, clinicians, and leaders)
in program design; develop the capacity of community
organizations; evaluate programs rigorously; design for
dissemination; and stay the course since basic resource needs
are difficult to resolve and prone to recur.
OA7.02
Assessing the Burden of Social and Economic
Needs Among Medicare Enrollees in an Integrated
Health Care System
Matthew Banegas,1 Stephanie Fitzpatrick,1 John
Dickerson,1 David Mosen,1 Gloria Coronado,1 Celeste
Machen,1 Alexandra Varga,1 Rachel Gold1
Kaiser Permanente Center for Health Research, Portland,
OR
1

Background: Unmet social and economic needs (SEN)
influence individuals’ ability to make health behavior
changes and attain their full health potential. We sought
to estimate the prevalence of, and identify characteristics
associated with, SEN among Medicare enrollees in an
integrated health care system.
Methods: We identified 4504 Kaiser Permanente Northwest
members who were ≥65 years of age, were enrolled in
Medicare, and had completed a SEN screening assessment,
Your Current Life Situation, during a care visit between
June 2017 and September 2018. Measures of SEN
included financial hardship, food insecurity, housing, and
transportation. We estimated the percentage of members
who reported experiencing each SEN and any SEN.
Separate multivariable logistic regression models were used
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to evaluate the associations between sociodemographic
characteristics (age, sex, race, Hispanic ethnicity, median
household income, and neighborhood deprivation index),
annual maximum out-of-pocket (MOOP) limit, and
comorbidity with having each SEN and any SEN.
Results: Among 4504 Medicare members, 25.6% reported
any SEN, 17.2% financial hardship, 6.7% food insecurity,
9.0% housing, and 9.8% transportation needs. In adjusted
models, factors statistically significantly associated with
greater odds of having any SEN included younger age
(P<0.001), female sex (P<0.001), lower income (P<0.001),
African American race (P<0.05), lower comorbidity burden
(P<0.001), higher MOOP (P<0.001), and lower neighborhood
deprivation (P=0.002); these findings were generally
consistent across each SEN. Specifically, female Medicare
members had significantly greater odds of experiencing
financial hardship (adjusted odds ratio [OR]: 1.44, 95% CI:
1.22–1.70), food insecurity (OR: 1.53, 95% CI: 1.19–1.97),
housing (OR: 1.39, 95% CI: 1.12–1.73), and transportation
needs (OR: 1.47, 95% CI: 1.19–1.80) compared to their male
counterparts. African American Medicare members had
significantly greater odds of experiencing financial hardship
(OR: 1.95, 95% CI: 1.26–3.03), food insecurity (OR: 2.04,
95% CI: 1.14–3.64), and housing needs (OR: 2.22, 95% CI:
1.34–3.69) compared to white Medicare members.
Conclusion: Our study provides valuable insights into
the percentage of Medicare members with SEN and
characteristics that may help identify those at greater risk of
SEN. As efforts to include social factors in risk adjustment
for payment models increase (eg, Medicare reimbursement),
evaluating the impact of SENs on health care use, costs, and
health outcomes across health plan membership subgroups
will be imperative.

code, self-reported GM status, encounters with the KPNW
Gender Pathways Clinic, referrals for transgender-specific
health services, and relevant text strings in the physician
note fields. We’re assessing differences between GM and
cisgender individuals in health care utilization, health
behaviors, preventive health screening and vaccination, and
a total of 67 validated chronic disease conditions.
Results: Our preliminary analysis included KPNW members
and has assessed 27 diagnosed conditions to date. We have
identified 1742 GM among a study population of 782,793
(0.22%). Compared to cisgender individuals, we found
significant, age-adjusted odds ratios (aOR) among GM for
benign prostatic hyperplasia (aOR: 0.5 [95% CI: 0.3–0.9]),
breast cancer (0.4 [0.1–0.9]), and depression (3.9 [3.6–4.2]).
Borderline significant aOR were found for asthma (1.2 [1.0–
1.4]), chronic obstructive pulmonary disease (0.9 [0.7–1.0]),
diabetes (1.2 [1.0–1.5]), hypertension (0.9 [0.8–1.0]), and
rheumatoid arthritis (0.8 [0.6–1.0]). We also found the GM
were more likely to have been screened for depression,
using PHQ-9, than their cisgender counterparts (aOR: 1.7
[95% CI: 1.5–1.8]).
Conclusion: Our preliminary findings are mixed to date,
although consistent with a previously reported increase in
the occurrence of depression among GM. Analysis of the
remaining 40 diagnosed conditions, health utilization, and
preventive health measures; the inclusion of data from
5598 GM individuals from the OCHIN study population
of 1,961,745 (0.29%); and the assessment of additional
covariates will be completed by the end of December 2018.
We will present the most significant health disparities
observed overall and across the age spectrum and will
further characterize relationships by gender identity and
receipt of gender-affirming hormone therapy.

OA7.03
The Health of Gender Minorities

OA7.04
Development of the PREMM5 Electronic Application
for Lynch Syndrome Risk Assessment in a Diverse
Population

Mark Schmidt, 1 Dagan Wright, 2 Denis Nyongesa, 1
A. Gabriela Rosales,1 Allison O’Neill,2 Erin Waters3
Kaiser Permanente Center for Health Research, Portland,
OR; 2OCHIN, Portland, OR; 3Gender Pathways Clinic,
Kaiser Permanente Northwest, Portland, OR
1

Background: While gender minorities (GM) are known to
experience significant disparities compared to their cisgender
counterparts, research in this area remains scant. Our goal
is to conduct the largest, most comprehensive analysis
to date of health metrics recorded in the electronic health
record from persons seeking care within Kaiser Permanente
Northwest (KPNW) and the OCHIN network of federally
qualified community health centers.
Methods: Our study population includes KPNW and
OCHIN members, 10–80 years of age, with at least one
in-person encounter from January 1, 2012 to December
31, 2017. We have defined GM status based on ICD-9/-10
Supplement

Tia Kauffman,1 Kathleen Mittendorf,1 Chinedu
Ukaegbu,2 Donna Eubanks,1 Jake Allen,1 Carmit
McMullen,1 Nangel Lindberg,1 Katrina Goddard,1
Sapna Syngal2
Kaiser Permanente Center for Health Research, Portland,
OR; 2Dana Farber Cancer Institute, Boston, MA
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Background: Lynch syndrome (LS) is the most common
hereditary colorectal cancer syndrome. A comprehensive
collection of patient family health history allows for the
identification of patients at risk for LS, but rarely is the
information collected in sufficient detail. While there are
tools to collect targeted family history for risk assessment,
these tools require high health literacy or are for providers.
These are barriers to genomic medicine access for
underserved populations. The PREMM5 model is a validated
www.aurora.org/jpcrr
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risk assessment algorithm used by health care providers to
identify individuals at risk for LS. To improve health care
access, we have developed a patient-facing version of
PREMM5 for implementation in low-literacy, low-resource
populations as part of the CSER2 consortium.
Methods: The PREMM5 developers worked with a team of
genetics professionals, researchers, user-experience design
experts, software engineers, and patient stakeholders. The
patient-facing version was created in both English and
Spanish and employs responsive design, allowing for ease
of completion on multiple types of electronic devices. The
web-based application is available at any time with personal
computers or mobile devices.
Results: Two major adaptations in developing the patientfacing application were 1) not relying on the patient to
determine the affected side of the family for risk assessment,
and 2) guiding the patient through the collection of medical
history on each relative to avoid the use of complex terms
such as “first-degree relative.” Embedded literacy aids,
including family tree infographics and pop-up definitions for
certain concepts, were accessible via links in the interactive
application. Additionally, to optimize the user’s experience,
skip-logic presented patients with questions relevant to
their previous responses. We have a 10% response rate to
an email and text sent to primary care patients; 164 patients
have successfully completed the tool, with 27% scoring
at ≥2.5% probability of having an LS mutation. Very few
patients requested assistance, and 49% of respondents
met our diversity criteria (racial/ethnic minority or low
socioeconomic status).
Conclusion: Patients can complete a lower literacy patientfacing family history risk assessment tool to assess their risk
of LS. While our response rate to email outreach is high, our
respondents skew toward those more likely to be at high risk.
OA14.01
Health Care Providers’ Perspectives on the
Opportunities for Mobile Health Technologies to
Support Patients’ Health Care Needs
Sharon Laing,1 Carlota Ocampo,2 Stacey Baugh2
University of Washington Tacoma, Tacoma, WA; 2Trinity
Washington University, Washington, DC
1

Background: Health care providers (HCPs) guide patients
and empower them to manage their care; however, patients
are becoming more informed from broad-based access to
health information. This qualitative study presents HCP
perspectives about the value of mobile health technologies
to enhance patient-centered care and facilitate trust-building.
Methods: Four 60-minute focus group sessions were
conducted with medical doctors, nurses, social workers,
behavioral health specialists, and community health workers
offering services to patients in safety-net settings. Focused
topics evaluated were: 1) role of mobile health tools in
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supporting health; 2) perceived value of an mHealth clinical
practice guide to inform patient care; and 3) perceived
role of mobile technology in increasing access for diverse
ethnic communities. Provider responses were tape-recorded,
transcribed, and analyzed for common themes. The method
of analysis was evaluating focus group questions for
codewords, codewords were then organized into codeword
clusters, and then clusters assessed to derive themes/
concepts. Respondents were offered $75 for participation.
Results: HCPs saw mHealth tools like tracking devices
and health apps as valuable for improving data accuracy
and treatment delivery; one respondent noted, “We missed
something completely and so let’s take a look at that so
that I can tailor my treatment to more of the day-to-day
instead of what that person is just bringing in on the day
that they happen to see me.” A clinical practice guide
supporting mHealth practices was welcomed by HCPs
with the recommendation that such a guide is interactive,
simple to use, and presents research-tested mobile devices
─ “Here is some research behind it, and then that can help
them buy in and use it, too.” Finally, HCPs perceived value
of mobile health technology when working with ethnically
diverse communities; they saw the technology as providing
a direct link to the patient and provider, thus building trust
and improving relationships.
Conclusion: Health care providers recognize the value of
mobile health technologies to advance patient outcomes
by helping to improve treatment delivery and supporting
patient-provider relationships. Providers support an mHealth
clinical practice guide with scientific evidence to support
recommendation of mobile health technologies.
OA14.02
Understanding the Health Care Needs of Children
in Foster Care in Oregon’s Community Health
Centers
Frances Lynch,1 M.J. Dunne,2 Megan Hoopes,2 Annie
Larson,2 Allison O’Neil,2 Brigit Hatch3
Kaiser Permanente Center for Health Research, Portland,
OR; 2OCHIN, Portland, OR; 3Oregon Health & Science
University, Portland, OR
1

Background: Children in foster care are a vulnerable
population. Early life circumstances, including placement in
foster care, can predict socioeconomic and health status in
adulthood. It is important for medical providers to understand
how the health and social needs of children in foster care
compare to children in other family arrangements.
Methods: We conducted a case-control study using secondary
analysis of electronic health record (EHR) data from Oregon
clinic members of the OCHIN community health information
network and Medicaid data. We constructed a retrospective
cohort of foster children between 6 months and 17 years old
in 2014–2016 (n=2223). We identified a comparison group
Supplement

of children from the same clinics meeting the same criteria
but without evidence of foster system contact (n=6304). In
this descriptive analysis, we compared foster children to their
matched controls on a range of demographic characteristics,
health care access and utilization measures, and chronic
condition and comorbidity burden. All study variables were
obtained from the EHR. Time-varying characteristics (eg,
federal poverty level, Charlson comorbidity index) were
assigned as of each patient’s last visit in the study period. We
tested for differences between the groups using generalized
estimating equation models. These models took on different
forms and link functions depending on the distribution of
each outcome (normal, binomial, multinomial, or Poisson).
Statistical significance was set at α=0.05.
Results: Youth in foster care had much greater need, with over
50% having multiple comorbid chronic health conditions. In
particular, youth had many more mental health conditions.
Most striking was the prevalence of depression, anxiety,
attention-deficit/hyperactivity disorder, and posttraumatic
stress disorder in youth in foster care. Youth in foster care
have greater service use in some categories, such as mental
health (mean: 5.6 visits [standard deviation (SD): 5.0] vs
non-foster care mean: 2.3 visits [SD: 10.9]), and less use in
other categories, such as dental care (mean: 0.7 visits [SD:
1.8] vs non-foster care mean: 1.0 visits [SD: 2.4]).
Conclusion: Youth in foster care have much greater need
than comparable youth served in community health clinics.
However, many may not receive as many services as needed.
OA14.03
Neighborhood
Socioeconomic
Disadvantage
Is Associated With Multimorbidity in a Large,
Geographically Defined Population
Alanna Chamberlain,1 Lila Finney Rutten,1 Patrick
Wilson,1 Chun Fan,1 Walter Rocca,1 Jennifer St.
Sauver1
Mayo Clinic, Rochester, MN

1

Background: Approximately 1 in 4 adults in the United
States have multimorbidity, and the number of persons
with multimorbidity will increase exponentially over time,
causing escalating health care costs and burden on the health
care system. The prevalence of multimorbidity varies across
populations, and one potential source of this variation may be
differences in socioeconomic status. Thus, we aimed to study
the association of an area-level measure of socioeconomic
status at the census-block-group level with multimorbidity
in a large, geographically defined population.
Methods: Adults (≥20 years of age on April 1, 2015) from 7
counties in southern Minnesota (N=198,941) were identified
using the Rochester Epidemiology Project. Diagnostic
codes between April 1, 2010, and March 31, 2015, were
used to define the prevalence of 21 chronic conditions.
Each patient’s geolocation (latitude and longitude) was
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calculated and spatially linked to census block group (n=251
census block groups). For each census block group, 5-year
estimates (2011–2015) from the American Community
Survey or the 2010 U.S. Census were used to calculate the
Singh area deprivation index (ADI), a composite measure
of neighborhood socioeconomic disadvantage including 17
census measures. The ADI was divided into quintiles, and
modified Poisson regression was used to model associations
between ADI and multimorbidity (≥2 chronic conditions)
after adjusting for age, sex, race, and ethnicity.
Results: The age- and sex-standardized (to 2010 Census)
prevalence of multimorbidity ranged from 9.9% to 36.4%,
with a median of 23.4% across census block groups.
Compared with persons in the lowest quintile of ADI, those in
the highest quintile had nearly a 20% increased risk of having
multimorbidity (relative risk: 1.19, 95% CI: 1.17–1.21).
There also was evidence of an interaction between age and
ADI (P<0.001): after age 70 years, no difference in the risk of
multimorbidity was observed across quintiles of ADI.
Conclusion: Higher ADI was associated with increased
risk of multimorbidity, with more pronounced associations
observed for younger persons.
OA14.04
Re-Evaluation of Race and Ethnicity With Adverse
Outcomes in Heart Failure
Samuel Savitz,1 Jamal Rana,1 Keane Lee,1 Sue Hee
Sung,1 Thomas Leong,1 Grace Tabada,1 Alan Go1
Kaiser Permanente Northern California, Oakland, CA
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Background: Conflicting evidence exists about the
relationships between race and ethnicity with heart failure
(HF) hospitalization and death in adults with HF. In addition,
it remains unclear to what degree modifiable factors may
explain variation in these clinical outcomes, especially when
health care access is similar. We examined the association of
race/ethnicity and outcomes in a diverse community-based
cohort of adults with HF receiving care in a large, integrated
health care delivery system.
Methods: We identified all adults with HF, 2005–
2012, within Kaiser Permanente Northern California.
Demographics, clinical characteristics, receipt of therapies,
and left ventricular ejection fraction were ascertained from
electronic health records, and regional workforce and
socioeconomic status factors from state data. We conducted
Cox proportional hazards models separately for 1) time
to first HF hospitalization following diagnosis for index
cases or identification for prevalent cases, and 2) all-cause
mortality. The models serially adjusted for distinct domains
to identify potential confounders and mediators.
Results: We identified 25,386 HF patients (70% white, 9%
Asian/Pacific Islander (API), 11% black, 11% Hispanic).
Whites were older (mean: 75 years) than other groups (mean:
69 years for API, 67 years for blacks, and 71 years for
www.aurora.org/jpcrr
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Hispanics. Blacks had a significantly higher fully adjusted rate
of HF hospitalization compared to whites (hazard ratio [HR]:
1.34, 95% CI: 1.24–1.50), which was not seen with APIs and
Hispanics. APIs had significantly lower mortality compared
to whites in fully adjusted models (HR: 0.83, 95% CI: 0.74–
0.93), while blacks and Hispanics had similar mortality.
Conclusion: The associations between race/ethnicity and
HF hospitalization and death remain complex. Unlike
Hispanics and APIs, blacks had a higher rate of HF
hospitalization compared to whites but similar mortality. In
contrast, APIs had lower mortality compared to whites but a
similar rate of HF hospitalization. The findings of higher HF
hospitalizations among blacks and lower mortality among
APIs are consistent with prior research. However, we did
not replicate the previous findings of lower mortality among
blacks and lower HF hospitalizations among APIs.
P8.01
Asian Ethnic Group Disparities in Health and
Behavioral Risk Factors in Kaiser Permanente
Northern California
Nancy P. Gordon,1 Joan C. Lo,1 Teresa Y. Lin1
Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background: The category “Asian” is generally used for
reporting race/ethnic differences in health-related measures.
This broad “Asian” category may be problematic for service
planning and comparing populations with different ethnic
group compositions.
Methods: We used data for a cohort of 276,671 Kaiser
Permanente Northern California Asian adults 45–84 years
of age, 97% of whom were assignable to an Asian ethnicity.
The cohort was restricted to members enrolled all of 2016 and
included 88,983 Filipinos, 86,322 Chinese, 8968 Koreans,
17,822 Japanese, 32,483 Southeast Asians, and 35,179 South
Asians. We used electronic health record data to produce
prevalence estimates age-sex standardized to the 2010 U.S.
Census for “Asian” and all ethnic groups: for age 45–84,
moderate/severe obesity (body mass index [BMI] of ≥35;
Asian-specific BMI of ≥32.5), smoking, diabetes, hypertension,
hyperlipidemia, and asthma; for age 65–84, coronary artery
disease (CAD) and heart failure. A >2-percentage-point
(PP) difference between “Asian” and ethnic groups (>1 for
smoking, CAD, and heart failure) was considered meaningful.
Results: 23.1% of Asians (age 45–84) had diabetes, 42.7%
hypertension, 44.8% hyperlipidemia, and 10.2% asthma;
3.3% had a BMI of ≥35, 6.9% a BMI of ≥32.5; and 5.9%
were current smokers. Among those 65–84 years of age,
5.4% had CAD and 4.7% heart failure. We found significant
differences across Asian ethnic groups on all measures except
BMI of ≥35 (ranges:15.4%–31.9% for diabetes; 33.6%–
56.1% for hypertension; 37.5%–47.9% for hyperlipidemia;
6.1%–14.3% for asthma; 3.6%–8.1% for CAD; 3.5%–6.4%
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for heart failure; 3.1%–10.1% for BMI of ≥32.5; and 3.0%–
7.6% for smoking). On all 6 chronic conditions and BMI of
≥32.5, Filipinos and South Asians were higher than “Asian”
and Chinese, while Chinese and Koreans were lower than
“Asian” on these conditions. Southeast Asians measured
lower than “Asian” on diabetes, hypertension, heart failure,
and BMI of ≥32.5, and Japanese were lower on diabetes,
hypertension, hyperlipidemia, and heart failure but higher
on BMI of ≥32.5. Chinese and South Asians were lower
than “Asian” on smoking, while Filipinos, Koreans, and
Southeast Asians were higher.
Conclusion: We found disparities across Asian ethnic groups
in prevalence of chronic conditions, smoking, and moderate/
severe obesity based on Asian-specific criteria. Filipinos
and South Asians have an overall worse chronic-disease and
risk-factor profile than East Asians, with exceptions of lower
smoking among South Asians and higher obesity among
Japanese. Capture of Asian ethnicity in electronic health
records is recommended.
P8.02
Use of Geospatial Data for Assessing and
Addressing Health Disparities Within a Lung
Cancer Screening Population
Caroline Joyce,1 Brian Hixon,1 Nikki Carroll,1 Andrea
Burnett-Hartman,1 Debra Ritzwoller1
Institute for Health Research, Kaiser Permanente Colorado,
Denver, CO
1

Background: Many studies use census-based data to ascertain
proxies of education and income; however, these measures are
limited because they are not sufficiently granular and therefore
do not adequately estimate measures of wealth, access to
care (ie, travel time, density of providers), neighborhood
deprivation, and other social determinants of health.
Methods: We are using newly available sources of
geospatial data to derive more nuanced proxy measures for
social determinants of health and health disparities in lung
cancer screening. These sources include the Food Access
Research Atlas; open-source property data from sources like
Zillow, Redfin, and Realtor.com; restricted microdata from
the U.S. Census Bureau; the Centers for Disease Control
and Prevention’s Social Vulnerability Index (SVI); and
other data such as maps from the Environmental Protection
Agency, The Opportunity Atlas, and The Eviction Lab.
By mapping data from these sources to the census-based
variables available in our electronic health records (EHR)
(eg, FIPS codes, zip codes), we can calculate robust proxies
for social determinants of health.
Results: One of the strengths of our study is the heterogeneity
among our 5 health systems. At Henry Ford Health System,
Kaiser Permanente Hawaii, Kaiser Permanente Colorado
(KPCO), University of Pennsylvania (UPenn), and Marshfield
Clinic Health System, there is a total of 1,603,546 patients
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eligible for the study. At KPCO, 99.6% of adults in the health
system live in metropolitan areas, whereas 87.6% of adults
in Marshfield’s health system live in micropolitan or rural
areas. Within the UPenn health system, 34.0% of households
are below the federal poverty limit (FPL) while only 0.7% of
households within KPCO are below the FPL. That said, there
are more accredited lung cancer screening facilities in the
city of Philadelphia (828) than in the whole state of Colorado
(623) ─ nearly 6 per square mile covering 1.58 million people
vs 6 per 1000 square miles covering 5.61 million people.
Conclusion: Although we will still use proxies for measuring
social determinants of health, by using multiple and more
granular sources of geospatial data than census tract alone,
we will be able to improve these proxies and, thus, better
assess health disparities within our lung cancer screening
study population.

CHRONIC CONDITIONS, MULTIMORBIDITY,
AND AGING POPULATIONS

current smokers (20% vs 13%, P<0.001), and more physically
active (51% engaged in at least some moderate activity in a
week vs 40%, P<0.001) compared to patients in the higher
morbidity profiles. FEV1 percentage of predicted, which was
obtained from a subsample of patients, was not different across
the morbidity profiles (68% ± 21% for low morbidity to 64%
± 19% for multimorbidity). There was a trend in increasing
use of acute care (hospitalizations, observational stays, and
emergency department visits) with increasing class-average
CCI (P<0.001) in the year of cohort identification.
Conclusion: Our finding of 4 comorbidity clusters
in COPD patients resonates with previous studies;
previous psychological profile was not seen as CCI does
not include mental health diagnoses. The distribution
across clusters suggests that earlier studies using limited
samples may overestimate the burden of comorbidities
in community settings. We demonstrated independence
of the multimorbidity profiles to airflow obstruction,
though spirometry data was limited to half of the sample.
Subsequent work will examine downstream health care
utilization patterns across these 4 comorbidity profiles.

OA8.01
Multimorbidity in Chronic Obstructive Pulmonary
Disease Across Three Geographic Regions of a
Large Integrated Health Care Organization

OA8.02
A Multimodal
Intervention
for
Improving
Osteoporosis Treatment Initiation and Adherence

Richard Mularski,1 Earnest Shen,2 Janet Lee,2 Phillip
Crawford,1 Alan Go,3 Huong Nguyen2

Ryan Outman,1 Paul Muntner,1 Andrew Bradlyn,2 Lee
Cromwell,2 Brandi Robinson,2 Douglas Roblin,3 Dennis
Tolsma,2 Kenneth Saag1

Kaiser Permanente Northwest, Portland, OR; 2Kaiser
Permanente Southern California, Pasadena, CA; 3Kaiser
Permanente Northern California, Oakland, CA
1

Background: Previous studies in limited geographic datasets
have reported that more than 50% of chronic obstructive
pulmonary disease (COPD) patients have at least 4 or more
comorbidities. We aimed to identify comorbidity profiles in a
community-based sample of patients with COPD from a large
integrated health care system across 3 U.S. geographic regions.
Methods: In this retrospective cohort study, we used latent
class analysis (LCA) to identify comorbidity profiles in a
population-based sample of 91,453 patients with a COPD
diagnosis between 2011 and 2015. We included specific
comorbid conditions from the Charlson comorbidity
index (CCI) and accounted for variation in underlying
prevalence of different comorbidities across study sites.
Sociodemographic, clinical, and health care utilization data
were obtained from electronic records.
Results: The mean age was 71 years, 55% were females, 23%
were nonwhite, and 80% were former or current smokers. LCA
identified 4 distinct comorbidity profiles with progressively
higher CCI scores: low morbidity (61%, 1.9 ± 1.4), metabolicrenal (21%, 4.7 ± 1.8), cardiovascular (12%, 4.6 ± 1.9), and
multimorbidity (7%, 7.5 ± 1.7). Patients with a low morbidity
profile tended to be younger (68 vs 74 years, P<0.001), were

Supplement

University of Alabama at Birmingham, Birmingham, AL;
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Institute, Rockville, MD
1
2

Background: Adherence to a prescribed bisphosphonate
regimen is low, despite its demonstrated efficacy in reducing
risk of osteoporotic fractures. The objective of this pilot
randomized trial was to evaluate the potential for simple,
short web-based videos to improve bisphosphonate initiation
and adherence.
Methods: We recruited Kaiser Permanente Georgia
members who were English speakers, 55 years of age or
older, had internet access, and had an initial bisphosphonate
prescription in the 30 days prior to invitation. Participants
were randomized to a nurse phone consultation plus a
web-based video (“enhanced intervention”) or a webbased video alone (“basic intervention”). We also included
nonparticipants (“passive refusals”) in comparisons. The
enhanced intervention included a video describing benefits
of osteoporosis treatment along with several short videos
of patient experience. Two weeks following the video,
participants were asked to complete a nurse consultation
by telephone. The nurse consultation focused on possible
barriers to initiation and continuation of therapy. The basic
intervention included a video that presented narrated bullet
www.aurora.org/jpcrr
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points of the benefits of osteoporosis treatment.
Results: The mean age for the enhanced intervention,
basic intervention, and passive refusals was 69.3, 69.6,
and 69.3 years, respectively; 19.1%, 32.1%, and 28.2%,
respectively, were of black race. In the 180 days following
the initial bisphosphonate order date, 90.5% of enhanced
intervention participants, 85.7% of basic intervention
participants, and 90.9% of passive refusals had at least one
bisphosphonate fill (P>0.4 for all pairwise comparisons).
Among participants with at least one bisphosphonate fill,
71% in the enhanced intervention, 68% of participants in
the basic intervention, and only 37% of passive refusals had
180 days of bisphosphonate supply. The difference in days
supply between the enhanced and basic interventions was
not statistically significant; however, days supply in each
of these two groups was greater than that among passive
refusals (P<0.01).
Conclusion: In this sample of postmenopausal women,
primary adherence to an initial prescription of a
bisphosphonate was high; neither the enhanced nor
basic intervention increased this percentage. The active
intervention ─ whether basic or enhanced ─ improved refill
adherence in the subsequent 180 days compared to matched
postmenopausal women who did not participate in the trial.
OA8.03
Abstract OA8.03 withdrawn by authors
Multiple Chronic Conditions and Functional
after initial publication
Limitations Among Nursing Home Residents With
Obesity
Ning Zhang,1 Terry Field,1 John Zeber,2 Kathleen M.
Mazor,1 Jerry Gurwitz1
Meyers Primary Care Institute, Worcester, MA; 2University
of Massachusetts Amherst, Amherst, MA
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Background: Prevalence of obesity in nursing home
residents has increased from 15% in 1992 to 29% in 2015,
affecting about 300,000 older adults in nursing homes.
We aimed to characterize the nursing home residents
with obesity and combined effects of multimorbidity and
functional limitation on hospitalizations.
Methods: We used the national Minimum Data Set 3.0
from 2012 to 2015 for long-stay nursing home residents, ie,
residents residing in a facility 100 or more days in a year. The
outcome variable was the hospitalization (0/1) during a year.
Information on body weight and height came from admission
or annual assessment for each resident in a year to calculate
body mass index (BMI, weight in kilograms divided by height
in meters squared). Residents with no information on body
weight or height were excluded. Residents were categorized
as underweight (BMI < 18.5), normal weight (18.5 ≤ BMI
< 25), overweight (25 ≤ BMI < 30), or obese (BMI ≥ 30).
Residents with obesity were categorized as having class I (30
≤ BMI < 35), class II (35 ≤ BMI < 40), or class III (BMI ≥
40) obesity. Multimorbidity was defined as the presence of
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2 or more nonmetabolic comorbidities. Functional limitation
was measured according to activities of daily living. Other
demographic characteristics of interest included age, sex,
race, and ethnicity. Cox proportional hazards regression was
used to examine the association between the multimorbidity
and functional limitations and hospitalization.
Results: About 10% residents with obesity had neither
multimorbidity nor functional limitation, 65% had
multimorbidity, 39% had functional limitation, and 30% had
both. After adjustment, residents with class III obesity who
had multimorbidity and functional limitation had greater
risks of hospitalization (hazard ratio (HR): 3.85, 95% CI:
3.74–4.70) than those with neither. Residents with class III
obesity who had functional limitation alone had similar risks
of hospitalization (HR: 3.79, 95% CI: 3.75–4.21).
Conclusion: Nursing home residents with class III obesity
who have both multimorbidity and functional limitation
have the highest risk of hospitalization. Individuals with only
functional limitation have similar rates of hospitalizations.
These results underscored the need to consider both when
managing residents with obesity.
OA8.04
Early Weight Change as a Predictor of Long-Term
Treatment Response in a Behavioral Lifestyle
Program for Diabetes Prevention in Clinical
Practice
Robert Romanelli,1 Qiwen Huang,1 Sylvia Sudat,2 Alice
Pressman,2 Kristen Azar2
Palo Alto Medical Foundation Research Institute, Sutter
Health, Palo Alto, CA; 2Division of Research, Development
& Dissemination, Sutter Health, Walnut Creek, CA
1

Background: Evidence-based behavioral interventions for
diabetes prevention have demonstrated efficacy in reducing
diabetes risk, primarily though weight loss. Variation in
treatment response is high yet is poorly understood when
such programs are implemented within real-world clinical
settings. The ability to identify potential nonresponders early
during a behavioral lifestyle program (BLP) presents an
opportunity to assess if more intensive treatment is needed.
We sought to develop and validate a predictive model for
the early identification of nonresponders to a 12-month BLP.
Methods: Data were derived from the electronic health
records of a Northern California health care delivery
system. We included BLP participants ≥18 years of age
with 4 or more weight measurements recorded during the
first 12 weeks of the program and a weight measurement
at 12-month follow-up. We defined nonresponse as weight
gain or no weight loss at 12 months from program initiation.
We used logistic regression with percent weight change at
12 weeks from program initiation as the sole independent
variable to predict nonresponse at 12 months. A secondary
model included patient characteristics as independent
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variables. We performed 10-fold cross-validation for model
assessment. We examined model performance by area
under the receiver operating characteristic curve (AUROC),
sensitivity, specificity, and positive (PPV) and negative
(NPV) predictive values.
Results: The study cohort included 961 BLP participants;
30% were classified as nonresponders. For the model with
percent weight change as the sole predictor, the AUROC was
0.785, corresponding to fair discrimination of nonresponders
from responders. The addition of patient characteristics
resulted in slightly poorer discrimination (AUROC: 0.755).
For the simpler model, sensitivity and PPV were maximized
at 0.56, with a specificity and NPV of 0.81. With this model,
BLP participants with a predicted probability of nonresponse
of ≥41%, corresponding to <1.83% weight loss at 12 weeks
from baseline, would be flagged as potential nonresponders
and candidates for treatment intensification assessment.
Conclusion: In this cohort of BLP participants in a realworld clinical setting, percent weight change in the first 12
weeks, alone, predicts nonresponse at 12 months. Clinicians
can apply this algorithm to identify and assess patients in
potential need of treatment intensification, thereby improving
long-term treatment response through an individualized,
patient-centered approach to diabetes prevention.
P5.01
Personalized and Marginal Concurrent Risk in
Older Persons With Multiple Chronic Conditions
Receiving Polypharmacy
Heather Allore, Terrence Murphy, George Agogo,
Gail McAvay1
1
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Background: Older adults accumulate chronic conditions
requiring medications that bear on patient-centered outcomes.
There is a need to understand how specific factors affect the
probability of patient-centered outcomes, such as limitations
in social activity and mobility that are correlated and nonmutually exclusive. Knowing the probability of experiencing
pairs of patient-centered outcomes within the next year
may help patients and providers achieve goals of care. We
define and illustrate personalized concurrent risk (PCR), ie,
the person-specific risk of an outcome in an interval of time
while at concurrent risk for a separate outcome, and the
corresponding marginal concurrent risk (MCR).
Methods: Data are from older community-dwelling persons
with both hypertension and chronic obstructive pulmonary
disease. Exposure was polypharmacy, defined as the use
of 5 or more classes of prescription medications. The two
concurrent patient-centered outcomes were social activity
and mobility limitations. To address imbalances, propensity
scores of each person’s likelihood of polypharmacy were
used to generate inverse probability of polypharmacy
weights. These weights were applied to the models of the
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occurrence of limitations in social activity and mobility
over two consecutive 1-year periods joined through a shared
person-specific random intercept. PCRs and MCRs were
calculated from weighted joint models of the two outcomes
regressed on polypharmacy, age, sex, and arthritis.
Results: Among persons with polypharmacy, the MCRs for
limitations in social activity and mobility were from 1.6% to
10.3% and from 10.1% to 86.8%, respectively, dependent on
the patient characteristics. However, the PCRs for limitations
in social activity and mobility ranged from 0.1% to 97.7% and
from 2.0% to 99.9%, respectively, showing that information
captured by jointly modeling through a shared person-specific
random intercept increases the accuracy of the estimated
probability of an outcome occurrence within a time frame.
Conclusion: PCR provides a personalized estimate of
risk conditional on a patient’s characteristics and exhibit
heterogeneity. In contrast, MCR provides the average
risk. Application of PCR and MCR to health care system
datasets may facilitate personalized medicine and decisionmaking for patients that may face tradeoffs or value multiple
outcomes by providing the risk of an outcome in the presence
of another correlated outcome. SAS code is available.
P5.02
Recruitment Challenges in Trials of Low-Risk
Health Care Delivery System Interventions:
Improving Medication Safety Postdischarge in
Older Adults
Kathryn Anzuoni,1 Kathleen M. Mazor,1 Terry Field,1
Alok Kapoor,2 Lawrence Garber,3 Jerry Gurwitz1
Meyers Primary Care Institute, Worcester, MA; 2University
of Massachusetts Medical School, Worcester, MA; 3Reliant
Medical Group, Worcester, MA
1

Background: Recently hospitalized older adults are at
increased risk for adverse drug events (ADEs) during the
days immediately after discharge. We sought to test the
effectiveness of a pharmacist-based intervention targeting
these patients; the intervention included a home visit from
a clinical pharmacist with medication review, patient
education, and telephone follow-up. The challenges we
encountered in enrolling older patients immediately
posthospitalization led us to examine whether enrolled
patients were representative of all invited eligible patients
and to explore reasons for declining.
Methods: Adults who were >50 years of age, recently
discharged from a local hospital, and prescribed at least
one high-risk medication (ie, anticoagulants, diabetes
agents, or opioids) were eligible to enroll. Eligible patients
were contacted via telephone within 3 days of discharge
and invited to participate; those who declined were asked
their reason(s). We compared demographic and clinical
characteristics of enrolled patients to characteristics of all
invited eligible patients.
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Results: Overall, 9.9% (n=353) of 3563 eligible patients
reached by phone enrolled in the trial. Enrolled participants
tended to be younger than the population of reached eligible
patients; 27% of reached eligible patients were 80 years or
older compared to only 14% of enrolled patients. Enrolled
patients were less likely to have been admitted through the
emergency room than reached eligible patients (59% vs 69%,
respectively) and more likely to be on more than 1 high-risk
medication compared to reached eligible patients (54% vs
48%, respectively). Patients’ reasons for declining suggested
they did not perceive a need for help with medications: 15%
did not expect the study would be useful; 10% believed they
had all the medication information they needed; and 19%
relied on assistance from the Visiting Nurse Association, a
spouse, or family member. Some patients (6%) were too ill
or too tired to enroll.
Conclusion: Recruiting older, recently hospitalized
patients during the immediate posthospitalization period
when patients are most at risk for ADEs resulted in a low
enrollment rate, a loss of power, and an inability to look at
subgroups that may be of particular risk. Better strategies are
needed to encourage and facilitate participation of high-risk,
vulnerable patients in low-risk health care system-based
interventions.
P5.03
Kidney Graft Survival Outcomes for Older Adults
Over Time: An Examination of Factors From the
United Network for Organ Sharing Database
Cinamon Romers, Kiumars Zolfaghari, Jinmyoung
Cho,1 Hilary Linderman,2 Laurel Copeland3
1
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Background: Kidney transplantation is a preferred
treatment for individuals with end-stage renal disease.
With an increase in life expectancy, there is a need for
transplantation for aging patients. Due to comorbid health
problems and increased morbidity, advanced age has been
considered a contraindication for transplant. This study aims
to explore factors associated with mortality and graft failure
among patients 50 to 79 years old.
Methods: Data from the United Network for Organ Sharing
registry identified 86,696 kidney transplant recipients
from 2006 to 2015. Recipients were stratified into 3 age
groups (50–59, 60–69, and 70–79 years). Graft mortality
and patient mortality were examined for recipients at 30
days, 90 days, 1 year, 3 years, and 5 years posttransplant.
Chi-squared test and Student’s t-test were used to assess
recipient’s characteristics, and Kaplan-Meier survival curves
evaluated unadjusted all-cause mortality by age groups. In
addition, Cox proportional hazards regression models were
applied to adjust for potential confounding variables in the
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posttransplantation survival analysis.
Results: Transplantation increased among the oldest
group in comparison to the youngest group over the years
(P<0.0001). Death not associated with graft failure was
more common in the 70–79-year age group (22.1%) than
in the 60–69-year age group (15.4%) and the 50–59year age group (9.9%). When controlling for all-cause
mortality associated variables (body mass index, diabetes,
hypertension, peripheral vascular disease, dialysis at time
of transplant, prior transplant experience, receiving multiple
organs, and lengthy wait-list time), the 50–59 age group was
14% more likely to experience graft failure than was the
70–79 age group.
Conclusion: Age is a primary criterion in transplant
eligibility. In our analyses, fewer older recipients experienced
graft failure than younger recipients. Candidates in the
youngest age group were most likely to receive multiorgan
transplants, with worse outcomes, than candidates in the
oldest age group. Careful consideration should be given to
age as a primary allocation criterion factor.
P5.04
A Qualitative Examination of Experiences
Managing Type 1 Diabetes Among Patients 18 to
26 Years of Age
Tina Davis,1 Josh Barzilay,1 Doraina Walker-Williams,1
Brandi Robinson,1 Negah Rassouli1
Kaiser Permanente Georgia, Atlanta, GA
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Background: Sustaining target A1c levels early during
diabetes is essential to preventing and delaying disease
complications, including hypoglycemia and cardiovascular
disease. Research suggests most adults in their 20s
will not achieve target A1c until age 30. Longitudinal
research indicates adolescents and young adults (AYA)
have declining glycemic control during adolescence and
higher rates of diabetes complications compared to adults
with diabetes. Adolescents must manage developmental
challenges, including transitioning into adulthood,
cognitive development, and navigating relationships, while
concurrently managing their chronic condition. Therefore,
the purpose of this research study is to understand barriers
and facilitators of type 1 diabetes management among AYA.
Methods: We conducted one-on-one, qualitative phone
interviews with Kaiser Permanente Georgia (KPGA)
members (N=14) with type 1 diabetes (T1D) to understand
their experiences with T1D management, treatment,
and medication adherence. Eligibility criteria included
age 18–26 years, a confirmed T1D diagnosis, current
enrollment at KPGA, and English-speaking. The sample
was dichotomized into two groups using their A1c levels
in the past 2 years: “managers” (A1c level of <7%) and
“non-managers” (A1c of >9.5%) were asked to participate.
Interviews were audio recorded, transcribed verbatim, and
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cleaned. All study procedures were approved by the KPGA
institutional review board. Two coders will use open coding
to develop a codebook and axial coding to code transcripts
using NVivo 12.0 software.
Results: Preliminary results are as follows. All participants
reported challenges monitoring glucose levels, feeling
isolated, finding jobs to accommodate health needs,
transitioning between health care practices, financing the
cost of care, and communicating the nuances of T1D to
peers, family, intimate partners, and supervisors. “Managers”
reported receiving support and education early in their
diagnosis, including parental support, clinician support, and
attending camps for children with T1D.
Conclusion: AYA need resources and education that
concurrently address social, nonmedical needs related to
learning to communicate T1D needs to others, navigating
social experiences and T1D management, and education on
navigating resources. While classes are available at KPGA,
most focus on type 2 diabetes management. Group sessions
tailored to needs of members with T1D are essential, and
considering the widespread use of technology among AYA,
there should be a mobile health component.

smoking status, health system, and NMIBC stage/grade to
model the association between MetS and time to recurrence.
Results: Overall, 423 patients (28.5%) had MetS and 1062
patients did not (71.5%). Median follow-up for the cohort
was 5.9 years. Follow-up for patients with MetS was slightly
shorter as compared to those without MetS (4.7 vs 6.4
years). Patients had a median of 1 recurrence (interquartile
range: 1–2) over the study period. Individuals with MetS
tended to be younger (mean age: 73 years vs 73.8 years),
more frequently male (83.7% vs 76.8%), and never smokers
(81.6% vs 71.4%). After adjusting for age, sex, smoking
status, health system, and stage/grade, MetS was associated
with a reduction in the risk of recurrence (adjusted hazard
ratio: 0.77, 95% CI: 0.63–0.95, P=0.01).
Conclusion: In this cohort of older NMIBC patients
from two health systems, we found that the presence of
MetS was associated with a decreased risk of NMIBC
recurrence. Further research is needed to understand the
complex pathophysiology underlying NMIBC outcomes
and metabolic syndrome. In future analyses, we will assess
how factors such as lipid- or glucose-lowering medications
influence this association.

P5.05
Association Between Metabolic Syndrome and
Recurrence in Older Adults Treated for NonMuscle-Invasive Bladder Cancer

P5.06
Prevalence of Social/Economic Needs Among
Seniors in a Non-Safety-Net Health Plan

Tullika Garg, Amanda Young, Maureen O’KeeffeRosetti,2 Terrence Murphy,3 Carmit McMullen,2
Matthew Nielsen,4 H. Lester Kirchner1
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Carolina at Chapel Hill, Chapel Hill, NC
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Background: Non-muscle-invasive bladder cancer
(NMIBC) disproportionately affects older adults (median
age: 73 years) who also have a high prevalence of chronic
conditions, including metabolic syndrome (MetS).
Prior research suggests that MetS is a risk factor for the
development of bladder cancer; however, limited data exist
on how MetS impacts oncologic outcomes. The objective
was to evaluate the association between MetS and recurrence
in older adults treated for NMIBC.
Methods: We identified 1485 older (≥60 years) NMIBC
patients (stage ≤I) from two community-based health systems
who underwent cancer treatment (bladder instillation and/or
transurethral resection). MetS was defined as the presence
of 3 of the following based on diagnosis codes or electronic
health data: hypertension, hyperlipidemia, diabetes, or body
mass index of >30. Follow-up time was determined by date
of last follow-up in the cancer registry, and data was truncated
at 10 years. Cox proportional hazards regression adjusting
for competing risks was performed, adjusting for age, sex,
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Background: Many health plans are looking at screening
Medicare-age adults for social/economic risks (SERs). This
study examined prevalence of SERs among seniors in a nonsafety-net health plan population.
Methods: In 2018, we conducted a mailed survey of a
stratified (age, sex, COPS2 comorbidity score), random
sample of English-speaking Kaiser Permanente (KP)
Northern California members 65–89 years of age using
KP’s Your Current Life Situation questionnaire (56%
response, 2061 of 3065). Using responses from multiple
questions, we classified adults as being at-risk for food
insecurity (FoodInsec), housing insecurity (HousInsec),
transportation insecurity (TransportInsec), financial strain
(FinanStrain, defined as trouble paying for food, housing,
utilities, medical needs, transportation, debts, other basics),
social isolation (SocIsolRisk, defined as lives alone and
not in a relationship), feeling overwhelmed by difficulties
(Overwhelm), medical SERs (MedSER, defined as trouble
paying for medical needs or medical-related transportation
issues), and nonmedical SERs (NonMedSER, defined as
1 or more nonmedical SER, excluding SocIsolRisk). We
estimated population prevalence of SERs using weighted
www.aurora.org/jpcrr

107

survey data and evaluated differential risk for SERs by
race/ethnicity, age group, sex, and COPS2 level (<45 vs
≥45) using multivariable logistic regression models that
additionally controlled for being married/partnered and
living in a residential facility.
Results: Overall prevalence of SERs was 8.5% FoodInsec,
8.4% HousInsec, 4.3% TransportInsec, 12.0% FinanStrain,
and 20.4% SocIsolRisk. Nearly 16% felt overwhelmed at
least sometimes, 2% often. Approximately 5% had 1 or
more MedSER and 22.5% 1 or more NonMedSER (36%
if SocIsolRisk included). Logistic regression models
showed that blacks and Filipinos were more than 2 times
as likely as whites to be at risk for FoodInsec, HousInsec,
TransportInsec, FinanStrain, Overwhelm, MedSER, and
NonMedSER. Women were twice as likely as men to have
SocIsolRisk but were not at greater risk for other SERs. A
COPS2 level of ≥45 more than doubled risk for all SERs,
MedSER, and NonMedSER, while being married halved
risk. SER risk was not associated with age.
Conclusion: Among seniors in this non-safety-net health
plan, 5% of seniors had medical-related social/economic
risks, while 3 times that percentage had 1 or more
nonmedical-related risks that potentially could affect health
and quality of life. Black or Filipino race and sicker seniors
were more likely to have both medical and nonmedical
social/economic risks.
P5.07
Primary Care Treatment for Migraine: Experience
From a Large Health Care System
Alice Jacobson,1 Shruti Vaidya,1 Reeti Sharma,1
Victoria Chia,2 Dawn Buse,3 Richard Lipton,3,4 Walter
Stewart,5 Alice Pressman1
Sutter Health, Walnut Creek, CA; 2Amgen Inc, Thousand
Oaks, CA; 3Albert Einstein College of Medicine, New York,
NY; 4Montefiore Medical Center, New York, NY; 5HINT
Consulting, Orinda, CA
1

Background: The majority of those diagnosed with
migraine seek treatment only from primary care, but little is
known about the approach by which primary care providers
(PCPs) manage migraine. We sought to compare prescribing
patterns for migraine patients in a large health care system,
comparing those who seek care from neurology (N-M) with
those treated exclusively by a PCP (PC-M).
Methods: From electronic health records (EHR), we applied
a previously validated migraine probability algorithm (MPA)
to identify 94,149 PC-M and N-M patients at Sutter Health in
Northern California from January 1, 2013, to December 31,
2017. We extracted medication orders for acute treatments
(non-narcotic-analgesic, narcotic-analgesic, triptan, and
other migraine-specific) and the most commonly-prescribed
preventive treatments (beta-blocker, calcium channel
blocker, antidepressant, anticonvulsant, and neurotoxin).
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Because higher scores on the migraine probability algorithm
indicate more extensive utilization, we classified 45% of
PC-M and 55% of N-M patients with a maximum score as
“frequent-consulters.”
Results: During the 5-year period, PC-M patients
(n=72,624, 77%) were less likely to receive 1 or more
acute (81% vs 89%) or 1 or more preventive (55% vs 81%)
prescription orders than N-M patients. Among frequentconsulters, a larger proportion of PC-M patients received
orders for 1 or more acute treatments (98% vs 93%) and the
difference between PC-M and N-M in orders for 1 or more
preventives was smaller (73% PC-M vs 86% N-M). The
most commonly prescribed preventive type for PC-M and
N-M was antidepressant (41% PC-M, 62% N-M); among
frequent-consulters, neurotoxin was the least prescribed
(<1% PC-M vs 9% N-M).
Conclusion: Neurology patients at Sutter Health were
more likely to receive both acute and preventive medication
orders than PC-M patients, with triptans and antidepressants
most commonly ordered preventive and acute, respectively.
However, among frequent-consulters, this relationship was
reversed for acute treatments and attenuated for preventive.
A limitation of this study is that using EHR data alone, we
cannot reliably differentiate between chronic and episodic
migraine. It is likely that neurologists treat more patients
with chronic migraine than PCPs do, and that may account
for the prescribing differences. Further study is underway
to assess the impact of migraine severity on prescribing
patterns using a patient survey combined with EHR.
P5.08
Understanding
Communications
Challenges
Between Care Facilities and Primary Care
Physicians to Improve Care for Facility Residents
Elizabeth Liles,1 Paula Carder,2 Inga Gruß1
Kaiser Permanente Center for Health Research, Portland,
OR; 2Portland State University, Portland, OR
1

Background: Assisted living includes all group homes not
licensed as nursing homes that provide personal care and can
respond to unscheduled needs in a homelike environment. In
2014, 30,200 residential care/assisted living (RC/AL) facilities
in the United States housed more than 1 million residents. More
than half are 85 years or older, and 4 out of 10 have dementia.
They commonly require assistance with bathing or toileting.
These vulnerable adults require timely evaluation of acute
symptoms and injuries. State regulations mandate that RC/AL
residents receive nursing oversight of medications and chronic
health conditions, and evaluation of acute symptoms and
injuries such as those due to falls. States also set regulations for
physician responsibilities, although the duties of primary care
providers are vaguely defined. Communication difficulties
arise in a system in which care is dispersed between facility
staff and primary care medical offices.
Supplement

Methods: We conducted 3 focus groups with 21 primary
care physicians (PCPs) at 3 Kaiser Permanente medical
offices in the greater Portland metro region. The goal was
to learn about communication between RC/AL staff and
PCPs, including barriers and facilitators. We also surveyed
more than 300 such facilities in Oregon, asking about their
perceived successes and barriers in communicating with
primary care offices.
Results: We found a lack of standardization of
communications, challenges to incorporating different
modes of communication, and a lack of transparency about
the perceived importance of communications. From 276
returned surveys, the top 3 concerns about communications
with primary care medical offices were lack of timely
response to fax or phone message, physicians not providing
necessary information on orders, and PCPs’ lack of
understanding of facilities’ regulatory requirements. About
63% of respondents remarked that replies to messages sent
to primary care offices via fax or phone were frequently
slow.
Conclusion: Stakeholder input on communications between
PCP offices and residential care/assisted living facilities
revealed communications gaps. We will use our findings
to draft standardized communications forms between PCP
offices and RC/AL facilities that can be used by any physician
group or health system. Improving communications will
improve health, well-being, and safety for patients living in
these facilities.

were classified as AC for those with a discharge diagnosis or
history of COPD (COPD, chronic bronchitis or emphysema)
and SA for those without. We defined readmission as returning
to the ED with similar chief complaints within 30 days. We
compared demographics and ED utilization between patients
with SA and AC by readmission status.
Results: Among 3625 patients who met criteria during 2017,
2364 (65%) had SA and 1261 (35%) had AC. Readmissions
differed by group, with 321 (12%) of SA and 295 (25%) of
AC returning to the ED within 30 days (P<0.01). For both
types of asthma patients, those who readmitted were more
likely to be African American than those who did not (49%
vs 45% for SA, P=0.07; 54% vs 46% for AC, P=0.01). Those
with AC who readmitted were significantly older (61 ± 14.3
years) than those with SA (44 ± 17.9 years; P<0.01), while
gender patterns were similar.
Conclusion: Patients with AC are more likely to have
recurring ED visits than those with SA. Further, those with
AC who readmit are more likely to be African American
and older than their SA counterparts. An adaptive approach
to designing intervention programs for these different
subgroups should include more customized education for
patients with comorbid COPD who also differ culturally.

P5.09
Emergency Department Recurring Visits for Adult
Patients With Asthma or Asthma Plus Chronic
Obstructive Pulmonary Disease

Mayra Tisminetzky,1 Jerry Gurwitz,1 Joel Gore,2 Ruben
Miozzo,3 Darleen Lessard,2 Jorge Yarzebski,2 Robert
Goldberg2

Zijun Shen, Reeti Sharma, Shruti Vaidya, Maria
Moreno,1 Kristen Azar,1 Stephen Lockhart,1 Alice
Pressman1
1

1

1

Sutter Health, Walnut Creek, CA

1

Background: Breathing difficulty (BD) is one of the most
common reasons for emergency department (ED) encounters.
As part of an initiative to advance health equity, Sutter
Health, a large not-for-profit health care system in Northern
California, implemented an educational intervention
program for African American adult ED patients with a chief
complaint of BD and history of asthma. Early evaluation
showed that enrolled asthma patients with a comorbidity of
chronic obstructive pulmonary disease (COPD) were more
likely to return to the ED after intervention than those with
asthma alone. We studied these two subgroups of ED patients
to identify their patterns of ED utilizations that could inform
the development of interventions to reduce readmissions.
Methods: We extracted data from electronic health records of
adult asthma patients with ED encounters for BD at 4 Sutter
Health hospitals in 2 counties in Northern California. Patients
Supplement

P5.10
Impact of Cardiac- and Noncardiac-Related
Conditions on Adverse Outcomes in Patients
Hospitalized With Acute Myocardial Infarction

Meyers Primary Care Institute, Worcester MA; 2University
of Massachusetts Medical School, Worcester MA; 3Johns
Hopkins University, Baltimore MD
1

Background: To examine the effects of cardiac- and
noncardiac-related conditions on in-hospital complications
and 7- and 30-day rehospitalizations after an acute
myocardial infarction.
Methods: The study population consisted of 3863 patients, 65
years and older, hospitalized with acute myocardial infarction
at 3 medical centers in Worcester, Massachusetts, during 6
annual periods between 2001 and 2011. Individuals were
categorized into 4 groups based on the presence of cardiacand noncardiac-related conditions: those with 0–2 cardiac and
0 noncardiac conditions; 0–2 cardiac and 1 or more noncardiac
conditions; 3 or more cardiac and 0 noncardiac conditions; and
3 or more cardiac and 1 or more noncardiac conditions.
Results: The median age of the study population was 79
years; 49% were men. Overall, 28% of patients had 0–2
cardiac and 0 noncardiac conditions, 21% had 0–2 cardiac
and 1 or more noncardiac conditions, 20% had 3 or more
cardiac and 0 noncardiac conditions, and 31% had 3 or
more cardiac and 1 or more noncardiac conditions. After
www.aurora.org/jpcrr
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multivariable adjustment, individuals with 3 or more cardiac
and 1 or more noncardiac conditions were at greatest risk for
all adverse outcomes. Patients who presented with cardiacrelated conditions were at higher risk of dying or developing
complications during hospitalization, whereas those with
noncardiac-related conditions were at slightly higher risk of
being rehospitalized within 7 days.
Conclusion: Patients hospitalized with acute myocardial
infarction carry a significant burden of cardiac- and
noncardiac-related conditions. Increased attention to the
management of this vulnerable population is warranted.

CARDIOVASCULAR DISEASE
OA12.01
Long-Term Effects on Cardiovascular Events
of Home Blood Pressure Telemonitoring With
Pharmacist Management in Patients With
Uncontrolled Hypertension
Karen L. Margolis,1 Stephen Dehmer,1 Michael
Maciosek,1 JoAnn Sperl-Hillen,1 Stephen Asche,1 Anna
Bergdall,1 Beverly B. Green,2 Rachel Nyboer,1 Pamala
A. Pawloski,1 Nicole Trower,1 Patrick J. O’Connor
HealthPartners Institute, Minneapolis, MN; Kaiser
Permanente Washington Health Research Institute,
Seattle, WA
1

2

Background: Uncontrolled hypertension is a leading
contributor to cardiovascular (CV) disease. We previously
reported results of a cluster-randomized trial evaluating a
1-year home blood pressure telemonitoring and pharmacist
management intervention, with significant reductions
in blood pressure favoring the intervention group for 24
months. This analysis examined the intervention effect on
CV events over 5 years of follow-up.
Methods: The Hyperlink trial randomized 16 primary care
clinics with 450 patients with uncontrolled hypertension
to either telemonitoring intervention (TI, n=228) or usual
care (UC, n=222). CV events and deaths were ascertained
though self-reports and electronic health records. Medical
records for all potential events were adjudicated by trained
reviewers blinded to intervention assignment. The primary
composite endpoint included nonfatal myocardial infarction
(MI), nonfatal stroke, hospitalized heart failure (HF), and
CV death. Coronary revascularization was included in a
secondary composite endpoint. Generalized estimating
equations with robust standard errors were used to test
differences in CV incidence by treatment group. Marginal
Cox models were used to estimate the hazard ratio for time
to first event by treatment group. Both methods account for
the cluster-randomized design.
Results: There were 15 CV events (5 MI, 4 stroke, 5 HF, 1
CV death) among 10 patients in the TI group and 26 events
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(11 MI, 12 stroke, 3 HF) among 19 patients in the UC group.
The incidence of the primary CV composite endpoint was
4.4% in the TI group vs 8.6% in the UC group (odds ratio:
0.49, 95% CI: 0.21–1.13, P=0.09). Including 2 coronary
revascularizations in the TI group and 10 in the UC group,
the incidence of the secondary CV composite endpoint was
5.3% in the TI group vs 10.4% in the UC group (odds ratio:
0.48, 95% CI: 0.22–1.08, P=0.08). In the time-to-first-event
analysis for the primary outcome, hazard ratio was 0.50
(95% CI: 0.22–1.11, P=0.09). For the secondary endpoint
including coronary revascularization, hazard ratio was 0.49
(95% CI: 0.23–1.04, P=0.06).
Conclusion: The intervention lowered blood pressure and
may have reduced CV events by 50% over 5 years, even
in this small study. Cost-effectiveness estimates using
microsimulation models will be presented.
OA12.02
Blood
Pressure
Checks
and
Diagnosing
Hypertension
(BP-CHECK):
A
Randomized
Controlled Diagnostic Study Comparing Clinic,
Home, and Kiosk to 24-Hour Ambulatory BP
Monitoring ─ Comparative Accuracy Primary
Outcome Results
Beverly B. Green,1 Melissa L. Anderson,1 Andrea
J. Cook,1 Kelly J. Ehrlich,1 Yoshio N. Hall,2,4 Predjag
Klasnja,1 Karen L. Margolis,3 Jennifer B. McClure,1
Matthew J. Thompson4
Kaiser Permanente Washington Health Research Institute,
Seattle, WA; 2Kidney Research Institute, Seattle, WA;
3
HealthPartners Institute, Minneapolis, MN; 4Department
of Family Medicine, University of Washington, Seattle, WA
1

Background: The U.S. Preventive Services Task Force
recommends out-of-office blood pressure (BP) measurements
before making a new diagnosis of hypertension, using 24-hour
ambulatory monitoring (ABPM) or home BP monitoring.
However, this approach is not common in routine practice. Blood
Pressure Checks and Diagnosing Hypertension (BP-CHECK)
is a randomized controlled diagnostic study comparing the
accuracy and acceptability of clinic-, home-, and kiosk-based
BP monitoring to ABPM for diagnosing hypertension.
Methods: Within an integrated health care system, adults
18–85 years of age without diagnosed hypertension, on no
hypertension medication, and with elevated BPs in clinic
and at the baseline research visit are randomized to 1 of
3 regimens for diagnosing hypertension: 1) clinic BPs, 2)
home BPs, or 3) kiosk BPs. All participants subsequently
complete ABPM. Clinic BP patients are asked to make a
clinic appointment to have their BP rechecked. Home BP
patients are trained to use a validated home BP monitor and
asked to check their BP twice a day, with 2 measurements
each time for 5 days. Kiosk BP patients are trained to use
a validated BP kiosk and asked to check their BP at least 3
Supplement

more days with 3 measurements each time. All patients are
asked to complete ABPM at 3 weeks. All BP data is being
collected electronically (electronic health record, Bluetooth,
web). The primary outcome is the accuracy of each method as
compared to ABPM. Secondary outcomes include adherence
to the assigned protocol and patient-reported outcomes
related to diagnostic testing (discomfort, anxiety, perception
of accuracy). Linear regression models will estimate the mean
difference in systolic BP between the diagnostic and ABPM
reference standard measures for each group.
Results: At the time of abstract submission 427 of 510 (84%) of
the expected total participants had been enrolled. Participants
were 48% female, were 21% nonwhite or Hispanic, and had
a mean body mass index of 30. Average baseline BP was 150
mmHg systolic and 88 mmHg diastolic. Enrollment ends in
January 2019, and we expect to have preliminary primary
accuracy outcomes at the time of the meeting.
Conclusion: BP-CHECK will inform which hypertension
diagnostic methods are most accurate, acceptable, and
feasible to implement in primary care.
OA12.03
Real-World
Outcomes
Associated
With
Idarucizumab: Population-Based Retrospective
Cohort Study
Sonal Singh,1 Amit Nautiyal,2 Kathy Belk3
University of Massachusetts Medical School / Meyers
Primary Care Institute, Worcester, MA; 2Pulmonary and
Critical Care, Department of Medicine, Albany Medical
College, Albany, NY; 3Health Data Analytics, Irving, TX
1

Background: Idarucizumab reverses the anticoagulant effect
of dabigatran, but few comparative studies have reported on
clinical outcomes with idarucizumab. Our objective was to
determine the effect of idarucizumab on clinical outcomes.
Methods: We conducted a retrospective cohort in a nationally
representative sample of hospitals in the United States. The
study population included adults ≥18 years of age who were
hospitalized for dabigatran-associated major bleeding between
January 1, 2015, and December 31, 2017. We compared
idarucizumab-exposed patients to the unexposed group. Our
primary outcome of interest was in-hospital mortality.
Results: We included 266 exposed and 1345 nonexposed
participants across 271 hospitals. Among participants
with gastrointestinal bleeding, there was no statistically
significant difference in the odds of in-hospital mortality (9
of 153 [5.9%] vs 37 of 1124 [3.3%]; adjusted odds ratio:
1.39, 95% CI: 0.51–3.45) between the idarucizumabexposed and nonexposed groups. Among participants with
intracranial bleeding, there was an excess of in-hospital
mortality (13 of 112 [11.6%] vs 6 of 217 [(2.8%]) associated
with idarucizumab exposure, but limitations include sparse
data and the inability to rule out residual confounding or
confounding by disease severity.
Supplement

Conclusion: Among a large nationally representative sample
of adult patients with dabigatran-associated intracranial
bleeding in the United States, we found no difference in
in-hospital mortality among patients with gastrointestinal
bleeding associated with idarucizumab exposure. An excess
risk of in-hospital mortality associated with idarucizumab
exposure among participants with intracranial bleeding
deserves further exploration.
OA12.04
Impact of a Multicomponent Care Transition
Intervention on Hospitalizations and Emergency
Department Visits in Patients Diagnosed With
Venous Thromboembolism
Alok Kapoor,1 David McManus,1 Bruce Barton,2 Chad
Darling,2 Saud Javed,2 Kathleen M. Mazor1
University of Massachusetts Medical School / Meyers
Primary Care Institute, Worcester, MA; 2University of
Massachusetts Medical School, Worcester, MA
1

Background: Hospitalizations and emergency department
(ED) visits after venous thromboembolism (VTE) diagnosis
are the cause of significant health burden in the United
States, yet few interventions have specifically targeted these
outcomes for patients with VTE. We assessed the impact of
a multicomponent intervention on hospitalizations and ED
visits in the 90 days after VTE diagnosis.
Methods: We randomized patients adults with new episode
of VTE to usual care or a multicomponent intervention
consisting of home pharmacist visit in the week after
diagnosis, illustrated medication instructions, and follow-up
phone call with an anticoagulation expert scheduled for 8 to
30 days from time of diagnosis. To examine the impact of the
intervention we measured the incidence of hospitalizations
and ED visits and identified those visits related to the
index condition (ie, VTE, bleeding, or anticoagulation)
and the preventability of these visits. To assess the relative
effectiveness of the intervention we calculated an incidence
rate ratio of the count of hospitalizations and ED visits,
adjusting for potential confounders from residual imbalance
of demographic and clinical variables.
Results: We enrolled 77 and 85 patients in the intervention
and control groups, respectively. The incidence rate was
4.50 vs 6.01 visits per 1000 patient days in the intervention
vs control groups. Most of the events in the control group
were not related to the index condition (21%), and of those
that were related to it, most were not preventable (25%). The
adjusted incidence rate ratio (IRR) for the intervention was
1.05 (95% CI: 0.57–1.91).
Conclusion: Patients have a significant number of hospital
and ED visits in the 90 days after randomization, but most
visits were not related to recurrent VTE, bleeding, or
anticoagulation and were not preventable. After adjustment
for confounders, there was no difference in utilization
www.aurora.org/jpcrr
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between intervention and control patients. Future research
should focus on testing other interventions for patients with
VTE or determining whether our intervention would be
beneficial in other groups of patients.
P2.01
Statin Therapy and Risk of Incident Diabetes
Mellitus in Adults With Cardiovascular Risk Factors
Kevin Kheder,1 Andrew Ambrosy,1 Dongjie Fan,2 Sue
Sung,2 Joan C. Lo,1 Alan Go2
Kaiser Permanente Northern California, San Francisco,
CA; 2Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background: Several meta-analyses have found statin use
to be associated with an increased risk of incident diabetes
mellitus that is proportional to the intensity of lipid lowering
therapy (LLT). However, the magnitude of this increased
risk in nondiabetic adults with cardiovascular (CV) risk
factors has not been well-defined.
Methods: The Kaiser Permanente CHAMP study identified
nondiabetic adults with CV risk factors and no prior LLT
between January 1, 2008, and December 31, 2010. CV
risk factors included known atherosclerotic CV disease
(ASCVD), an elevated (>190 mg/dL) low-density lipoprotein
cholesterol (LDL-C), or an LDL-C from 70 to 189 mg/dL
and an estimated 10-year ASCVD risk > 7.5%. Incident
diabetes mellitus was defined as more than 2 abnormal tests
(ie, hemoglobin A1c of >6.5% or a fasting blood glucose
of >126 mg/dL) or as 1 abnormal test and 1 new diagnostic
code or medication for diabetes mellitus.
Results: There were 213,289 nondiabetic adults initially
identified as having high CV risk. A total of 28,149 patients
with a new statin prescription were matched to an equal
number of patients with no prior LLT. Patients initiated on
a statin were similar in terms of age (67.9 ± 9.4 years) and
gender (42.8% women) but were more likely to have LDL-C
of >130 mg/dL (71.1% vs 34.8%) or a prior myocardial
infarction (6.0% vs 0.1%). The unadjusted rate (per 100
person-years) of incident diabetes mellitus was low (0.55,
95% CI: 0.52–0.59) but was marginally higher in patients
who were treated with a statin (0.69, 95% CI: 0.64–0.74) vs
no LLT (0.42, 95% CI: 0.38–0.46). After adjustment, statin
therapy was associated with an increased risk of incident
diabetes mellitus (adjusted hazard ratio [aHR]: 1.17, 95%
CI: 1.02–1.34). Results were consistent in a sensitivity
analysis comparing the low-potency statin group to no LLT
(aHR: 1.22, 95% CI: 1.06–1.40).
Conclusion: Among nondiabetic adults at high risk for
ASCVD, initiation of LLT with a statin was independently
associated with a modestly increased risk of incident
diabetes mellitus.
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P2.02
Optimization of a Risk Calculator to Predict LongTerm Outcomes and Utilization After Percutaneous
Coronary Intervention
Samuel Savitz,1 Matthew Solomon,1 Sue Hee Sung,1
Thomas Leong,1 Alan Go1
Kaiser Permanente Northern California, Oakland, CA
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Background: Risk calculators for clinical outcomes and
utilization have become increasingly common tools to assist
in cardiovascular care. We aimed to improve a risk calculator
for predicting long-term outcomes and utilization after
percutaneous coronary intervention (PCI). The strategies
we evaluated for potentially improving the risk calculator
included 1) adding predictors that have not typically been
used in clinical risk calculators, and 2) using alternative
machine learning approaches.
Methods: The original risk calculator used data from 2008
to 2012 for patients who received PCI at Kaiser Permanente
Northern California, an integrated health care delivery
system caring for >4 million members. The risk calculator
predicted outcomes at 1 year for death, coronary heart
disease hospitalization and emergency room visits, and repeat
revascularization. The original model used Cox proportional
hazards (Cox PH) regression with backwards selection to
estimate absolute risks. We evaluated the potential value of
novel potential predictors in three domains: 1) area-based
socioeconomic status; 2) access to care; and 3) patient
behavior measures. We assessed for change in the C-index and
the net reclassification index (NRI). The alternative modeling
approaches were 1) Cox PH with lasso regression, 2) Cox PH
with ridge regression, 3) Cox PH with elastic net regression,
and 4) conditional inference trees. The improvement in
predictive discrimination was assessed using changes in the
C-index.
Results: The NRI results showed significant but small
improvements from adding access to care measures but no
improvement for the other domains. However, there was a
consistent pattern across all three domains of only small,
nonsignificant improvement in the C-index after adding the
novel predictors. The alternative methodological approaches
also resulted in only small, nonsignificant improvement in
the C-index for any approach or outcome.
Conclusion: The new predictors and alternative approaches
did not significantly improve the discrimination for risk
predictions after PCI. Variables that measure socioeconomic
status and access to care may be less important predictors
in the context of integrated care structures. Improving the
risk calculator may still be possible by identifying additional
variables more related to patient clinical characteristics or
implementing more advanced modeling approaches (eg,
deep learning).
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P2.04
Statin Discontinuation and Cholesterol Control
in Central Wisconsin Adults With Cardiovascular
Disease
Jeffrey VanWormer,1 Sumithra Tirunagaram,1 Shereif
Rezkalla1
Marshfield Clinic, Marshfield, WI
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Background: The revised clinical practice guidelines
on the treatment of blood lipids included broad shifts in
statin eligibility and targets of statin therapy. Some recent
trial evidence has called into question the subduing of
the previous treat-to-target emphasis on low-density
lipoprotein (LDL) cholesterol. This study examined
Wisconsin adults with cardiovascular disease (CVD) over
2 years since the new cholesterol guidelines were released.
Specific aims were to 1) identify the proportion of patients
who persisted with statin therapy, and 2) compare LDL
cholesterol reduction between patients who persisted vs
discontinued statin therapy.
Methods: This was a retrospective analysis of data from
adults in the Marshfield Epidemiologic Study Area with a
first CVD event between January 1, 2014, and December 31,
2015. Outcomes included statin discontinuation and LDL
change over 1 year since their CVD event. Analyses were
adjusted for age, gender, baseline LDL, and time to postLDL measurement.
Results: There were 461 patients who initiated (or
continued with their existing) statin therapy following their
CVD event. Of these, 27 (6%) discontinued statin therapy
within 1 year. The primary documented reasons for statin
discontinuation were patient-reported side effects (41%;
mainly myalgia) and beliefs that statin medication was
unnecessary (22%). No reason for statin discontinuation was
documented for 30% of patients. Those who discontinued
their statin had a median atorvastatin-equivalent dose of
10 mg, while statin persisters had a median dose of 20 mg.
After 1 year, statin discontinuers had 86% lower adjusted
odds of having LDL less than 70 mg/dL, relative to statin
persisters (P=0.009).
Conclusion: As expected, statin use was widespread among
central Wisconsin adults with CVD. But some patients
discontinued statin therapy and, although this had a usual
negative impact on their LDL, it did not appear to be
related to high-intensity statin prescriptions (which were
uncommon). Reasons for statin discontinuation were not
consistently documented in the medical record. Educational
needs remain for clinicians to adhere to statin dosage
guidelines and for some patients to adhere to their statin
prescription. Future research should examine how lipids are
managed over time among statin discontinuers as well as
long-term impacts on recurrent CVD events.
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CANCER
OA13.01
Financial Incentives to Increase Colorectal Cancer
Screening Uptake and Decrease Screening
Disparities: A 3-Arm Randomized Controlled Trial
Beverly B. Green,1 Melissa L. Anderson,1 Andrea
J. Cook,1 Jessica Chubak,1 Sharon Fuller,1 Kilian J.
Kimbel,1 Jeffrey T. Kullgren,2 Richard T. Meenan,3
Sally W. Vernon4
Kaiser Permanente Washington Health Research Institute,
Seattle, WA; 2University of Michigan Medical School, Ann
Arbor, MI; 3Kaiser Permanente Center for Health Research,
Portland, OR; 4The University of Texas School of Public
Health at Houston, Houston, TX
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Background: Colorectal cancer (CRC) screening rates
are suboptimal, particularly among disadvantaged
populations. The study objective was to determine whether
fixed (money) or probabilistic (lottery) financial incentives
conditional on completion of CRC screening increased
screening uptake and decreased screening disparities.
Methods: A parallel 3-arm randomized controlled trial
was conducted between February 2017 and May 2018
with 22 medical centers in an integrated health care system
in Washington State; 838 participants, age-eligible and
overdue for CRC screening, were enrolled and randomized
to either: 1) up to 3 mailings with information on the
importance of CRC screening, screening test choices, a
mailed fecal immunochemical test (FIT), and a reminder
letter; or 2) this plus 1 of 2 different financial incentives
─ guaranteed money ($10) or probabilistic lottery (1
in 10 chances of $50) ─ conditional on completion of
CRC screening. The primary outcome was completion
of CRC screening within 6 months. Secondary outcomes
included FIT completion and colonoscopy completion
within 6 months. Intervention effects were compared
across sociodemographic subgroups and self-reported
psychosocial measures.
Results: Participants were predominantly female (65%)
and nonwhite or of Hispanic ethnicity (48% nonwhite
race, 12% Hispanic). Completion of any CRC screening
was not significantly higher among +Monetary (76.6%)
and +Lottery (74.7%) than mail-only (71.5%) participants;
P=0.11. When limiting the analysis to FIT, there was a
statistically significant intervention effect (P=0.032), with
a net increase of 8.1% (+Monetary) and 7.0% (+Lottery)
compared to mail-only. Patient subgroups more responsive
to financial incentives included those with Medicaid
insurance (FIT completion rates: 42.9% mail-only, 81.8%
+Monetary, 82.6% +Lottery; P=0.028) and those selfreporting opt-out behaviors (eg, not seeking health care
unless ill) (FIT completion rates: 50.7% mail-only, 68.7%
+Monetary, 67.7% +Lottery; P=0.016).
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Conclusion: Financial incentives increased FIT uptake
but not colonoscopy completion. Financial incentives
combined with direct mailing of FIT kits may decrease
FIT completion disparities among some disadvantaged and
harder-to-reach groups.
OA13.02
Diagnosis
and
Treatment
of
Neuropathy
Postchemotherapy in Three Health Systems
Alyce Adams,1 Mary Becker,2 Jessica Chubak,3 Laura
Ichikawa,3 Tatjana Kolevska,4 Lin Ma,1 Pamala A.
Pawloski,2 Donna Rivera,5 Rebecca Ziebell3
Division of Research, Kaiser Permanente Northern
California, Oakland, CA; 2HealthPartners Institute,
Minneapolis, MN; 3Kaiser Permanente Washington Health
Research Institute, Seattle, WA; 4Oncology and Hematology,
Kaiser Permanente Northern California, Vallejo, CA;
5
National Cancer Institute, Bethesda, MD
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Background: We examined factors associated with
peripheral neuropathy (PN), a common side effect of
chemotherapy, and PN treatment.
Methods: This observational study used data from Kaiser
Permanente in Northern California and Washington and
from HealthPartners in Minnesota. We included active (≥1
in-person visit) enrolled members ≥40 years of age with
diagnosis of invasive cancer (January 1, 2010, to December
31, 2014) and who initiated select chemotherapies (eg,
platinums, taxanes) within 12 months of cancer diagnosis.
We excluded patients previously diagnosed or treated for
PN. Patients were followed until death, disenrollment,
new cancer diagnosis, or study end (December 31, 2016).
The primary outcomes were time to clinical diagnosis of
PN from start of chemotherapy and time to treatment after
PN diagnosis. We calculated cumulative incidence curves
accounting for competing risks and used Cox proportional
hazards models to identify potential risk factors.
Results: We identified 13,058 patients, 23.1% (95% CI:
22.4%–23.8%) of whom received a PN diagnosis within 1
year of chemotherapy. Factors associated with higher rates of
PN diagnosis included black race (hazard ratio: 1.23 [95% CI:
1.10–1.38]), diabetes (1.14 [1.05–1.25]), chronic pain (1.25
[1.17–1.33]), nonchemotherapy medications associated with
PN (1.15 [1.06–1.24]), comorbidity (1.19 [1.10–1.29]), and
concurrent platinum and taxane use compared to platinum
alone (1.29 [1.18–1.42]) or taxane alone (1.23 [1.12–1.34]). PN
rates also varied by health system and age (lower rates at 40–49
and ≥70 years). One-third of patients with a PN diagnosis (95%
CI: 30.9%–33.9%) started new PN treatment within 1 year.
Treatment rates were associated with black race (1.24 [1.03–
1.50]), chronic pain (1.26 [1.12–1.40]) and recency of cancer
diagnosis. Rates also varied across health systems.
Conclusion: Type of chemotherapy, comorbidity, race, and
ethnicity were associated with higher rates of PN. Yet, variations
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in PN treatment were not adequately explained by clinical risk
factors. Additional studies are needed to begin understanding
observed variation in PN diagnosis and treatment and to
identify strategies for improving patient care and outcomes.
OA13.03
A Cost-Effectiveness Analysis of PARP Inhibitors
as Maintenance Therapy for Patients With
Recurrent Ovarian Cancer
Lixian Zhong,1 Anh Thu Tran,1 Taylor Tomasino,1
Elizabeth Nugent,2 Judith Smith2
Texas A&M University, College Station, TX; 2The University
of Texas Health Science Center at Houston, Houston, TX
1

Background: Ovarian cancer is the most fatal gynecologic
cancer in the United States. Recently, a new class of therapeutic
agent, the poly (ADP-ribose) polymerase (PARP) inhibitor,
has been approved by the Food and Drug Administration
to be used in advanced ovarian cancer patients who have
gone through platinum-based chemotherapy and relapsed.
The aim of the study is to evaluate the cost-effectiveness
of two PARP inhibitor therapies, olaparib and niraparib, as
maintenance therapy for patients with platinum-sensitive,
recurrent ovarian cancer.
Methods: We constructed a decision-tree model to evaluate
the cost-effectiveness of olaparib and niraparib compared to
placebo. The study was done from a U.S. health care sector
perspective. Costs included drug costs and costs of disease
monitoring and management of adverse events throughout
the treatment course. Costs were estimated from the Redbook,
Medicare reimbursement rate, and literature in 2017 U.S.
dollars. Clinical effectiveness was measured in progressionfree survival based on clinical trial results (NCT00753545,
NCT01874353, and NCT01847274). Cost-effectiveness was
measured using the incremental cost-effectiveness ratio (ICER).
Results: At base case, niraparib was the more effective
treatment option, with slightly higher PFS, followed by
olaparib. The ICERs for niraparib and olaparib compared
to common baseline placebo were $235K and $287K per
PFS life-year, respectively, with olaparib being extendeddominated by niraparib. Both drugs were associated with
lower ICERs in patients with gBRCA mutation(s) than in
patients without gBRCA mutation(s). One-way sensitivity
analysis suggested that drug prices and PFS could impact
ICERs significantly, but the ICERs remained above $100K/
PFS within the plausible ranges of all parameters. Probabilistic
sensitivity analysis suggested that niraparib and olaparib were
associated with higher net benefits only when willingness to
pay (WTP) was above $210K per PFS life-year thresholds.
Conclusion: PARP inhibitors will extend PFS in platinumsensitive, recurrent ovarian cancer patients but also are
associated with high drug acquisition costs. The base case
ICERs were around or above $250K/PFS in our model. No
formal WTP threshold for health technology assessment
Supplement

exists in the United States. At a reference WTP of $100K per
PFS life-year, they may not be cost-effective options.
OA13.04
Understanding Referrals to Outpatient Palliative
Care and Goals-of-Care Discussions With
Individuals Diagnosed With Stage IV Advanced
Cancer
Ellis Dillon, Jinnan Li, Amy Meehan, Su-Ying Liang,
Steve Lai,1 Natalia Colocci,1 Harold S. Luft1
1

1

1
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Background: For individuals diagnosed with a stage IV
cancer, earlier referral to palliative care may improve
patient outcomes. We know little about when, if, and how
patients and their providers discuss palliative care.
Methods: At a multispecialty practice with an established
outpatient palliative care program, we identified stage
IV cancer patients diagnosed from January 1, 2012, to
December 31, 2017. We analyzed electronic health record
data of patients who had died regarding formal referrals
to and encounters with palliative care. We also conducted
interviews with 16 oncology and palliative care team
members regarding their experiences.
Results: Of the patients diagnosed with stage IV cancer,
695 were deceased; of these, 347 (50%) were referred to
palliative care and 286 (41%) had at least one palliative
care visit. Providers made 384 unique referrals for these
deceased patients, 279 (73%) by oncologists, 41 (11%)
by primary care physicians, and 64 by other specialties.
Median time between diagnosis and referral was 64 days
(mean: 204, max: 1780). A quarter of patients died within
108 days, a quarter lived more than 529 days. Among the
first group, 137 (85%) survived at least 30 days; among
these, 45% were referred and 45% of these referrals were
within 14 days of diagnosis. Among patients in the top
quartile for survival, 59% had a referral, but only 4%
of those occurred within 14 days of diagnosis. Among
19 oncologists, focusing on those with 10+ patients,
referral rates ranged from 5%–6% (3 physicians) to one
physician who referred 72%. Interviews suggest widely
varying perceptions across the oncologists. Some reported
discussing palliative care at the first visit, while others
described taking their cues from patients. Many physicians
described patients with worsening symptoms as the best
palliative care candidates but noted that, once initiated,
many patients and families benefit from other services
provided by the palliative care team such as goals-of-care
conversations and more emotional support.
Conclusion: These data indicates wide variation in
referrals to palliative care by oncologists. Interviews
suggest patient preferences play a role, but the variability
across oncologists presents a challenge to ensuring patients’
needs and preferences are elicited and honored.
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The Acceptability, Appropriateness, Feasibility,
and Effectiveness of a Cancer Survivorship Care
Delivery Intervention
Sarah Birken,1 Jennifer Leeman,1 MaryBeth Grewe,1
Emily Haines,1 Darren DeWalt,1 Deborah Mayer,1
Katherine Reeder-Hayes,1 Morris Weinberger1
The University of North Carolina at Chapel Hill, Chapel
Hill, NC

1

Background: A large and rapidly increasing number of
U.S. cancer survivors who have completed active treatment
continue to seek oncology care. Low-risk survivors who
continue to seek oncology care incur greater costs but
experience worse care quality and outcomes than those
who seek primary care. To improve the transition of
low-risk survivors to primary care, we used a theorydriven, stakeholder-engaged approach to develop START
(Supporting Transitions AfteR Treatment) and assess its
acceptability, appropriateness, feasibility, and effectiveness
in practice.
Methods: We identified desired outcomes of START based
on existing frameworks for quality survivorship care and our
preliminary studies. We identified facilitators and barriers to
achieving outcomes through a literature review, interviews,
and a focus group with stakeholders including oncology
providers and administrators, primary care providers,
survivors, and caregivers (n=28). We comprised START of
strategies targeting modifiable determinants of outcomes that
stakeholders deemed highly salient. Beginning in January
2019, we will collect data on START’s implementation
in a pilot test of its effectiveness in two large academic
and one community cancer center. We will analyze data
from electronic health records to assess the feasibility
of identifying low-risk survivors and document changes
to care processes, and we will conduct in-depth, semistructured interviews with oncology providers and staff
and survivors regarding their perspectives on acceptability,
appropriateness, and feasibility.
Results: START was designed to facilitate transitioning
survivors through persuasive communication from
clinical champions and improving information handoff
from oncology providers to primary care providers and
survivors. Based on our success in previous studies, we
anticipate interviewing at least 5 oncology providers and
staff and 2 survivors in each of the 3 pilot cancer centers
(n=21).
Conclusion: At the conference, we will report on oncology
provider and staff and survivor perceptions of START’s
acceptability, appropriateness, and feasibility for improving
survivorship care delivery. Findings will be used to refine
START and form the basis of a clinical trial to evaluate its
effectiveness in improving survivorship outcomes.
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P1.02
Differential Impact of Charlson Comorbidity Index
on Overall Survival in Head and Neck Cancers
Steven Chang1
Henry Ford Health System, Detroit, MI

1

Background: Comorbidity burden has been associated with
poorer survival in several types of cancer. We investigated
the impact of the Charlson comorbidity index (CCI) on
patient survival with head and neck cancer and determined a
CCI cutoff based on stage and cancer site.
Methods: A retrospective cohort study was performed of
all patients with any type of head and neck cancer from
January 1997 to November 2016 in a single academic center
in the Midwest. Data extracted included age, race, gender,
primary site of malignancy, mode of treatment, clinical
staging, posttreatment survival, and CCI. The value at which
CCI best predicted death was identified for each site using
receiver operator curves, defined as the point on the curve
that maximizes sensitivity and specificity. Kaplan-Meier
survival curves by CCI, stage, and site were determined.
Results: There were a total of 3720 patients. Kaplan-Meier
curves demonstrated that for both early and advanced thyroid
cancer, a CCI cutoff of 1 differentiated overall survival.
A CCI cutoff of 3 differentiated survival in early and late
laryngeal cancers, and a CCI cutoff of 1 differentiated
overall survival in patients with early oral cavity cancers.
Conclusion: CCI cutoffs are clinically relevant and may
inform treatment choices in thyroid, laryngeal, and oral cavity.
P1.03
A Centralized Mailed Program With Stepped
Increases of Support and Time in Compliance With
Colorectal Cancer Screening Guidelines Over 9
Years: A Randomized Trial
Beverly B. Green,1 Melissa L. Anderson,1 Andrea J.
Cook,1 Jessica Chubak,1 Sharon Fuller,1 Richard T.
Meenan,2 Sally W. Vernon3
Kaiser Permanente Washington Health Research Institute,
Seattle, WA; 2Kaiser Permanente Center for Health
Research, Portland, OR; 3The University of Texas School of
Public Health at Houston, Houston, TX
1

Background: Colorectal cancer (CRC) is the second-leading
cause of cancer deaths in the United States. Morbidity and
mortality could be reduced through higher uptake and
adherence to CRC screening and follow-up. Most information
on longer-term screening adherence comes from organized
programs that lack a comparison group. No prior trials aimed
at increasing CRC screening uptake and follow-up have
evaluated outcomes beyond 5 years. Systems of Support to
Increase Colorectal Cancer Screening and Follow-Up (SOS) is
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a randomized controlled trial comparing a centralized mailed
fecal test and stepped support program to usual care. The
primary outcome is time in compliance with CRC guidelines.
Nine-year results will be available at the end of 2018.
Methods: SOS was implemented in an integrated health
care organization in Washington State. Between 2008 and
2009, 4653 individuals 50–74 years of age were eligible and
randomized to receive usual care (UC) or 1 of 3 steppedintensity interventions: mailings with a call-in number for
colonoscopy and mailed fecal tests; mailings plus brief
telephone assistance; or mailings and assistance plus nurse
navigation. In years 3 and 5, intervention arm participants still
eligible for CRC screening were randomized to stopped or
continued mailings. UC participants continued to receive UC.
We compared time in compliance with CRC screening over 9
years in persons assigned to any intervention vs UC. Screening
tests contributed time based on national guidelines for
screening intervals (fecal tests annually, sigmoidoscopy every
5 years, colonoscopy every 10 years). Active intervention-arm
patients still eligible for CRC screening continued to receive
stepped-intensity mailed and navigation interventions. Nineyear results will be available at the end of 2018.
Results: All participants contributed data but were censored
at disenrollment, death, age 76, or CRC diagnosis. Compared
with UC participants, intervention participants had 31%
more adjusted time in compliance with CRC guidelines
(incidence rate ratio: 1.31; 95% CI: 1.25–1.37; coveredtime: 47.5% vs 62.1%. Fecal testing accounted for almost
all additional covered-time.
Conclusion: In a health care organization with clinic-based
activities to increase CRC screening, a centralized program
led to increased CRC screening adherence over 5 years.
Longer-term data on screening adherence and its impact on
CRC outcomes will be presented.
P1.04
Provider,
Patient,
and
Family
Caregiver
Perspectives on Adopting an EHR-Integrated WebBased Tool to Coordinate Oncology Care
Christian Adonizio,1 Lisa Bailey-Davis,1 Chelsie Hauer,1
Amanda Milo,1 Mark Wojtowicz1
Geisinger Health, Danville, PA

1

Background: Technological innovations allow for the
integration of multisector data with the potential to
relieve pain points experienced by patients and family
caregivers during cancer care that often require scheduling
and communication, identifying and understanding the role
of health care team members, and managing medications.
Engaging clinicians and a panel of patients/caregivers, we
designed, developed, and deployed a web-based tool to
integrate electronic health record (EHR) data with patient/
caregiver personal characteristics and events, their care
partner team, and their personal calendars, with the objective
Supplement

to evaluate utility and usability of a minimally viable product.
Methods: Patient/caregiver dyads were recruited to use
the tool during their hematology oncology and/or radiation
oncology treatment. Participants received training on
the tool, and patients and caregivers were reimbursed for
their time. Observations and semi-structured interviews
were conducted with patients (n=29), caregivers (n=23),
and providers (n=8). Adoption factors evaluated included
knowledge, persuasion, implementation, and confirmation.
Results: Patients and caregivers learned about the tool from
staff, yet providers who directly endorsed the tool persuaded
use. Patients/caregivers experienced challenges accessing
the tool via the EHR patient portal. Personalization features
enabled patients/caregivers to add photos and interests and
view health care team profiles. Integration of multiple calendars
worked well to coordinate oncology care and personal
activities. Medication management and message features were
underutilized. Providers emphasized the need to introduce
the tool early in care through a synthesized HER-integrated
dashboard. Providers confirmed the utility of the tool in helping
to establish a holistic approach to family-centered care. Patients/
caregivers confirmed tool’s utility in easing communications
and recognizing health care team members.
Conclusion: The web-based tool offers the potential to
address patient and family caregiver stress and burden
related to a variety of tasks and engage clinicians to improve
the quality of family-centered care that recognizes the
important contributions of caregivers. Future research
would rigorously evaluate care coordination with attention
to patient, caregiver, and provider outcomes.
P1.05
Reasons for Lack of Referral to Colonoscopy After
an Abnormal FIT Result in a Community Health
Center Network
Ian Neff, Victoria Gawlik, Michael Kwon, Amanda
Petrik,1 Jamie Thompson,1 Matthew Slaughter,1 Gloria
Coronado1
1
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Kaiser Permanente Center for Health Research, Portland,
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Background: Colorectal cancer (CRC) is the second most
frequent cause of cancer-related death in the United States.
Screening for CRC with fecal immunochemical tests (FIT)
is an effective, noninvasive, and inexpensive way to reduce
mortality. However, lack of timely colonoscopy follow-up for
abnormal FIT results diminishes the benefit of using FIT as a
screening modality. Screening rates, especially in underserved
populations, continue to lag behind guidelines, and one reason
is lack of referral to colonoscopy from primary care.
Methods: We identified 144 patients who had a positive FIT
result but did not receive a referral for diagnostic colonoscopy.
One author (I.N.) completed a retrospective chart review
using a data collection tool developed by the research team
Supplement

and guided by a literature review of studies examining
CRC screening in medically underserved settings. Variables
collected included demographic data, comorbidities, and
social determinants of health as informed by the literature.
The reviewer identified any reasons for lack of referral
documented in the chart by health care professionals.
Results: There are consistent emerging trends within
these data. About half of patients without referral have a
documented refusal or were lost to follow-up. Patients in
this sample are typically uninsured or on Medicaid, speak a
language other than English, and/or have documented mental
illnesses or substance abuse. Some patients lack referrals but
are already established with gastroenterologists or had recent
colonoscopies. Finally, about one-fourth of the charts reviewed
show no documentation of a discussion of abnormal FIT.
Conclusion: Results of chart review and lessons from
the process have implications for future research and
practice changes. This study highlights the need for greater
coordination between primary care and gastrointestinal
practices. The lack of interoperability between the two
settings is a barrier to both research and care delivery.
The frequency of patients lacking follow-up or being
inappropriately screened shows a need for better
coordination. There may be an opportunity to improve
CRC screening for people with diagnosed mental illness
as well, which needs further study. There is likely a role
for patient navigation in resolving barriers associated with
underinsurance or language.
P1.06
Breast Cancer Screening and Risk-Reducing
Surgeries for Patients at High Risk for Breast and
Ovarian Cancer at Kaiser Permanente Mid-Atlantic
States
Monica Ter-Minassian,1 Kala Visvanathan,2 Celeena
Jefferson,1 Marcy Schaeffer,2 Pim Suwannarat1
Kaiser Permanente Mid-Atlantic States, Rockville, MD;
Johns Hopkins University, Baltimore, MD
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Background: Current U.S. guidelines recommend more
intensive breast cancer screening and preventive strategies
for patients with a known pathogenic BRCA1/2 mutation or a
lifetime risk more than 20% based on risk prediction models
accounting for personal and family history. These patients
are at high risk for breast and ovarian cancer (HRBOC).
Guidelines recommend that yearly mammogram alternating
with magnetic resonance imaging (MRI) screening should be
considered as early as 30 years old. Furthermore, BRCA1/2
mutation carriers should consider bilateral mastectomy and
bilateral oophorectomy after age 35. It is unclear what the
uptake of screening and risk-reducing strategies are after
recommendations by genetic services at Kaiser Permanente
Mid-Atlantic States (KPMAS) for a HRBOC diagnosis.
Methods: We retrospectively studied female patients diagnosed
www.aurora.org/jpcrr
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as HRBOC (regardless of prior cancer) and/or tested for BRCA
mutations by KPMAS genetics between 2005 and 2016. We
identified cancer diagnoses, mammogram and MRI screening,
mastectomies, and oophorectomies through ICD diagnosis or
CPT procedure codes during the study period.
Results: Our cohort included 813 women with a HRBOC
diagnosis; median age at diagnosis was 51 years; racial
makeup was 45% white, 38% black, and 15% other
race. Since genetic services for cancer at KPMAS were
established recently, 98% of visits occurred after January 1,
2013. Most cancers occurred prior to the genetics visit ─
513 of 527 breast and 55 of 57 ovarian cancer diagnoses.
Only 4 prophylactic mastectomies and 89 prophylactic
oophorectomies were identified. For 228 patients who were
30–75 years old, breast cancer-free at time of HRBOC
diagnosis, and members over 6 months, 158 (69%) had at
least 1 screening test (mammogram/MRI) after the genetics
visit; of these, 65 had 2–3 subsequent tests and 3 had 4–6
tests. The median time to the latest screen after HRBOC
diagnosis was 14.3 months, (range: 2 days to 39 months).
Conclusion: The majority of women visited genetic services
after a diagnosis of breast or ovarian cancer. Patients received
prophylactic oophorectomies more often than prophylactic
mastectomies. Screening in cancer-free patients with a
HRBOC diagnosis appears to be limited to 1–3 screens postdiagnostic visit. Our findings suggest that earlier detection
of patients at high risk for breast and ovarian cancer, as well
as closer monitoring, is needed.
P1.07
Positive Predictive Value and Sensitivity of ICD-9
Codes for Childhood Leukemia in Integrated Health
Plans
Sheila Weinmann,1,2 Melanie Francisco,1 Erin Bowles,3
Robert T. Greenlee,4 Alanna Rahm,5 Marilyn Kwan,6
Rebecca Smith-Bindman,7 Natasha Stout,8 Jason
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Background: Tumor registries are excellent sources
for identifying leukemia cases for research, but they
may be unavailable or incomplete for some health care
populations. ICD-9 diagnosis codes from administrative
databases may be an alternative; however, their accuracy
and completeness are unknown. We calculated positive
predictive value (PPV) and sensitivity of ICD-9 codes for
childhood leukemia case identification.
Methods: In the Radiation-Induced Cancer study, 6 U.S.
integrated health plans examined and validated ICD-9
diagnosis codes associated with leukemia for calendar years
1996–2015. Subjects were children born in the health plans
and enrolled continuously for at least 120 days (unless they
died) after the date of the first leukemia ICD-9 code or tumorregistry diagnosis date. We counted the number of leukemiarelated codes per subject within 120 days after the first
code. We classified ICD-9 codes as specific leukemia codes,
myelodysplastic syndrome/myeloproliferative disorder codes,
and nonspecific codes for leukemia and related diseases. The
gold standard was leukemia identified from health plan tumor
registries and/or manual medical record review. We calculated
PPV and sensitivity by the number of ICD-9 codes in the 120day period, overall and stratified by code categories, sites,
treatment codes, and demographic factors.
Results: In a population of 857,760 subjects, 652 subjects had
at least one ICD-9 code of interest and sufficient membership
duration; 293 (45%) were validated as leukemia. Among
validated leukemia cases (n=295), 97% had at least 1 specific
leukemia code, 2% had codes in other categories but no
specific leukemia code, and 1% were in a tumor registry but
had no ICD-9 codes of interest. Of those with nonspecific
codes only, 2% were leukemia. Requiring 4 or more ICD9 codes gave good PPV and sensitivity. PPV for 4 or more
codes was 88% for all codes combined and 97% for leukemiaspecific codes (range: 84%–100% by site). The sensitivity for
4 or more codes was 94% for all codes combined and 92% for
leukemia-specific codes (range: 83%–94% by site).
Conclusion: Requiring at least 4 ICD-9 leukemia-specific
codes within 120 days after the date of the first code
maximizes PPV and sensitivity for identifying most cases of
childhood leukemia.
P1.08
Budget Impact of Adopting PARP Inhibitors as
Maintenance Therapy for Patients With Recurrent
Ovarian Cancer
Lei Wu,1 Lixian Zhong1
Texas A&M University, College Station, TX
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Background: Ovarian cancer is one of the leading causes of
death in women and accounts for an estimated 14,070 deaths
in the U.S. in 2018. Recently, a new class of therapeutic
agent, the poly (ADP-ribose) polymerase (PARP) inhibitor,
has been approved by the Food and Drug Administration
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to be used in advanced ovarian cancer patients who have
gone through platinum-based chemotherapy and relapsed.
PARP inhibitors have been shown to significantly extend
progression-free survivals yet are priced at over $10K (WAC
price) a month. This study aimed to evaluate the budget
impact of adopting these therapies in a hypothetical health
plan from a U.S. third-party payer perspective.
Methods: We constructed a budget impact model to assess
the additional per member per month (PMPM) costs
associated with the introduction of two PARP inhibitors:
niraparib and olaparib. The model assessed both pharmacy
costs and medical costs. Pharmacy costs included adjusted
drug costs, coinsurance and dispensing fees. Medical
costs included costs associated with disease monitoring
and management of adverse events from the treatment.
Epidemiological data from literature were used to estimate
the target population size. The analysis used 1-year time
frame, and patients were assumed on treatment until disease
progression or death. All costs were computed in 2017 U.S.
dollars. One-way sensitivity analyses were conducted to
evaluate the model robustness.
Results: In a hypothetical plan of 1 million members,
206 patients were estimated to be potential candidates for
niraparib or olaparib maintenance treatment after applying all
epidemiological parameters. At listed WAC prices of $14,750
for niraparib and $13,482 for olaparib, budget impacts of
these two drugs were $0.169 PMPM and $0.156 PMPM,
respectively, most of which were contributed by pharmacy
costs. Sensitivity analyses suggested that assumptions around
market share, platinum-sensitive rate after the first treatment,
and WAC prices affected results most.
Conclusion: The new PARP inhibitors niraparib and olaparib
are associated with high costs for patients on treatment.
However, relatively few patients are eligible for the treatment
due to the relatively low prevalence of the disease state and low
initial market penetration. From a U.S. payer’s perspective,
the overall budget impact of these two new treatment options
is moderate in the first 12-month period.

CHILD AND ADOLESCENT HEALTH
P4.01
Validation of the Pediatric Appendicitis Risk
Calculator in the Community Emergency
Department Setting
Dustin W. Ballard,1 Laura E. Simon,1 Adina S.
Rauchwerger,1 David R. Vinson,1 Gabriela VazquezBenitez,2 E. Margaret Warton,1 Dale M. Cotton,1 Elyse
O. Kharbanda,2 Anupam B. Kharbanda3

Background: Pediatric appendicitis is a challenging
diagnosis in the emergency department (ED). Established
prediction rules, such as the pediatric appendicitis score
(PAS), may encourage overutilization of diagnostic
imaging. The pediatric appendicitis risk calculator
(pARC) was recently derived and validated in a
retrospective cohort of children’s hospital patients. We
prospectively evaluated the performance of pARC in a
community setting.
Methods: As part of a larger electronic clinical decision
support trial for pediatric patients with abdominal pain,
we conducted a multicenter, prospective validation
study from October 1, 2016, to April 30, 2018, in 11
community EDs within an integrated delivery system.
To collect clinical variables, treating ED physicians
enrolled patients 5–20.9 years of age with a chief
complaint of abdominal pain and <5 days of right-sided
or diffuse abdominal pain via a web-based application
embedded in the electronic health record (EHR).
Patients with abdominal trauma, pregnancy, and known
history of appendectomy were excluded. Outcomes
(appendicitis, perforation, negative appendectomy rate,
missed appendicitis) were identified from automated
EHR data and confirmed by manual chart review.
Descriptive results are reported by pARC risk category,
and validation analyses included discrimination
(area under the curve [AUC] of receiver operating
characteristic curve) and calibration (goodness of fit) of
the PAS and pARC.
Results: We enrolled 2089 eligible patients (46.1% male)
with a median age of 12.4 years (interquartile range: 9–16).
Appendicitis was confirmed in 353 (16.9%) patients; 52
(14.7%) had perforation, negative appendectomy rate
was 6.1%, and missed appendicitis occurred in 10 (0.5%)
patients. The distribution of pARC was: 53.8% at low
risk (<15%); 38.9% at intermediate risk (15%–74%);
and 7.4% at high risk (>74%). Appendicitis rates ranged
from 2.0% in the low-risk group to 75.3% in the high-risk
group. The pARC had an AUC of 0.89 (95% CI: 0.87–
0.91) vs 0.80 (95% CI: 0.77–0.82) for PAS. Calibration
testing resulted in a Hosmer-Lemeshow goodness of fit
of P=0.16.
Conclusion: The pARC accurately quantified appendicitis
risk in children presenting to community EDs with
abdominal pain and outperformed the PAS. Over half of
the patients in this community validation sample could be
accurately classified as low or high risk for appendicitis.
Incorporation of the pARC into clinical practice may help
guide imaging and treatment decisions.
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GENETICS, GENOMICS, AND PRECISION
MEDICINE
P7.01
The New CESR Virtual Data Warehouse Molecular
Marker Result Database (Genetic Tests and Tissue
Markers) ─ Scheduled to Launch by the End of
2019
Don Bachman,1 Andrea Burnett-Hartman,2 Susan
Gouchoe,3 Lawrence Kushi,4
Kaiser Permanente Center for Health Research,
Portland, OR; 2Institute for Health Research, Kaiser
Permanente Colorado, Denver, CO; 3Genomic Strategy &
Implementation, National Health Plan and Hospital Quality,
Kaiser Permanente, Oakland, CA; 4Division of Research,
Kaiser Permanente Northern California, Oakland, CA
1

Background: The Kaiser Permanente (KP) Center for
Effectiveness and Safety Research (CESR) is a national
research collaborative comprising the research centers
from the 8 KP regions. Most KP member molecular marker
(genetic and tissue marker) test results are evaluated
by 15 outside vendors and by internal staff within 3 KP
regions. While these results are viewable in the electronic
medical record, the vast majority are not currently stored in
discrete data fields for population analysis. So, the CESR
Data Coordinating Center (DCC) convened a workgroup
consisting of investigators, genetic counselors, research
network consultants, programmers, and the KP genomic
strategy & implementation department to create a virtual
data warehouse (VDW) molecular marker result database at
each KP region.
Methods: The molecular marker workgroup designed the
CESR VDW molecular marker results data dictionary,
consistent with the 2017 Health Level Seven International
specifications whenever possible. The tables include
positive, negative, and inconclusive results. The genomic
strategy & implementation department programmers
link the test result records to appropriate KP member and
region identifiers. The KP DCC then codes an ETL (extract,
transform, load) program that transforms each data source
to the CESR VDW molecular marker specifications. The
research data warehouse staff from each region will execute
this ETL program to pull their own site’s data. The VDW
molecular marker database consists of 3 tables within each
region’s VDW: an order-level table; a marker-level table;
and a variant-level table.
Results: While the key variables are being populated by the
vendors, not all requested fields are available from each one.
At the time of the abstract, we have collected at least some
data from 5 of the 15 main vendors.
Conclusion: This CESR VDW molecular marker database
is designed to facilitate single- and multiregion genetic
research. It contains results and interpretations at the order,
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marker, and variant levels; includes positive, negative,
and inconclusive results; and is scheduled to be ready for
projects by the end of 2019.
P7.02
Predictors of Current Posttraumatic Stress
Disorder Among Deployed Veterans: Significance
of Predisposition, Stress Exposures, and Genetic
Factors
Yirui Hu,1 Xin Chu,1 Thomas Urosevich,1 Stuart
Hoffman,1 H. Lester Kirchner,1 Richard Adams,2 Ryan
Dugan,1 Joseph J. Boscarino,3 Carrie Withey,1 Charles
Figley,4 Joseph A. Boscarino1
Geisinger Health, Danville, PA; 2Kent State University,
Kent, OH; 3William James College, Newton, MA; 4Tulane
University, New Orleans, LA
1

Background: Previously (2012) we reported that a genetic
risk model improved posttraumatic stress disorder (PTSD)
predictions among a trauma-exposed civilian population
(69% female; mean age of 55.4 years [standard deviation
(SD): 13.4]). We sought to assess this prediction model
among a trauma-exposed U.S. military population.
Methods: We examined postdeployment PTSD status
among a cross-sectional sample of 1074 community-based
veterans of Vietnam, Persian Gulf, Iraq/Afghanistan, and
other recent conflicts, who were receiving care in a large nonVA multihospital system in Pennsylvania. Approximately
95% of these veterans were male (mean population age:
61.4 years [SD: 12.1]). To avoid confounding due to genetic
admixture, non-Caucasian veterans (n=40) were excluded.
Results: 7.1% of veterans (95% CI: 5.6–8.8) met DSM-5
criteria for current PTSD. The mean risk-allele count was
significantly higher among PTSD cases vs non-cases (3.9 vs
3.5, P=0.027). The PTSD risk variants studied were within
genetic loci previously associated with PTSD, including
CRHR1, CHRNA5, RORA, and FKBP5 genetic variants,
which were used to calculate a total PTSD risk score (range:
0–8, mean: 3.6, SD: 1.4). The final logistic regression
prediction model included the genetic risk score, plus
demographic factors (age, sex), trauma exposures (combat,
lifetime trauma exposures), concussion history, current
traumatic brain injury symptoms, current life stressors, and
history of attention deficit disorders. Significant variables
in the final PTSD model included current traumatic brain
injury symptoms (odds ratio [OR]: 7.5, P<0.001), history of
attention deficit disorders (OR: 3.0, P<0.001), current life
stressors (OR: 3.0, P<0.001), lifetime trauma exposure (OR:
2.0, P=0.021), concussion history (OR: 2.1, P=0.021), and
PTSD risk allele count (OR: 1.3, P=0.021). Inconsistent with
previous research with nonveterans, no interaction effects
were detected for trauma exposures by genetic risk score.
Conclusion: Our study partially replicated previous results
among trauma-exposed civilians. After deployment, both
Supplement

warzone and non-warzone factors predicted current PTSD
among U.S. veterans seen in non-VA facilities, including a
genetic risk score for PTSD. However, no interaction effects
were detected for trauma exposures by genetic risk score.
Further research is planned.

MATERNAL AND PERINATAL CARE
P11.01
Bias in Self-Reported Prepregnancy Weight Across
Maternal and Clinical Characteristics
Joanna Bulkley,1 Kimberly Vesco,1 William Callaghan,2
Padmavati Dandamudi,1 Ashley Stoneburner,3 Michael
Leo,1 Andrea Sharma2
Kaiser Permanente Center for Health Research, Portland,
OR; 2Centers for Disease Control and Prevention, Atlanta,
GA; 3Nurse-Family Partnership, Denver, CO

Conclusion: An accurate measure of prepregnancy weight
is essential for clinical guidance during pregnancy and
for surveillance efforts that monitor maternal health and
evaluate progress of public health programs. SR-weight
performs relatively well when it is used to categorize BMI,
but the misreport observed may result in misclassification of
GWG. Our analysis identified characteristics associated with
misreport of SR-weight, which can inform understanding of
bias when assessing the influence of prepregnancy BMI or
GWG misclassification on associations with maternal and
child health outcomes.
P11.02
Hospital Emergency Department Visits for Women
Prior to Birth and After Pregnancy, 2014
Geoffrey Jackson,1 Sonja Williams,1 Karishma Chari1

1

Background: Prepregnancy body mass index (BMI) and
gestational weight gain (GWG) are known determinants of
maternal and child health; both require an accurate measure
of prepregnancy weight. Prepregnancy weight is typically
self-reported. We used electronic health record (EHR) data
to compare self-reported prepregnancy weight (SR-weight)
to measured clinic weights to assess reporting bias by
maternal and clinical characteristics.
Methods: Pregnant women ≥18 years old who began
pregnancy and started prenatal care from January 2000
to December 2010 at Kaiser Permanente Northwest were
screened for this retrospective cohort study and included in
the analysis if their EHR contained 1) SR-weight (obstetric
questionnaire), 2) at least 2 measured weights between
≤365 days prior to and ≤42 days after conception, and 3)
measured height. Covariates were extracted from the EHR
and birth certificates. The measured weight closest to date of
conception between 6 months prior to (≤182 days) and ≤42
days after conception was considered the “gold standard”
prepregnancy weight. Generalized-estimating equations
were used to assess predictors of misreport, controlling for
covariates.
Results: Of 56,122 pregnancies screened, 16,227 (29%)
had the required data. Close agreement (±1 kg or within
2% of measured weight) between SR-weight and measured
weight was 44% and 59%, respectively (rc=0.99). Overall,
SR-weight averaged 1.3 kg (standard deviation: 3.8) less
than measured weight. The degree of underreporting was
higher among women with elevated BMI, late entry into
prenatal care, and a pregnancy outcome other than live
birth or stillbirth (P<0.05). Misreport did not differ by age,
race/ethnicity, marital status, education, smoking, parity, or
Medicaid enrollment. Using SR-weight, BMI was correctly
classified for 91% of pregnancies (range: 70%–98%,
depending on BMI category).
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Background: Hospital emergency departments (EDs) are
commonly used by pregnant women for nonurgent care and
for urgent routine care. In 2015, there were an estimated 2.3
million visits to hospital EDs by women between the ages of
15 and 64 years for complications of pregnancy, childbirth,
and the puerperium (National Hospital Ambulatory Medicare
Survey: 2015 Emergency Department Summary Tables).
Describing maternal care in the ED setting provides insight
on the care and creates new opportunities for improvement
in care.
Methods: This study utilizes 2014 data from the National
Hospital Care Survey (NHCS), which collects information
on patients, conditions, and care received during visits to
hospital inpatient and emergency departments, from a
sample of hospitals across the nation. The survey collects
demographic information and diagnoses and procedures
related to the visit. NHCS is unique in that patient identifiers
are collected, allowing patients to be tracked across hospital
settings and over time. The 2014 NHCS collected hospital
claims data on 1.6 million inpatient and 4.5 million ED
visits from 95 hospitals throughout the United States. NHCS
data are not nationally representative yet but can be used for
exploratory analysis on hospital care. This study provides
information on women who delivered a baby in the inpatient
setting, whether they visited the sampled hospital’s ED prior
to or after the birth of their children, the reason for the visit,
and if there were any complications related to pregnancy.
Results: The 2014 NHCS dataset contains information
on women who delivered a baby in a sampled hospital’s
inpatient department (n=177,000). Of these women,
approximately 15% sought care in a sampled NHCS
hospital’s ED prior to the birth and 9% visited a sampled
hospital’s ED postdelivery. This study examines women who
visited an ED for pregnancy complications by age category
before or after giving birth (eg, early labor, hemorrhaging,
excessive vomiting, symptoms involving the abdomen and
www.aurora.org/jpcrr
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pelvis, and disorders of urethra). This study also analyzes
the relationship of pre- and postbirth health issues with the
presence of complications during birth.
Conclusion: This complete picture of pregnancy-related
hospital care can provide greater insight into pre- and
postnatal care.

METHODS, DESIGNS, AND ANALYTICS
TOOLS
P13.01
Prognosticating Outcomes and Nudging Decisions
With Electronic Records in the Intensive Care Unit
(PONDER-ICU) Trial: Implementation in a Learning
Health System
Katherine Courtright,1 Erich Dress,1 Jaspal Singh,2
Brian Bayes,1 Steven Brooks,1 Elizabeth Cooney,1
Vanessa Madden,1 Scott Halpern1
University of Pennsylvania, Philadelphia, PA; Atrium
Health System, Charlotte, NC
1

2

Background: Almost all critically ill patients wish to
receive therapies that promote both the duration and quality
of their lives. Yet, too often such patients’ care focuses
exclusively on one of these goals. The mismatch between
the care that patients want and the care they receive stems,
in part, from the failure of clinicians to discuss patient goals
and preferences in a timely manner. The PONDER-ICU trial
will test the effectiveness of two electronic health record
(EHR) interventions designed to increase intensive care
unit (ICU) clinicians’ engagement of critically ill patients
and caregivers in discussions about alternative treatment
options, including care focused on comfort.
Methods: This pragmatic, stepped-wedge cluster
randomized controlled trial is being conducted in 19 ICUs
of 10 hospitals within the Atrium Health System. Eligible
patients are identified in real time using an EHR-based
algorithm with no research personnel onsite. The EHR will
then automatically trigger the clinician-facing interventions.
ICU clinicians will be required to 1) document a prognostic
estimate of their patients’ functional outcomes at 6 months,
and 2) provide a justification if they choose not to offer
patients the option of comfort-oriented care. We hypothesize
that these simple, scalable interventions will prompt
physicians to reflect more deeply on the most appropriate
care for their patients. The primary outcome is hospital
length of stay, with death ranked as the longest length of
stay. Secondary outcomes include clinical and palliative
care process-related measures
Results: The trial launched in February 2018 and began
collecting control phase data at all 10 hospital sites. To date,
4 hospitals have begun the intervention phase of the trial.
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This work-in-progress presentation will include preliminary
data including rates of clinician adherence, responses to the
interventions, and challenges faced with implementing a
purely EHR-based trial.
Conclusion: The results of this trial hold great potential to
affect clinical practice, as hospitals and payers are highly
motivated to identify best practices that can be broadly
implemented to improve quality while containing costs.
In addition, the simple EHR-based interventions being
tested are highly scalable ─ thereby facilitating adoption by
hospitals and ICUs across the United States if shown to be
effective.
P13.02
Development of Algorithms to Identify Pregnancy
Outcomes From the Electronic Health Record
Kajal Angras,1 Shantel Quinn,1 Dustin Hartzel,1 Grant
Walter,1 A. Dhanya Mackeen1
Geisinger Health, Danville, PA
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Background: Pregnant women are counseled regarding the
risk of adverse outcomes based on prepregnancy body mass
index (BMI). Obesity, defined as BMI greater than or equal
to 30 kg/m2, places women at risk for several complications
such as fetal anomalies, hypertensive disorders of pregnancy,
gestational diabetes, and cesarean delivery. This study’s aim
was to develop algorithms, in addition to the diagnostic
codes, using data from electronic health records (EHR)
for identification of maternal and neonatal adverse risks
outlined by specific prepregnancy BMI classes for a large
retrospective cohort study.
Methods: We first developed a pregnancy algorithm using
the prenatal event from the EHR. Using a combination of
information from ultrasound, smart forms, and flow sheets,
the dataset was then completed for any missing data. After
identifying the total number of pregnant patients, exclusion
criteria were applied using International Classification of
Diseases (ICD) codes. We then extracted data variables that
were readily available such as Apgar scores, birth weight, and
gender of neonate. Prepregnancy BMI was calculated from
heights and weights chosen from the value closest to the start
of the pregnancy date. Outcome variables were identified by
ICD codes and algorithms. Manual chart review was then
conducted to validate the dataset. Adjustments were made to
the algorithms to better capture the outcomes. Re-review of
the charts validated the final algorithms.
Results: We showed that use of rigorous research
methodology for data extraction through the development of
algorithms significantly improved the detection of outcomes.
Relying solely on ICD codes may compromise the accuracy
of the dataset.
Conclusion: Development of algorithms, in addition to the
use of ICD codes, improved the quality of the data for our
large retrospective cohort study.
Supplement
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Perspectives From a Coordinating Center: Lessons
Learned From the Biologics and Biosimilars
Collective Intelligence Consortium
Sarah Malek,1 Katelyn King,1 Cate Lockhart,2 Aaron
Mendelsohn,1,3 Jeffrey Brown1,3
Harvard Pilgrim Health Care Institute, Boston, MA;
2
AMCP Biologics and Biosimilars Collective Intelligence
Consortium, Alexandria, VA; 3Harvard Medical School,
Boston, MA
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Background: The Biologics and Biosimilars Collective
Intelligence Consortium (BBCIC) was established in 2015
to analyze real-world evidence on safety and effectiveness
of biological drugs, including both originator biologics and
biosimilars. Harvard Pilgrim Health Care Institute, a Health
Care Systems Research Network member, has served as the
BBCIC coordinating center since BBCIC inception.
Methods: BBCIC is a multiuse, multisite distributed
research network. It is a nonprofit subsidiary of the Academy
of Managed Care Pharmacy (AMCP), overseen by a separate
board of directors. BBCIC is funded by pharmaceutical
manufacturers and in-kind health plan contributions.
Research plans are developed by a science committee
and approved by a planning board. BBCIC activities are
contracted independently; to date, 8 workgroups have been
formed. All stakeholders can contribute to research through
workgroup participation. BBCIC leverages infrastructure
from the Food and Drug Administration’s Sentinel Initiative,
specifically claims data formatted in the Sentinel Common
Data Model and publicly available analytic tools.
Results: Administratively establishing the network and
individual workgroups required development of statements
of work (SOWs), budgets, contract execution, and
institutional review board submissions for participating
research data partners and additional investigators. Sufficient
time is needed for start-up activities to ensure clarity and
avoid later delays. SOW terminology should be consistent
and deliverables defined. Expectations for dissemination,
including authorship, should be predefined, and a
dissemination process should be established. Infrastructure
leveraging the Sentinel capabilities enabled the BBCIC to
initiate research quickly. However, planning for and having
adequate resources to educate and train stakeholders who
varied in their knowledge of the capabilities of the analytic
tools and data were identified as critical elements to ensure
appropriate and efficient implementation of consortium
research. Workgroups operating multiple concurrent
workgroups required coordination and prioritization. Large
workgroups require detailed workflows to define process
and responsibilities. Smaller workgroups mitigate delays
but must be balanced with the value of incorporating
diverse stakeholder expertise. A central repository to share
documentation and facilitate communication is crucial.
Conclusion: Managing a multiuse, multisite distributed
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research network is complex. Complexity is heightened
with an intricate, yet transparent, governance structure
that includes multiple stakeholders. Responsiveness to
a fluid environment, effective communication, and clear
expectations are essential.
P13.05
Evidence for Nonpharmacologic Treatment for
Chronic Pain: Results and Research Gaps
Andrea Skelly,1 Roger Chou,2 Joseph Dettori,3 Judith
Turner,4 Janna Friedly,4 Sean Rundell,4 Rochelle Fu,2
Erika Brodt,1 Ngoc Wasson,2 Cassandra Winter,1
Aaron Ferguson1
Aggregate Analytics, Inc., Fircrest, WA; 2Oregon Health &
Science University, Portland, OR; 3Spectrum Research, Inc.,
Tacoma, WA; 4University of Washington, Seattle, WA
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Background: Opioids are commonly utilized for chronic
pain management. In 2016, more than 2 million Americans
reported struggling with opioid use disorder and an
estimated 17,087 overdose deaths involving prescription
opioids occurred. Consideration of nonopioid management
alternatives, including nonpharmacologic options, and
assessment of the evidence for them is vital, as is the need to
address evidence gaps.
Methods: Randomized controlled trials of noninvasive,
nonpharmacological treatments for 5 chronic pain conditions
(low back pain, neck pain, fibromyalgia, osteoarthritis, and
tension headache) that reported results for at least 1 month
postintervention were included. Results were summarized
for function and pain and focused on persistence of effects.
Results: A total of 202 trials were included. Interventions
associated with slight to moderate improvement of function
and/or pain for at least 1 month postintervention were 1) for
chronic low back pain: exercise, psychological therapies
(cognitive behavioral therapy), spinal manipulation,
low-level laser therapy, massage, mindfulness-based
stress reduction, yoga, acupuncture, multidisciplinary
rehabilitation; 2) for chronic neck pain: exercise, lowlevel laser, Alexander Technique, acupuncture; 3) for knee
osteoarthritis: exercise, ultrasound; for hip osteoarthritis:
exercise, manual therapies; 4) for fibromyalgia: exercise,
cognitive behavioral therapy, myofascial release, tai chi,
qigong, acupuncture, multidisciplinary rehabilitation;
and 5) for chronic tension headache: spinal manipulation.
The level of supporting evidence varied from condition to
condition. There tended to be more evidence for the effects
of interventions on pain than for function; effects on function
were generally smaller. No evidence suggesting serious
harms was identified. Studies comparing interventions with
pharmacological or active interventions were few. Longterm evidence and data on harms were sparse.
Conclusion: Our findings provide some support for
strategies and policies that focus on nonpharmacological
www.aurora.org/jpcrr
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therapies for specific chronic pain conditions, but evidence
gaps are many. Studies with long-term follow-up that focus
on effect sustainability; use methods to enhance recruitment,
retention, and adherence; employ standardize protocols;
and evaluate comparisons with active interventions are
needed. This project was funded under Contract No.
HHSA290201500009I from the Agency for Healthcare
Research and Quality (AHRQ), U.S. Department of Health
and Human Services (HHS). The authors of this abstract
are responsible for its content. Statements in the abstract
do not necessarily represent the official views of or imply
endorsement by AHRQ or HHS.
P13.06
Demonstrating Impact of Design and Evaluation
Choices on Estimation of Effectiveness of
Transition-of-Care Program
Shruti Vaidya,1 Sylvia Sudat,1 Alice Pressman1
Sutter Health, Walnut Creek, CA
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Background: Health care interventions are frequently
implemented without evaluation in mind. When the time
comes to measure effectiveness, this creates analytical
challenges, and the choices made during the evaluation can
introduce limitations on the interpretation of final results.
We describe the challenges faced during an evaluation of
a hospital-based transition-of-care (TOC) program using
electronic health records (EHR) and show the impact of
these challenges on our ability to effectively evaluate the
program.
Methods: The TOC program was implemented at Sutter
Health, a large health care system in northern California.
We developed EHR-based inclusion/exclusion criteria
to mimic the care team’s process of identifying patient
hospitalizations for intervention. To understand the extent
of disagreement, we compared patient hospitalizations that
actually received an intervention (TOC intervention cohort)
with hospitalizations identified using EHR-based criteria.
We then used a matching algorithm to create controls for 3
treatment cohorts: a cohort identified using only EHR-based
criteria (C-1, n=1,558); a subset of the TOC intervention
cohort that overlaps with EHR-based criteria (C-2, n=375);
and the actual TOC intervention cohort (C-3, n=565).
Results: The cohort identified using EHR-based criteria
captured only 66% of the actual interventions. This
introduced challenges for defining controls post hoc for
valid comparison. Although we could identify matched
controls for 92% of treatment cohort C-1, only 24% of
actual interventions qualified on EHR-based criteria. For
C-2, the matching algorithm identified controls for 89%
of the treatment cohort, but this left out 34% of actual
interventions. Finally, when we considered cohort C-3,
the differences between EHR-based criteria and the actual
intervention cohort became evident, as the matching
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algorithm found controls for only 71% of those treated.
Conclusion: In our study, a lack of agreement between the
EHR-based cohort and actual intervention criteria made a
confident evaluation nearly impossible. Although these TOC
interventions were beneficial to individual patients, we were
unable to demonstrate measurable outcomes due to study
design limitations. We believe that the methods to illustrate
and showcase patient stories and individual patient outcomes
are warranted in situations for which delivering the best
clinical care does not lend itself to rigorous evaluation.
P13.07
Identification of Persons With Disorders of Sex
Development in Electronic Medical Records:
Methodology and Results
Michael Goodman,1 Rebecca Nash,1 Andrew Bradlyn,2
Lee Cromwell,2 Melissa Gardner,3 Darios Getahun,4
Trenton Hoffman,1 Theresa Im,4 Timothy Lash,1 Peter
Lee,5 Brandi Robinson,2 Douglas Roblin,6 Christine
Truong,6 Suma Vupputuri,6 Rami Yacoub,1 David
Sandberg3
Emory University, Atlanta, GA; 2Kaiser Permanente
Georgia, Atlanta, GA; 3University of Michigan, Ann Arbor,
MI; 4Kaiser Permanente Southern California, Pasadena,
CA; 5Pennsylvania State University, University Park, PA;
6
Kaiser Permanente Mid-Atlantic States, Rockville, MD
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Background: The terms “intersex” and “disorders of sex
development” (DSD) refer to a broad and heterogeneous
group of conditions in which development of chromosomal,
gonadal, or anatomic sex is atypical. What constitutes optimal
DSD care is a matter of ongoing debate within and across
various constituencies representing health care providers,
advocacy groups and DSD patients. A direct assessment
of how patients are evaluated, the types of treatments they
receive, and the outcomes of these treatments requires large
longitudinal studies representing the full range of DSD
diagnoses.
Methods: A computer program scanned the electronic
medical record (EMR) from Kaiser Permanente (KP)
Georgia, KP Southern California, and KP Mid-Atlantic
States from January 2006 through December 2017 for 131
potentially relevant diagnostic codes. As some patients
with DSD may not have specific diagnoses documented
in the EMR, we also searched free-text clinical notes for
the presence of 143 keywords that may be indicative of
the conditions of interest. Code and keyword lists were
developed based on consultations with health care providers
and researchers with specific and relevant expertise in
this area; the lists were designed to be broad and included
keywords not necessarily specific to DSD. This was done to
minimize the probability of missing an eligible participant,
but with an understanding that most of the candidates will
turn out to be noneligible on a more detailed record review.
Supplement

Results: Preliminary results from KP Georgia identified a
DSD cohort of 7605 members with at least one diagnostic
code or keyword of interest ─ 6357 of those had keywords
only, and 1248 had both diagnostic codes and keywords.
In contrast, 1313 candidates had diagnoses or keywords
consistent with true DSD after record review. Keywords
alone could contribute 30% of total cohort but consist mostly
of persons with distal hypospadias and bicornuate uterus
(non-DSD). Very few true DSD patients were identified
without diagnostic codes, and none were recently diagnosed.
Additional results of the full cohort will be presented.
Conclusion: The methodology used in this study is relatively
low-cost, rapid, and effective. It will allow the examination
of specific, and sometimes rare, DSD, which have been
difficult to study in the past.

(but not black-white) differences in E-PFI. Based on selfreported survey data, we estimated that of those who were
immunized, approximately 20% of adults 20–34 years old,
15% of those 35-49 years old, 12% of those 50–64 years old,
and 4% of those 65–89 years old were immunized outside
KPNC and would not have EHR documentation.
Conclusion: EHR-based flu immunization prevalence was
significantly lower than survey-based prevalence. Survey
data suggest that without outreach to encourage health
plan members to report out-of-plan flu immunization, EHR
documentation will likely underestimate flu immunization
coverage, especially among adults younger than age 65.

POPULATION, COMMUNITY, AND
WORKSITE HEALTH

Thomas Kottke,1 Jason Gallagher,1 Marcia Lowry,1
Sachin Rauri,1 Juliana Tillema,1 Jeanette Y. Ziegenfuss,1
Nico Pronk,1 Susan Knudson1

P15.01
Comparison of Flu Immunization Prevalence Based
on Electronic Health Records vs Survey Data
Nancy P. Gordon, Ousseny Zerbo
1

1

Division of Research, Kaiser Permanente Northern
California, Oakland, CA
1

Background: Quality reporting for adult flu immunization
may shift from survey-based to electronic health record
(EHR)-based data. We wanted to learn how flu immunization
prevalence (PFI) estimated from a member survey (S-PFI)
compared to PFI based on EHR data (E-PHI) and the extent
to which E-PHI might underestimate actual flu immunization
coverage due to nonreported out-of-plan immunizations.
Methods: We estimated PFI and percentages of immunized
adults, age 20–89 years, who were immunized outside Kaiser
Permanente Northern California (KPNC) using weighted
data from the 2014/2015 KPNC Member Health Survey
(n=15,678). E-PFI for the 2015/2016 flu season was produced
for a cohort of KPNC adults, age 20–89, who were members
from October 2015 to December 2016 (n=2,370,277). S-PFI
and E-PHI were compared for all adults, those 20–64 years
old, 4 age strata (20–34, 35–49, 50–64, 65–89), and those
at “high” (diabetes, prediabetes, heart disease, chronic
obstructive pulmonary disease, asthma, or body mass index
of ≥40) vs “average” risk (none of these conditions). We also
compared E-PFI by race/ethnicity and sex within age strata.
Results: S-PFI was higher than E-PFI for age groups 20–89
(62.8% vs 42.4%), 20–64 (57.6% vs 33.6%), all age strata
(49.7% vs 22.7%, 57.6% vs 32.9%, 65.1% vs 42.8%, 84.2%
vs 72.0%, respectively), and for high (65.6% vs 55.7%) and
average risk (44.1% vs 30.0%) adults less than 65 years of
age. Blacks and Latinos had lower overall E-PFI than whites
and Asians. Age-sex stratification narrowed Latino-white
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The Health and Well-Being of HealthPartners’
English-, Hmong-, and Spanish-Speaking Members

HealthPartners, Minneapolis, MN
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Background: HealthPartners has developed Summary
Measures of Health and Well-Being that comprise current
health, future health, and well-being. Current health is
assessed from claims; the other two components are assessed
by survey. Future health comprises 7 items (tobacco use,
fruits and vegetables, physical activity, alcohol, sleep,
healthy thinking, and preventive services). Our measure of
well-being is response to the question, “How satisfied are
you with your life?” To better meet the health and well-being
needs of its culturally diverse membership, HealthPartners
has surveyed a sample of its adult English, Hmong, and
Spanish speakers and analyzed their claims data to identify
similarities and differences. These observations will be used
to strategically inform program development.
Methods: We analyzed claims and surveys for the following
dates: July 1, 2016, to June 30, 2017, for English and Spanish
speakers; and January 1, 2016, to December 31, 2016, for
Hmong speakers. Survey respondents and response rates
were 7699 (46%) English speakers, 341 (40%) Hmong
speakers, and 871 (49%) Spanish speakers.
Results: The current health score (calculated as 1 – mean
disability-adjusted life years * 100) was 69 for English,
72 for Hmong, and 68 for Spanish speakers. The most
burdensome conditions were musculoskeletal, psychosocial,
and neurologic for all 3 groups. We found that Hmong
members suffer an unusually high burden from stroke. In all
3 groups better nutrition offered the greatest opportunity for
improvement in the future health score, followed by healthy
thinking. While 42%, 41%, and 60% of English-, Hmongand Spanish-speaking respondents reported high levels of
life satisfaction, far more Hmong (26%) reported very low
levels relative to English (13%) and Spanish (9%) speakers.
Conclusion: While there are important differences in
www.aurora.org/jpcrr
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current and future health among the 3 groups and the life
satisfaction data must be interpreted cautiously because of
cultural differences among the respondents, the threats to
current health, the threats to future health, and levels of wellbeing are more similar than different. This finding suggests
that health promoting programs can address the same issues
in all 3 communities. However, interventions must be
tailored to each to be culturally meaningful.
P15.05
Epidemiological Burden of Systemic Sclerosis ─
A Systematic Review
Lixian Zhong,1 Melinda Pope,1 Ye Shen,2 Jose
Hernandez,1 Lin Wu3
Texas A&M University, College Station, TX; 2University of
Georgia, Athens, GA; 3The University of Tennessee Health
Science Center, Memphis, TN
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Background: Systemic sclerosis is a debilitating
autoimmune disease of the connective tissue currently with
no cure. Systemic sclerosis is rare but present throughout the
world. Due to improved clinical awareness and diagnosis,
the prevalence and incidence of systemic sclerosis increased
significantly in the 20th century during the 50s and 90s.
Estimates of prevalence and incidence are challenging due
to the rarity of the disease and the wide spectrum of clinical
manifestations. They are further complicated by different
diagnosis criteria, clinical practice, study design, timing,
etc. This study aimed to assess the recent prevalence and
incidence of systematic sclerosis across the world via a
systematic literature review.
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Methods: Using a systematic search strategy, PubMed/
MEDLINE and Embase were searched to identify relevant
studies published from January 2006 to June 2016. Two
independent reviewers evaluated studies for inclusion
based on inclusion/exclusion criteria and performed
data extraction. The review was conducted and reported
according to Preferred Reporting Items for Systematic
Review and Meta-Analysis (PRISMA) statement.
Results: 1364 references were retrieved using initial
searching strategy, and 20 epidemiological publications
were selected for data extraction following inclusion/
exclusion criteria. The identified studies reported prevalence
ranging from 3.8 per 100,000 in Taiwan to 50 per 100,000 in
the United States. The prevalence was 23 per 100,000 (95%
CI: 16–29 per 100,000; 18 studies) in a pooled sample of
11,574 individuals. Incidence of systemic sclerosis ranges
from 0.77 per 100,000 in the Netherlands to 5.6 per 100,000
in the United States. Systemic sclerosis predominates, with
higher prevalence and incidence rates, in females than in
males. It’s important to note that different methodologies
were used to derive these numbers, so comparisons were
made with caution.
Conclusion: This review provides an updated literature
review on the current estimates of disease prevalence
and incidence of systemic sclerosis in different countries.
The review reports slightly higher incidence/prevalence
compared to previous studies.
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